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ABSTRACT 
Aerobic vaginitis has been implicated in preterm delivery of low birth weight infants. The 
presence of aerobic vaginitis (AV) -associated bacteria such as group B streptococci (GBS) and 
E. faecalis in pregnant women are regarded to be the leading cause of neonatal mortality and 
morbidity world-wide. 
 
The aim of the study was to detect the prevalence of AV and its associated bacteria with preterm 
delivery in the Western Cape, South Africa. Furthermore, it sought particularly to examine and 
investigate the predictive value of GBS and E. faecalis for preterm delivery (PTD). It also aimed 
to establish other factors which may predict adverse pregnancy outcomes. 
 
Three hundred and one pregnant women were recruited from four different antenatal in the 
Western Cape, South Africa. The study conformed with the Declaration of Helsinki (2013). 
Maternal data was collected from a questionnaire and maternal medical records. Vaginal and 
rectal swabs were collected and microscopically examined for AV, followed by culture 
characterization of GBS and E. faecalis. Antimicrobial susceptibility testing was also performed. 
 
In this study, AV was detected in 79 (26.2%) of the 301 pregnant women, and GBS and E. 
faecalis isolated from 50 (16.6%) and 21 (7.0%) respectively.  
 
GBS serotype V was the predominant serotype, followed by serotype III. Pulse field gel 
electrophoresis (PFGE) profile analysis for both GBS and E. faecalis yielded a total of 24 
restrictions profiles for GBS and 16 for E. faecalis. Multivariable analysis revealed that parity, 
gravidity, vaginal discharge, urinary tract infection, and smoking were significantly associated 
with PTD. The results from the study provides improved guidelines maternal screening of 
pregnant women. The early detection of AV-related bacteria may significantly reduce maternal 
and neonatal morbidity. 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
 
1.1. Introduction 
The vaginal microbiota is important for maintaining vaginal health and preventing 
infections of the reproductive tract (Stojanovic et al., 2012). The composition of the 
human vaginal microbiota can be affected by numerous host factors, such as poor 
hygiene, age, diabetes, change in hormone levels, infections, menopause, sexual activity, 
pregnancy and the use of contraceptives or spermicides, plus individual habits such as 
douching (Aila et al., 2009). A number of bacterial species are known to colonize both 
the gastrointestinal and the reproductive tract, and the rectum has been suggested to play 
an essential role as a source or reservoir for organisms that colonize the vagina (Aila et 
al., 2009). The vaginal microbiota of a healthy asymptomatic woman consists of an 
extensive diversity of anaerobic and aerobic bacterial genera and species dominated by 
the microaerophilic, genus Lactobacillus (Donati et al., 2010), known to produce lactic 
acid (reducing the vaginal pH to < 4.5), bacteriocines and hydrogen peroxide (H2O2) 
which inhibit the growth of potentially pathogenic non – acid tolerant microorganisms 
(Mijac et al., 2006; Li et al., 2011; Stojanovic et al., 2012). Amongst these, hydrogen 
peroxide is postulated to have a crucial role in protecting against the overgrowth of 
pathogens in the vagina, since it can be inhibitory to bacteria, fungi, viruses and 
mammalian cells (Mijac et al., 2006), either alone or in combination with halide and 
peroxidise that are present in vaginal secretions (Mijac et al., 2006; Donati et al., 2010). 
In addition, other mechanisms of lactobacilli include surface – binding proteins that 
inhibit adhesion to uroepithelial cells (Stojanovic et al., 2012). 
 
There are a variety of different strains of lactobacilli present in the vagina, the most 
frequent being Lactobacillus jensenii, L. gasseri, L. iners and L.crispatus, and the species 
and relative numbers of species differ according to the population studied (Donati et al., 
2010).  
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Lactobacillus – deficient conditions are believed to be associated with the development 
of several infections such as AV(Aerobic Vaginitis), which in turn promotes the 
transmission of sexually transmitted disease, such as Chlamydia, Syphilis, HIV (Human 
Immunodeficiency Virus), HPV (Human Papilloma Virus), Gonorrhoea and 
Trichomonasis (Donati et. al., 2010; Marconi et al., 2013). An alteration in the balance of 
lactobacilli in the vaginal microbiota has also been associated with bacterial vaginosis 
(BV), a condition which may be differentiated from AV by the lack of inflammation and 
the predominance of anaerobic vaginal species (Donders et al., 2002). 
 
 
1.2. Definition of Aerobic Vaginitis (AV)  
‘Aerobic vaginitis’ is a new vaginal pathology that is neither classifiable as specific 
vaginitis nor as bacterial vaginosis (Donders et al., 2002; Tempera et al., 2004). AV is 
also considered or described as a disruption of lactobacilli, accompanied by signs of 
inflammation and the presence of a rather scarce, mainly aerobic microbiota, composed 
of enteric commersals or pathogens (Donders et. al. 2011; Tansarli et. al, 2013). The 
clinical features which are considered to be associated with AV and BV in regards to the host 
response is specific and clearly different for each individual condition (Donders et al., 
2011). When the vaginal ecosystem is disrupted during AV, the pH increases to >6, with 
a decrease in lactic acid and an increase in inflammatory cytokines such as IL – IB 
(Hemalatha et al., 2012). 
 
AV is caused by the overgrowth of aerobic pathogens including Escherichia coli; Group 
B Streptococcus, Staphylococcus aureus, and Enterococcus faecalis that trigger a 
localized vaginal inflammatory immune response as evidenced by clinical signs and 
symptoms, which includes the presence of vaginal discharge, an elevation of the vaginal 
pH, inflammation with leukocyte infiltration and a marked depletion of healthy 
Lactobacillus species (Donati et. al., 2010; Donders et. al. 2011; MacPhee et al., 2013; 
Tansarli et. al, 2013). AV has been implicated in complications of pregnancy such as 
ascending chorioamnionitis, premature rupture of the membranes and preterm delivery 
(Rabiee et al., 2006; Najmi et al., 2013; Donders et. al. 2011). 
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1.3. Diagnosis of Aerobic Vaginitis (AV) 
AV diagnosis is based on wet mount microscopy (Donders 2007). Aerobic vaginitis is 
diagnosed when vaginal smears are deficient in lactobacilli, positive for cocci or coarse 
bacilli, positive for parabasal epithelial cells, and positive for vaginal leucocytes (plus 
their granular aspect) (Tansarli et. al., 2013). The diagnosis of AV is also based on 
molecular diagnostic methods and microscopic criteria (Table 1) graded as, not present (0 
points), moderate (1 points) or severe (2 points) (Tansarli et. al., 2013; Donders et. al., 
2011). The number of points establishes the composite AV score, with the maximum 
score being 10 (Donders et. al., 2011). Furthermore, comparable to the Nugent score used 
for grading BV, the AV score may be normal or slight, moderate or severe AV (Donders 
et. al., 2011). 
 
 
Table 1: Classification of AV  
Classification Grade Description 
Normal 1 Increased lactobacilli, decreased cocci 
Intermediate  II Corresponds to a diminished Lactobacillary microbiota, mixed 
with other bacteria (Donati et al., 2010). Due to their specific 
link to pathology, this group is further subdivided into different 
groups such as slightly disturbed, fairly normal (LBGIIa) and 
moderately disturbed, rather abnormal (LBGIIb) lactobacillary 
microbiota (Donders et al., 2011). 
Abnormal III Consists of a variety of of other bacteria that has no lactobacilli 
present (Donders et al., 2011). 
 
Studies have shown that the normal and abnormal lactobacillary microbiota are divided 
into three or four types called “Lactobacillary grades” (LBG’s) (Donati et al., 2010). 
Lactobacillary grades (LBGs) are the basis for a composite score to which the following 
four variables have been added.  
a) Proportional number of lactobacilli  
b) The presence of toxic leukocytes  
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c) The presence of parabasal epithelial cells 
d) The type of background microbiota 
 
In this classification, the immune reaction of the host is also taken into account for the 
diagnosis (Donders 2007). Parabasal cells are considered a sign of severe epithelial 
inflammation as they are encounted only in moderated or severe forms of AV such as in 
desquamative inflammatory vaginitis (Donders 2007). 
 
1.4. Treatment for AV 
The paramount approach for treating AV in both pregnant and non-pregnant women is 
unknown.  
Antibiotics may not be adequate for most patients with AV, due to the inflammatory 
component, including leukocytes and parabasal cells (Donders et al., 2011). For this 
reason, the appropriate diagnosis and distinction between these infectious conditions is 
very crucial as their treatment is different; for example, AV does not respond well to 
metronidazole which is commonly used for the treatment of Trichomonas vaginitis (TV) 
and BV (Donders 2007). Clindamycin is therefore considered to be a better choice than 
metronidazole for pregnant women with an abnormal vaginal microbiota. 
 
Optimal treatment includes antibiotics that have little consequence on the normal 
microbiota, usually the Lactobacillus species, while eradicating the Gram-negative 
enteric organisms such as E. coli, and Gram-positive GBS, S. aureus, and E. faecalis 
successfully (Subramaniam et al., 2012; Zarbo et al., 2013). Conventional treatment for 
AV consists of a course of broad-spectrum antibiotics that target anaerobic and aerobic 
bacteria. One such antibiotic or drug of choice is the aminoglycoside, kanamycin, the 
efficacy of which has been demonstrated (Zarbo et al., 2013; Donders et al., 2011). An 
additional antibiotic used for aerobic vaginitis (AV) is the quinolone, moxifloxacin 
(Zarbo et al., 2013). 
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Several studies have shown that the effects of screening and treatment for abnormal 
vaginal flora in order to reduce preterm delivery (PTD) remain controversial (Honda et 
al., 2014).  
 
 
1.5. Aerobic Vaginitis (AV) and its association with pregnancy outcomes 
Pregnancy is considered to be a period in which the vaginal microbiota, conditioned by 
high estrogen levels, have a good supply of glycogen and an elevated proportion of 
lactobacilli, which can surpass 90% of the microorganisms present in the vagina during 
fertile age (Zarbo et al., 2013).  
 
It is suggested that the presence of abnormality in the vaginal microbiota in early 
pregnancy is considered to be one of the most significant risk factors for preterm 
delivery, premature rupture of membranes and low birth weight (Donders et al., 2009; 
Donders et al., 2011).  
 
Other risk factors for spontaneous preterm births include a previous preterm birth, black 
ethnicity, periodontal disease, and low maternal body-mass index (Goldenberg et al., 
2008). In addition, a short cervical length and a raised cervical-vaginal foetal fibronectin 
concentration are considered to be predictors of spontaneous preterm birth (Goldenberg 
et al., 2008).  
 
The prevalence of AV is still largely unknown. Besides the prevalence studies on GBS 
colonization (Rocchetti et al., 2011), which ranges between 7 and 25% in women 
between 35 and 37 weeks of gestation, only sporadic papers have been published on the 
frequency of AV during pregnancy (Donders et al., 2011). Because of the high 
concentrations of circulating estrogens, severe AV, typically with increased numbers of 
parabasal cells, is reported to be infrequent in pregnancy (Donders et al., 2011). 
However, there is a clear indication that, even when asymptomatic, these vaginal 
infections represent a risk factor for preterm delivery (Stojanovic et al., 2012; Honda et 
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al., 2014). However, the mechanism by which abnormal vaginal microbiota results in a 
defined risk for preterm birth remains elusive (Stojanovic et al., 2012). 
 
Not only are the microscopic details different between AV and BV, the local immune 
response elicited in the host is unique in each individual condition (Donders et al., 2011). 
In pregnant women, the concentration of pro-inflammatory cytokines, IL-1b (Interleukin 
– 1b), IL-6 (Interleukin - 6) and IL-8 (Interleukin – 8), are evidently linked to LBG, and 
are inversely proportional to the numbers of lactobacilli (Donders et al., 2011). While IL-
6 and IL-8 are associated with adverse pregnancy outcomes, patients with AV may 
similarly be at increased possibility of having preterm delivery (Donders et al., 2011; 
Donati et al., 2010). Interleukin 1 - b increases significantly more in AV (eight fold 
increase) compared to bacterial vaginosis (BV). IL-6 increases fivefold in those 
diagnosed with AV (Donati et al., 2010; Hemalatha et al., 2012). Previous studies have 
shown that IL-6 is a well recognized marker for bacterial amnionitis and imminent term 
and preterm delivery (Donati et al., 2010). In addition, as a result of the increased 
immune response in AV, symptoms are related to the thinned vaginal mucosa and 
increased inflammatory reaction (Donders et al., 2011). 
 
 
1.6. AV associated bacteria implicated in PTD  
Among the organisms implicated in AV and associated with PTD are Group B 
Streptococci, Group D Streptococci, Staphylococcus aureus and Escherichia coli (Fatemi 
et al., 2009). Perinatal infection causes septicemia, meningitis or pneumonia, which are 
associated with a high mortality (Fatemi et al., 2009; Taminato et al., 2011).  
 
 
1.6.1. Escherichia coli (E. coli) 
One of the most commonly isolated microorganisms in AV is E. coli, frequently isolated 
as the sole organism (Donders et al., 2011). Even though the role of E. coli in vaginitis is 
particularly controversial, it is known to alter the micro – environment (Zarbo et al., 
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2013) and remains one of the most common causes of neonatal sepsis, often being 
recovered from placental tissues in chorioamnionitis (Donders et al., 2011).  
 
The physiologic changes in pregnancy are believed to predispose women to UTI. 
Reduced immunological status during pregnancy may also contribute. In the literature E. 
coli is described as the most common pathogen associated with both symptomatic and 
asymptomatic bacteriuria, accounting for 80 to 90% of infections in pregnant women 
(Schnarr et al., 2008). Other Gram negative bacteria and Group B streptococcus (Schnarr 
et al., 2008) are also reported.  
 
Specific virulence determinants in uropathogenic strains of E. coli are considered to be 
associated with invasive infection and pyelonephritis in pregnancy (Schnarr et al., 2008). 
These are comprised of toxins and adhesions, pili or fimbriae which allow adherence to 
uroepithelial cells preventing bacteria from urinary lavage, and allowing for 
multiplication and tissue invasion (Schnarr et al., 2008). 
 
 
E. coli has more often been reported in women who deliver PTD than full term delivery 
(FTD) (Krohn et al., 1997; McDodald et al., 2000; Cray et al., 2005). Neonates born at 
preterm gestational ages are believed to be more likely to develop neonatal sepsis and 
meningitis caused by E. coli in comparison with neonates born at term (Krohn et al., 
1997). The high rates of E coli infection were also reported in a study by Stoll et al., 
(2011) where the rates of GBS were lower amongst very low birth weight (VLBW) 
infants (5.09 vs 2.08 per 1000 LBs) and infants with a BW of 1501 to 2500 g (0.54 vs 
0.38 per 1000 LBs).  
 
Early onset neonatal sepsis (EOS) remains an uncommon but significant cause of 
morbidity and mortality among the very low birth weight (VLBW) infants (Hornik et al., 
2012; Stoll et al., 2005). Gram-negative organisms such as E. coli continue to be the 
predominant pathogens associated with EOS (Stoll et al., 2005) 
 
 
 
 
 
8 
 
Some studies have reported an emerging trend of E. coli predominating in PTD and in 
early neonatal sepsis following prophylaxis for GBS colonization during pregnancy 
(Baltimore et al., 2001; Hyde et al., 2002; Stoll et al., 2002; Towers et al., 2002; Lin et 
al., 2001; Cordero et al., 2004). EOS caused by E. coli was reported to increase slightly 
by 3.17 to 3.20 episodes per 1000 NICU admissions (Hornik et al., 2012). While most of 
EOS cases were reported to be caused by Gram-negative organisms, Hornik et al., (2012) 
associated LOS with Gram-positive organisms. 
 
Late onset neonatal sepsis (LOS) in the neonate is believed to contribute significantly to 
the morbidity and mortality of hospitalized neonates worldwide (Chu et al., 2012). The 
risk factors for LOS include prematurity, low birth weight, and invasive interventions 
(Chu et al., 2012). A study by Bizzaro et al., (2008) revealed that there were significant 
increases in both EOS and LOS which could be attributed to E. coli. Changes in the 
incidence or antibiotic resistance patterns of E. coli EOS were observed. Increased rate of 
early onset E. coli sepsis was also revealed in a study by Stoll et al., (2011) amongst the 
preterm neonates in particular. A significant increase in ampicillin-resistant E. coli was 
reported with very low birth weight infants while in E. coli LOS no significant change 
was reported (Krohn et al., 1997; Bizzarro et al., 2008).  
 
 
1.6.2. Staphylococcus aureus (S. aureus) 
Staphylococcus aureus is a prominent human pathogen contributing to a variety of 
infections, ranging from mild skin lesions to life - threatening toxic shock syndrome, 
breast abscesses, postoperative infections and menstrual toxic shock syndrome 
(Bourgeois-Nicolaos et al., 2010; Li et al., 2012). In most previous studies it has been 
demonstrated that Staphylococcus aureus infections are increasing among pregnant 
women, postpartum women and neonates, but the risk factors for S. aureus colonization 
in pregnancy and the association between maternal colonization and infant infections are 
not really well defined (Top et al., 2012). The rate of vaginal carriage of S. aureus has 
been reported to be 4% – 22% of the vaginal microbiata of pregnant women (Top et al., 
2012; Bourgeois-Nicolaos et al., 2010). Imperative factors that are considered to increase 
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the risk for neonates due to S. aureus colonization, include breastfeeding, number of 
household members, low birth weight, early gestation age at birth and the duration of 
antibiotic or ventilator days (Seybold et al., 2008; Jimenez - Truque et al., 2012; Lazenby 
et al., 2012).  
 
According to the literature, increased oxygen levels and a neutral pH increases the 
chances of toxic shock syndrome toxin-1 (TSST-1) production (MacPhee et al 2013). 
The production of TSST-1, encoded by the tst gene, is regulated in large part by the agr 
system of S. aureus (Jarraud et al., 2002; MacPhee et al 2013). AV – associated bacteria 
such as E. faecalis are considered to increase tst expression leading to increased 
production of TSST-1 while lactobacilli reduce S. aureus virulence (MacPhee et al 2013). 
S. aureus accounts for > 90 % of late-onset sepsis in neonates. Late-onset sepsis is noted 
to be four times higher in very low birth weight (VLBW) infants (Grass et al., 2013).  
 
The factors that contribute to S. aureus rectovaginal colonization in pregnant women are 
not well understood, but it is believed that being from black race is one of the risk factors 
for MRSA rectovaginal colonization (Andrews et al., 2008; Top et al., 2012). MRSA is 
noted as a significant pathogen in neonatal intensive care units (NICUs) (Seybold et al., 
2008). Community – acquired MRSA infections have been reported to occur in both 
neonates and pregnant women or postpartum women, as a result of vaginal colonization 
of S. aureus during pregnancy (Li et al., 2012). Traditional antibiotic therapy, even 
though highly effective, has led to the emergence of antibiotic-resistant strains, such as 
methicillin resistant S. aureus (MRSA) (Li et al., 2012). Studies report the prevalence of 
methicillin - resistant S. aureus (MRSA) in the range of 0.5% - 10% in infants and 
mothers even though in some areas, higher rates of colonization have been reported 
(Chen et al., 2006; Top et al., 2012; Jimenez – Truque et al., 2012). The literature reveals 
that 1.8% of neonates are MRSA colonized and 16 out of 50 (32%) of these colonized 
neonates went on to develop MRSA infection (Lazenby et al., 2012). 
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1.6.3. Streptococci 
 
1.6.3.1. Lancefield Group D Streptococci (Enterococcus faecalis) 
Lancefield group D Streptococci includes the enterococci-organisms now classified in a 
separate genus from other streptococci and nonenterococcal group D streptococci. Group 
D Enterococci and non-enterococci are part of the genital tract, but are a common cause 
of UT (Urinary tract) infections, subacute bacterial endocarditis, abdominal abscesses, 
and wound infections (Hufnagel et al., 2007; Al-Abbas 2012). The predominance of 
asymptomatic genital tract infection in pregnant women has been widely reported in the 
literature (Akerele et al., 2002), with enterocci causing life threatening infections in 
preterm infants and other immuno-compromised patients, (Hufnagel et al., 2007).  
 
The enterococcal species which are considered to be significant pathogens for humans are 
E. faecalis and E. faecium. These organisms are likely to affect patients who are elderly 
or whose normal microbiota has been altered by antibiotic treatment (Hufnagel et al., 
2007). Furthermore, E. faecalis is associated with 6% mortality rate in early onset 
septicaemia which increases to 15% in late – onset infections, whilst in general it is 
implicated in 7% to 50% of fatal cases (Al-Abbas 2012). 
 
Enterococci, have been previously reported to be harmless inhabitants of the 
gastrointestinal tract flora initially, and has emerged as one of the main causes of health 
care – associated infections (Coombs et al., 2014). Enterococci are believed to be 
difficult to treat because of their intrinsic resistance to antibiotics that notably include 
beta – lactams and aminoglycosides which are frequently used to treat infections with 
Gram-positive cocci (Al-Abbas 2012; Gaca et al., 2012).  
 
An association was found between enterococcal colonization and prematurity (Hufnagel 
et al., 2007). E. faecalis colonization rates were found to be higher in the age groups of < 
32 weeks of gestation (Hufnagel et al., 2007).  
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Seliga-Siwecka et al., (2013) has shown that the presence of E. faecalis in the amniotic 
fluid considerably increases the risk of histological inflammation of the placenta (OR 
10.7, 95% CI 1.27–89.9) and also increases the risk for necrotizing enterocolitis (NEC) 
and bronchopulmonary dysplasia (BPD). 
 
Preterm birth neonates are considered to be more likely to be suffering from necrotizing 
enterocolitis (NEC) than neonates born at term (Wang et al., 2014). NEC is described as 
the most serious gastrointestinal disorder in newborn infants with an incidence of 10 – 
15% in those with very low birth weight (VLBW <1500 g, Normann et al., 2013). 
Neonates who have developed NEC are believed to carry E. faecalis (Wang et al., 2014; 
Normann et al., 2013). 
 
The survival rate of the preterm neonates has improved considerably over the last 20 
years or so even with neonates who are born with VLBW (Thompson et al., 1992). 
However, preterm neonates and those with very low birth weight may require a 
prolonged ventilation and stay in neonatal intensive care units (NICU) (Thompson et al., 
1992). The defense mechanisms of these infants are considered to have been impaired 
against infections putting them at a high risk of nosocomial infection caused by 
microorganisms such as E. faecalis, GBS and S. epidermidis (Thompson et al., 1992). E. 
faecalis is believed to be the leading cause of the nosocomial infections (Gaca et al., 
2012; Thompson et al., 1992). 
 
Serum concentrations of IL-8 were elevated in severe cases of NEC from its onset 
through the first 24 hours (Wang et al., 2014). IL-8 are considered to play a significant 
role in infant infections (Wang et al., 2014). 
 
E. faecalis is described as one of the first colonizers that could suppress the inflammatory 
responses and also shape the immune system of the neonates (Wang et al., 2014). In the 
neonates, the intestines are likely to undergo acute inflammation when exposed to Gram-
negative bacteria (Wang et al., 2014). The presence of E. faecalis is believed to help the 
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intestines maintain the immune balance in response to such challenges (Wang et al., 
2014). However, the therapeutic effects of E. faecalis must be examined thoroughly, 
especially as E. faecalis was reported to be an opportunistic pathogen in hospital 
infections (Wang et al., 2014).  
 
At birth, an infant’s gastrointestinal tract is sterile. However it rapidly becomes colonized 
with organisms from the mother and the local environment, with enterococci and 
members of the family Enterobacteriaceae being the predominant organisms found in the 
stools during the first days of life in full-term infants (Hallstrom et al., 2004; Magne et al., 
2005). In the literature it is also reported that in the preterm neonates, especially those 
with a very low birth weight (weighting less than 1,000 g at birth), bacterial colonization 
and other factors may influence the biodiversity of the intestinal flora and may also be 
considered to increase the risk of gastrointestinal disease such as necrotizing enterocolitis 
(NEC) (Magne et al., 2005). Other factors, include the immaturity of the main crucial 
functions, the mode and environment at which the delivery took place, the feeding 
regimen and the type of drug therapy (i.e. antibiotics, corticoids) (Magne et al., 2005).  
 
Low grade squamous intraepithelial lesion (LS SIL) aerobic vaginitis in women is 
considered to be incredibly common although not believed to be an indicator of human 
papilloma virus (HPV) infection (Jahic et al., 2013). LS SIL and AV were revealed in 9 
cases of E. coli, while 4 had E. faecalis. E. coli was isolated in 3 cases of women who 
had a normal Papinocolaou (PAP smear) (Jahic et al., 2013).  
 
 
1.6.3.2. Group B Streptococci (GBS) 
GBS (also known as Streptococcus agalactiae and referred to as GBS for the remainder 
of this thesis) exists as normal microbiota in the female genital tract and anal areas of 
healthy adults (Uh et al., 1997; Dermer et al., 2004; Stronati et al., 2004; Domelier et al., 
2006; van der Mee-Marquet et al., 2006). However, even though the majority of women 
are unaware of their status, an estimated one out of three women is a carrier of GBS. The 
gastrointestinal tract serves as the natural reservoir for GBS and is expected to be the 
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source of vaginal colonization (O’Reilly et al., 1998; Dermer et al., 2004; Najmi et al., 
2013).  
 
Women who are colonized with GBS might develop infections associated with pregnancy 
including urinary tract infection, bacteremia, chorioamnionitis, postpartum endometritis 
(Campbell et al., 2000; Najmi et al., 2013; Milyani et al., 2011; Konikkara et al., 2013). 
Intrauterine infection has been associated with the ability of GBS to ascend from the 
lower genital tract (LGT) and colonize the upper genital tract (UGT) (Rocchetti et al., 
2011, Zhou et al., 2010; Romero et al., 2003). 
 
Pregnant women may express signs and symptoms of GBS colonization during gestation 
as well as during labour (Rallu et al 2006), increasing the risk of preterm labour (PTL), 
preterm prelabour rupture of membranes (PPROM) and perinatal transmission of the 
organism (Varma et al., 2006; Hiller et al., 2005; Maghaddam 2010).  
 
GBS has significant occurrence in septicaemia in elderly individuals and 
immunocompromised patients (Kong et al., 2002; Hajare et al., 2012) and emerged in the 
1960s as a significant human pathogen that caused neonatal sepsis and meningitis 
(Bohnsack et al., 2008; Domelier et al., 2006; Ramaswamy et al., 2006).  
 
In the newborn, GBS infection is divided into two diverse types, viz congenital and 
acquired (Rabiee et al., 2006; Baltimore 2007), and remains the foremost cause of 
neonatal mortality and morbidity in the world despite a recent decline in occurrence 
(Bohnsack et al., 2008; Li et al., 2006; Bergeron et al., 2004; Tsolia et al., 2003; 
Konikkara et al., 2013).  
 
In neonates and infants, GBS disease is defined as either early-onset disease (EOD, age, 
0-6 days) or late-onset disease (LOD, age, 7 to 90 days) (Martins et al., 2007; Mhaskar et 
al., 2005; Konikkara et al., 2013). EOD is associated with the presence of GBS in the 
vagina of the mother, and transmission is thought to take place vertically through 
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aspiration of infected amniotic fluid or passage through the birth canal (Martins et al., 
2007). 
 
Colonization of GBS in pregnant women is the single principal risk factor for early-onset 
newborn diseases (EOD) caused by vertical transmission and colonization of the infant 
during delivery (Bergseng et al., 2007; Rallu et al 2006). Intrapartum colonization is 
strongly associated with early onset GBS sepsis resulting in approximately 4% of the 
fatalities and serious morbidities that include sepsis, pneumonia, meningitis, illness and 
death in infants, but also long - term disabilities such as loss of hearing, impaired vision, 
developmental problems, cerebral palsy, osteomyelitis and septic arthritis (Rabiee et al., 
2006; Bergeron et al., 2004).  
 
Well-established risk factors for early-onset invasive GBS in newborns are rupture of 
membranes for more than 18 h before delivery, fever in the mother during labour, 
preterm delivery and a history of GBS disease in previous infants (Bergh et al., 2004; 
Bergseng et al., 2007; Rabiee et al., 2006). 
 
The source of bacterial strains causing late-onset disease (LOD) is less well understood 
and may involve community or nosocomial acquisition (Martins et al., 2007). However, 
there is evidence that in several infants with LOD, the GBS causing the infection share 
identical serotypes as the GBS isolated from their mothers, suggesting a maternal source 
(Martins et al., 2007; Konikkara et al., 2013).  
 
 
1.7. Justification of the study 
This study will provide valuable data which can be used in determining neonatal diseases 
by establishing the prevalence of AV amongst women of childbearing age, and 
identifying disparities that may exist between the different ethnic groups within the 
Western Cape, South Africa. The results obtained from this study could also possibly 
lead to the development of intervention programmes to target specific population groups, 
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to decrease vertical transmission of AV-associated bacteria from the mother to the 
neonate.  
 
In brief, this study will evaluate risk factors including the prevalence of AV, maternal 
demography and particularly, a history of previous preterm delivery as predictors of 
pregnancy outcomes in a population from the Western Cape. This study will also aid in 
the increased public awareness of AV and may inform the screening based prevention 
protocol within our communities, this reducing the treatment costs incurred for infants 
with EOD and LOD.  
 
1. 8. Null hypothesis 
Endogenous bacteria are not risk factors for adverse pregnancy outcomes. 
 
1.8.1. Objectives 
 
1.8.1. Objectives of this study: 
 
 To detect the prevalence of AV. 
 
 To identify and characterize the predominant facultative anaerobes implicated in 
AV. 
 
 To examine and investigate the predictive value of AV-associated GBS and E. 
faecalis in PTD 
 
 To establish whether maternal demography and reproductive history may predict 
current pregnancy outcomes. 
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CHAPTER 2: MATERIALS AND METHODS 
 
 
2. 1. Study population 
Patients were recruited from four Maternity Obstetric Units (MOU) in the Western Cape, 
South Africa. These were located in Mowbray, Mitchells Plain, Guguletu and 
Khayelitsha. The participants were from lower socioeconomic groups representative of 
four different ethnic groups. The Mowbray (MOU) serves as referral to communities of 
black and coloured ethnic groups, whereas Guguletu and Khayelitsha serve members 
predominantly from the black ethnic group and Mitchells Plain clinics serve 
predominantly the coloured ethnic group. 
 
 
2.2. Ethical consideration 
Participants were randomly recruited. The content and objectives of the study were 
explained and informed consent was obtained from all participants. Ethics approval for 
this study was obtained from the human ethics committee of the University of the 
Western Cape (UWC). The study complied with the declaration of Helsinki (2013).  
 
 
2.3. Patient Data collection 
After obtaining written informed consent, data were collected by means of a standard 
structured questionnaire (see appendix 2 A) designed to obtain socio - demographic data 
and other relevant information. This included information such as maternal age, 
gestational age, previous obstetric history, history of current pregnancy, parity, marital 
status, mode of delivery, and neonatal birth weight of previous deliveries (see appendix 2 
A). All 301 pregnant women received and completed the questionnaires. The women 
were recruited from the four MOU metioned aboved (Mowbray, Mitchells Plain, 
Guguletu and Khayelitsha). The women were not interviewed during labour nor after 
delivery.  
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2.4. Sample collection  
Samples were collected from 301 women at 28 to 37 weeks of gestation (Fig.1) (see 
appendix 2 D). A modification of the sample collection procedure described by Uh et al 
(1997) was used.  
 
Women who had received antibiotic therapy two weeks prior to recruitment were not 
included in the study.  
 
A vaginal and anorectal swab were collected from each patient (Bergeron et al., 2000) 
using sterile cotton-tipped swabs and transported to the laboratory in liquid Amies with 
charcoal medium (Sterilin, 18114CST, Italy).  
 
 
2.5. Criteria used for the microscopic diagnosis of AV 
A guideline was established in order to characterize the presence and severity of AV 
(Donders et al., 2009; Donders et al., 2011). This was based on Nugent scoring methods 
used for BV determination, employing a Gram – stained microscopic assessment that 
numerated specific bacterial morphotypes (Donders et al., 2011). The “AV” score, was 
calculated using high – power field light microscopy to evaluate the presence or absence 
of lactobacilli, leukocytes, (including toxic leukocytes) other vaginal flora and parabasal 
epithelial cells (Donders et al., 2009; Donders et al., 2011). The presence of healthy 
Gram–positive lactobacilli were compared to the presence of aerobic or facultative 
anaerobic Gram–positive cocci (such as Streptococci, Staphylococci, or Enterococcus) 
and Gram-negative bacilli ,such as Klebsiella species and E. coli  (Donders et al., 2009). 
 
Table 2 shows the scoring criteria for AV. Lactobacillary grades (LBG) I, consisted of 
numerous pleomorphic lactobacilli and no other bacteria; LBG IIa, showed a mixed 
microbiota, but predominantly lactobacilli; LBG IIb, was also a mixed microbiota, but 
the percentage of lactobacilli was severely decreased as a result of an increased number 
of other bacteria; whilst, LBG III, lactobacilli were considered to be severely depressed 
or absent because of the overgrowth of other bacteria.  
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AV score: <3, no signs of aerobic vaginitis (AV); 3 or 4, slight AV; 5 or 6, moderate AV; 
≥6, severe AV (Donders et al., 2011).  
 
 
Table 2: Microscopic diagnosis criteria for AV (Donders et. al., 2011) 
AV 
score 
Lactobacillary 
grades (LBG) 
Number of leukocytes Proportion of toxic 
leukocytes 
Background flora Proportion of 
parabasal 
epitheliocytes 
(PBC) 
      
0 I and IIa ≤ 10 / hpf None or sporadic Unremarkable or 
cytolysis 
None or <1% 
1 IIb > 10 / hpf and  
≤ 10 / epithelial cell 
≤ 50 % of leukocytes Small coliform bacilli ≤ 10% 
2 III > 10 / epithelial cell > 50% of leukocytes  Cocci or chains > 10% 
Lactobacillary grates (LBG); parabasal epitheliocytes (PBC); high – power field (hpf) (400X magnification).  
 
 
2.6. Sample processing 
Swabs were inoculated onto enriched blood agar (Colistin nalidixic agar, Becton 
Dickinson, Catalog number 63954, Bio-Rad Laboratories and MacConkey agar (Catalog 
number CM0109B, Oxoid, Basingstoke, Hampshire, England) and incubated at 37ºC for 
24 h. Plates showing no growth were incubated for another 24 h before being declared as 
negative for growth. After Gram - staining and agar inoculation, swabs were incubated in 
enriched broth (Todd-Hewitt Broth; Catalog number T1438, Sigma Aldrich, 
Deisenhofen, Germany) and GNS broth for 24 h at 37ºC to ensure recovery of suspected 
pathogens. GNS broth (Gentamicin Nalidixic Supplement), is a standard selective broth 
medium that consists of Todd–Hewitt broth supplemented with gentamicin (8 µg per 
milliliter) and nalidixic acid (15 µg per milliliter) (Bergeron et al., 2004).  
 
Bacterial suspensions were smeared onto a glass slide, fixed and stained according to 
Kopeloff’s modification of the Gram stain (Libman et al., 2006). Bacterial morphology 
was microscopically observed by light microscopy and recorded. Gram-positive cocci 
and Gram–negative bacilli were further identified as described in the following sections. 
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2.7. Identification of Gram–negative bacilli 
MacConkey agar allowed for the growth and differentiation between lactose fermenters 
and non-lactose fermenters. Lactose – fermenting colonies appeared pink on the 
MacConkey agar and were picked for further identification using the API 20E test API 20 
E test kit (BioMerieux ®SA, Marcyl; Etoile - France; Ref 20 160). 
 
A fresh culture for the API 20 E test was prepared by culturing fresh colonies from 
MacConkey grown overnight at 37
o
C for 24 h in a sterile glass tube containing 5 ml 
saline. Post incubation, the suspension was pipetted into API 20E strip (BioMerieux ® 
SA, Marcyl; Etoile - France; Ref 20 160) according to the manufacturer’s instructions.  
 
 
2.7. 1. Inoculation and incubation of the API strip  
In order to make it easier to transfer the bacterial suspension to the API 20 E strip, 
thereby avoiding creating bubbles, the strip was held at a slight angle from the bench, 
placed on the chamber top to hold it up - right and the bacterial suspension pipetted into 
each well using a sterile pipette. Care was taken to ensure that the end of pipette touched 
the side of the well, allowing for the fluid to be drawn into the well while slowly 
squeezing the bulb. The vials containing CIT, VP, and GEL wells were each filled to the 
top with the suspension, while for LDC, ODC, ADH, H2S, and URE (Table 3) wells, 
each was filled with half the suspension and the other half with sterile mineral oil.  
 
 
Prior to starting the test, the small indented wells in the bottom of the incubation chamber 
were filled with 5 ml of sterile water. The API 20 E strip was placed into this bottom 
chamber tray and the cover labeled with the sample number and the date. The strip was 
incubated at 37ºC for 24 h.  
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Table 3: Abbreviations used for API 20 E Strip Test 
Abbreviations Full name 
ADH Arginine Dihydrolase 
CIT Citrate 
GEL Gelatin 
IND Indole 
GLU Glucose 
H2S Hydrogen sulfide 
LDC Lysine Decarboxillase 
ODC Omithine Decarboxillase 
TDA Tryptophane Deaminase 
URE Urea 
VP Pyruvate 
 
 
2.7. 2. Reading and interpretation of the API 20 E Strip:  
After overnight incubation, the strip was examined for at least 3 or more positive tests 
before proceeding with the adding of the specific reagents to the test wells. The results 
were interpreted according to the manufacturer’s instructions. A pink colour following 
the addition of one drop of James agent (BioMerieux ®SA, Marcyl; Etoile - France; Ref 
70 542) indicated a positive indole (IND) after 1 min. One drop of TDA reagent was 
added to the TDA test and after 1 min a red colour indicated a positive result. Two drops 
of each of VP 1 and VP 2 reagents were added to the VP test, and allowed to stand for 10 
min at room temperature. A red colour indicated positive and yellow indicated negative 
results. Lastly, a yellow reaction was considered to be positive results for GLU glucose 
fermentation and blue or green was negative. Two drops of each nitrite test reagent was 
added to the GLU tube, and the reaction observed. A positive red result observed within 3 
min, indicated nitrate reduction.  
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2.8. Identification of Gram–positive cocci 
 
2.8. 1. Catalase test 
The test was performed in order to differentiate between staphylococci and streptococci. 
The principle of the catalase test is that the enzyme, catalase acts as a catalyst by 
converting 3% hydrogen peroxide (H2O2) into oxygen and water, resulting in immediate 
bubbling. A single colony taken from 5% sheep blood agar plate grown overnight at 37°C 
was transferred to a slide and mixed to a smooth suspension in saline. A hundred 
microliters (100 µl) of 3% hydrogen peroxide (H2O2) was added to the suspension. 
Effervescence indicated a positive catalase test (i.e. Staphylococcus) and the absence of 
effervescence indicated a negative catalase result i.e. Streptococcus and Enterococcus 
(Fig. 1). 
 
 
2.8. 2. Identification of Catalase+ve cocci 
The DNAse plate (Catalog number CM0321, Oxoid, Basingstoke, Hampshire, England) 
was used to differentiate between Staphylococcus aureus and Staphylococcus 
epidermidis. The DNAse test is used for detecting deoxyribonuclease activity of bacteria 
and particularly for identification of pathogenic Staphylococcus aureus which produces 
deoxyribonuclease (DNA - ase) enzymes (Reynolds 2011). The DNAse plate was 
inoculated by spotting or streaking a heavy inoculum of test organism. The plates were 
incubated at 37°C for 24 h. After 24 h incubation, the plates were flooded with 1 N HCl. 
A zone of clearing around the spot or streak organisms indicated DNAse activity 
(Staphylococcus aureus).  
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2.8. 3. Identification of Catalase–ve cocci  
 
Lancefield Grouping  
A latex slide agglutination grouping kit (Catalog number DR0585A, Oxoid, Basingstoke, 
Hampshire, England) was used to classify catalase–negative Gram-positive cocci into 
Lancefield groups. Grouping is dependent on the carbohydrate contained in the cell wall 
of the G+C. Depending on the Lancefield serology, species were further identified with 
confirmatory tests.  
 
2.8.3. 1. GBS typing 
Isolates producing a positive Lancefield grouping of B were further serotyped using 
Hemolytic Streptococcus Group B typing sera (Catalog number SSI-LATX-54985/7; 
Statens Serum Institut, Denmark) for the identification of the capsular polysaccharide 
antigens Ia, Ib, II, III, IV, V, VI, VII VIII and IX, according to the manufacturer’s 
instructions.  
 
Briefly, a colony of GBS was incubated overnight in 5 ml of THB (Todd-Hewitt broth). 
Approximately 10 µl of the bacterial suspension was added to the latex suspension on the 
circle card and thoroughly mixed using a sterile stick. The slide was rocked back and 
forth for a few seconds and examined for agglutination within 5 – 10 seconds. 
Agglutination tests were carried out on ten antisera (Ia, Ib, II-IX). Any agglutination after 
30 seconds was not considered to be a positive reaction. If no designation could be made, 
the isolate was then determined to be non-typeable.  
 
 
2.8.3. 2. Christie Atkins Munch-Petersen (CAMP) Test for GBS 
The CAMP test was performed to aid with the identification of GBS. GBS are able to 
produce CAMP factor (a diffusible extracellular protein) that synergistically acts with 
beta-lysin of Staphylococcus aureus (S. aureus) and enhances the lysis of red blood cells. 
 
 
 
 
 
23 
 
A known GBS strain served as a positive control. The CAMP test was performed on 
Columbia agar plate containing 5% sheep blood. A toxin - producing S. aureus was 
inoculated diagonally on to a sheep blood agar plate. A single colony of the beta 
hemolytic streptococci from overnight culture was streaked perpendicularly 
approximately 2 mm spaces away from S. aureus without touching. The inoculated plates 
were incubated anaerobically at 37ºC overnight.  
 
The isolates were considered to be GBS if they produced an enhancement of haemolysis 
in the form of a distinct arrowhead shape at 1 to 2 mm from the S. aureus, with the widest 
portion of the arrowhead on the GBS side.  
 
 
2.8.3. 3. Hippurate Test for GBS 
The hippurate test was used to detect the enzyme hippurate hydrolase which hydrolyzes 
sodium hippurate to form benzoic acid and glycine. The addition of ferric chloride to 
benzoic acid forms an insoluble brown ferric benzoate precipitate. The hippurate broth 
was inoculated with the fresh culture and the broth was then incubated for 24 h at 37ºC. 
Post incubation, the tube of broth was centrifuged for 20 min to sediment the bacteria. 
Clear supernatant (800 µl) was transferred to a 1.5 ml Eppendorf tube or small clear tube 
before adding 200 µl of ferric chloride reagent and thoroughly mixing. A positive test 
was indicated by a heavy precipitation that didn’t clear within 10 min. A clear golden-
brown liquid indicated a negative test.  
 
 
2.8.3. 4. Bacitracin Sensitivity Test for GBS 
All beta hemolytic colonies on CNA were tested for Bacitracin (0.04 units) sensitivity 
(Catalog number X3484D, Oxoid, Basingstoke, Hampshire, England).  
 
The bacitracin test was performed in order to differentiate between GBS and S. pyogenes 
(GAS). Fresh culture suspensions (100 µl for each individual isolate) were evenly spread 
on Mueller-Hinton agar plates containing 5% sheep blood. The plates were anaerobically 
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incubated at 37ºC overnight. A negative (resistant) test was indicated by no zone of 
inhibition around the bacitracin disc while susceptibility was indicated by the appearance 
of a zone of inhibition.  
 
 
2.8.3. 5. Enterococcus  
Confirmatory tests for Enterococcus faecalis included:  
I. Colonial morphology on blood agar and MacConkey agar. On blood agar, 
Enterococcus appears as a pale, non – haemolytic colony. While on MacConkey 
agar, E faecalis appears as tiny magenta – coloured colonies.  
II. Bile Esculin Agar slants for Enterococcus 
The bile esculin test was performed to aid with the differention of GBS from the 
Enterococcus, by demonstrating the ability of Enterococcus to hydrolyze esculin in the 
presence of bile. Using a sterile loop, a colony from a pure overnight culture was 
transferred to the bile esculin slant (Lot 7H2418, F92430, Bio-Rad, Marnes-la-Coquette). 
The tubes were incubated anaerobically for 18 h at 37ºC. The tube was examined for 
definite blackening of the agar indicating a positive test. No colour change in the agar 
indicated a negative test. 
 
 
2.9. Antimicrobial susceptibility  
 
2.9. 1. Kirby-Bauer Method 
The antimicrobial susceptibility test was based on the procedure described by Lopardo et 
al (2003). Isolates were tested for antibiotic sensitivity by performing the Kirby-Bauer 
disk diffusion method according to the Clinical Laboratory Standards Institute (CLSI) 
guidelines. Pure colonies from each individual isolate from 5% sheep blood agar plates 
containing CNA were suspended in 5 ml of saline. The inoculum was adjusted to the 
turbidity of a 0.5 McFarland standard. Fresh culture suspensions (100 µl) were evenly 
spread on the Mueller-Hinton agar plates containing 5% sheep blood. The following eight 
antibiotics were tested viz., Penicillin G (PG) 1 Unit; Clindamycin (CD) 2 µg; 
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Gentamicin (GM) 10 µg; Fusidic Acid (FC) 10 µg; Erythromycin (E) 5 µg; 
Trimethroprin (TM) 1.25 µg; Sulphamethoxazole (SMX) 25 µg; Tetracycline (T) 10 µg. 
Discs were placed on Mueller-Hinton agar streaked plates containing 5% sheep blood. 
Plates were anaerobically incubated at 37ºC overnight. Strains were considered resistant 
or susceptible to each individual antibiotic when the inhibition zones from the individual 
plates were interpreted. The zones of inhibition were measured from the edge of the disk 
to the edge of the inhibition zone using a ruler and reported as sensitive. Cultures 
showing no zones of inhibition were interpreted as resistant.  
 
 
2.9. 2. Sensititer trek system  
A fresh culture for the TREK system (Thermo, Scientific, Waltham, MA, USA) was 
prepared by culturing fresh colonies grown overnight at 37
o
C for 24 h. The inoculum was 
prepared by the direct colony suspension: colonies grown overnight on CNA agar with 
5% sheep blood were suspended in sterile glass tubes containing PBS. For the Gram-
negative isolates, the inoculum was prepared using colonies grown on MacConkey agar 
plates. The suspension was vortexed for 20 s adjusted to a 0.5 McFarland turbidity 
standard and read on the nephelometer (12 V DC. 1.25A: SN 437R03n098). Each PBS 
tube containing the suspension was vortexed for further 10 s and left to stand for 15 min 
at room temperature. One hundred microliters (100 µl) of the suspension from the top 
third of the tube was transferred and dispersed in the Mueller-Hinton Broth with 
TES/Lysed Horse Blood. Tubes were inverted and vortexed for a further 20 s. The 
inoculated tubes were again inverted and the suspension dispensed into a sterile petri dish 
lid. Using a multichannel pipette, 100 µl aliquotes of the suspension were delivered into 
the Trek microtiter plate (Catalog number STP6F, Trek Diagnostic System Inc, 982 
Keynote Circle, Suite 6, Cleveland, OH 44131), the plate sealed with the film supplied 
and the plate incubated at 37
o
C for 24 h. The Trek microtiter plates were placed into the 
Vizion Trek Diagnostic System (Magellan Biosciences; Model NO. 436 – A; Serial No. 
436/VR02N82) for reading.  
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The breakpoints were defined by the Clinical and Laboratory Standards Institute (CLSI); 
when breakpoints were unknown, breakpoints for comparable drugs or comparable 
microorganisms were taken. Quality control was performed using American Type 
Culture Collection (ATCC) strains as controls. 
 
 
2. 10. Molecular biology  
 
2.10. 1. Isolation of DNA 
DNA isolation was based on a procedure described by Sambrook et al., (2001). DNA 
extraction was carried out for all samples collected. Total genomic DNA was extracted 
from vaginal and rectal swabs as follows: A standard loop of Group B streptococci was 
inoculated into 5 ml of Todd Hewitt broth and grown for 24 h at 37ºC. The culture (1.5 
ml) was transferred to a 2.0 ml Eppendorf tube and centrifuged at 4000 x g for 2 min 
using a microcentrifuge (Geratebau Eppendorf Centrifuge GmbH, 04436 Engelsdorf, No. 
5415 C 65232, Germany). In some cases, centrifugation was carried out until a visible 
pellet was observed. The supernatant was discarded and the pellet resuspended in 567 µl 
buffer by repeated pipetting. Afterwards 20% SDS (30 µl) and 20 mg/ml protease K (6 
µl) were added. The samples were mixed thoroughly by inverting and incubated for 1 h at 
37ºC. Thereafter, 5 M NaCl (100 µl) was added and thoroughly mixed, followed by 
incubation for 2 min at 65ºC and the addition of 80 µl CTAB/NaCl (10% CTAB, 
hexadecylytrimethyl ammonium bromide; 0.7M NaCl, sodium chloride). The samples 
were mixed thoroughly and then incubated for 10 min at 65ºC. The suspension was 
extracted with an equal volume (700 µl) of chloroform/isoamyl alcohol (24:1) solution, 
mixed thoroughly and then centrifuged at 10,000 x g for 5 min. This step was done in 
order to remove the CTAB-protein/polysaccharide complexes. The upper aqueous phase 
was transferred to a new 2.0 ml Eppendorf tube and an equal volume (700 µl) of 
phenol/chloroform/isoamyl alcohol (25:24:1) added. After thoroughly mixing, the tube 
was centrifuged at 15,000 x g for 5 min and the supernatant or upper (aqueous) phase 
containing nucleic acid was transferred to a new 2.0 ml Eppendorf tube. Isopropanol (0.6 
volumes) was added to precipitate the DNA. After thoroughly mixing, the solution was 
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allowed to stand for 15 min to allow for precipitation before centrifugation at 12,000 x g 
for 15 min resulted in a visible pellet. The pellet was washed with 500 µl of 70% ethanol 
and then centrifuged for 5 min after being thoroughly mixed by inverting. The 
supernatant was carefully removed. The pellet was air-dried and finally resuspended in 
100 µl of TE buffer. The DNA concentration (calculated as OD260nm x 50ng/μl) and 
purity (ratio OD260nm/ OD280nm) was determined by using the spectrophotometer 
(Thermo Scientific Nanodrop 2000/2000C) and the purity determined by electrophoresis 
on a 1% agarose gel at 100 volts for 1 h. The genomic DNA was used for the PCR assay. 
 
 
2.10. 2. Agarose gel electrophoresis 
DNA extracts were separated in 0.8% (w/v) agarose gels and PCR products in 1% (w/v) 
agarose gels using 0.5 x TBE buffer (Sambrook et al., 2001). Samples were prepared by 
mixing with loading buffer 1x (0.2 ml/ml glycerol and 5 mg/ml bromophenol). 
Electrophoresis was performed in 0.5 x TBE buffer at 100 V. Ethidium bromide (0.5 
µg/ml) was added to the agarose gel during the preparation for the staining procedure. 
The DNA fragments were sized according to their migration in the gel compared to the 
DNA molecular weight markers (λ Pst1 DNA restriction fragments, Catalog no.Fe-
SM0361, and FE-SM0613 O’RangeRuler 50 bp DNA Ladder, Fermentas, Inc). The gels 
were analyzed with the Doc-ItLS® Image Acquisition Software, Version 5.5.5a (Doc-It 
Life Sciences Software, UVP™, Inc., San Gabriel, USA). The gels were visualized using 
ultraviolet (UV) illumination (UVP™, Inc., San Gabriel, CA 91778, USA). 
 
 
2.10. 3. DNA Amplification by Polymerase Chain Reaction (PCR) 
Pairs of primers (Table 4) were designed for the PCR amplification of the universal 
bacterial and GBS-specific 16S rRNA genes. A standard 50 µl PCR reaction solution 
contained 1 x PCR amplification buffer (10 x buffer being 200 mM Tris pH 7.6, 100 mM 
KCL, 100 mM (NH4)2 SO4, 20 mM MgSO4, 1% (w/v) Triton X- 100), 0.2 mM each of 
dATP, dCTP, dGTP and dTTP, 0.5 µM of each primer, 1U of Taq DNA polymerase, and 
10 ng template DNA.  
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A total of 30 cycles were run under the following conditions after the initial heating step 
of 94ºC for 4 min: denaturing at 94ºC for 30 s, primer annealing at 50ºC for 30 s and 
extension 72ºC for 1 min 30 s and final extension at 72ºC for 10 min. The universal 
bacterial 16S rRNA gene primer pair of E9F (McInerney et al., 1995) and U1510R 
(Reysenbach et al., 1995) was used to amplify the nearly complete 16S rRNA gene from 
the majority of bacterial organisms (Baker et al., 2003). Amplified products were 
separated on 0.8% agarose gels using electrophoresis in 0.5 x TBE buffer. The products 
were stained with ethidium bromide and visualized under UV using a transilluminator. 
 
The pair of GBS specific primers, Sag 40 and Sag 445, was used for PCR amplification 
under the following conditions: A pre – PCR step was use at 94ºC for 2 min. Initial 
denaturation at 94ºC for 45 s followed by 35 cycles of three temperature cycles involving 
denaturation at 95ºC for 30 s, annealing at 60ºC for 1 min, extension at 72ºC for 2 min. 
This was followed by a final extension at 72ºC for 10 min. The presence of each PCR 
product was then verified using electrophoresis in 1% agarose gel and stained with 
ethidium bromide. 
 
 
Table 4: Oligonucleotide specific primers used in this study for the amplification of the 
universal bacterial and GBS specific 16S rRNA genes. 
Primers  Nucleotide sequences (5’-3’) Position (16S 
rRNA gene) 
Annealing 
temp. 
Specificity References 
E9F GAGTTTGATCCTGGCTCAG 9-27 50ºC Universal McInerney et al., 1995 
U1510R GGTTACCTTGTTACGACTT 1510-1492 50ºC Universal Reysenbach et al., 1995 
      
Sag 40 CGCTGAGGTTTGTGTTTACA 40-61 60ºC Bacteria Riffon et al., 2001 
Sag 445 CACTCCTACCAACGTTCTTC 445-465 60ºC Bacteria Riffon et al.,2001 
 
 
DNA molecular analysis such as pulsed-field gel electrophoresis (PFGE), PCR-based 
typing methods, and sequence analysis were used to determine molecular relatedness of 
isolates for epidemiologic investigation. 
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2.10. 4. Pulse Field Gel electrophoresis (PFGE) 
A PFGE method was based on a procedure described by Manning et al, (2005). Contour 
clamp homogenous electric field (CHEF) gel electrophoresis is a molecular technique 
used to separate large, restricted DNA fragments (>30kb) (Benson et al., 2002). The 
bacterial DNA is embedded in agarose, and cell lysis and DNA restriction occurs in situ. 
This prevents DNA shearing. The restricted fragments are separated on an agarose gel 
matrix by alternating the electric fields for optimal separation of large DNA fragments. 
The CHEF gel electrophoresis is traditionally used for molecular typing in medical 
epidemiology. In this particular study, the technique was used to determine the 
relatedness amongst the GBS strains. 
 
 
2.10.4.1. Preparation of unsheared DNA 
Two to three colonies of GBS from pure cultures were picked and incubated in 5 ml of 
Todd Hewitt broth for 24 h at 37°C. The microorganisms were suspended in TE buffer 
(10 mM NaCl, 1 mM EDTA, pH 8.0) to a turbidity equivalent to 2.5 McFarland or 0.27 
Absorbance. Four hundred microliters (400 µl) of this suspension was pipetted into a 
separate microcentrifuge tube, then 20 µl Lysozyme/Lysostaphin (20 mg/ml) was added 
to the suspension before being incubated in water bath at 56-60ºC for 15 min. Twenty 
microliters (20 µl) Proteinase K (20 mg/ml) and 400 µl of embedding 1% agarose was 
added to each individual sample (cell suspension) and carefully mixed. The suspension 
(100 µl) was immediately transferred into one well of the plug mold avoiding creating 
any air bubbles. The agarose was allowed to solidify for 15-20 min at room temperature. 
The plugs were transferred into sterile 15 ml tubes containing 5 ml of Lysis buffer (50 
mM Tris: 50 mM EDTA, pH 8.0 + 1% Sarcosyl) and 25 µl of Proteinase K (20 mg/ml). 
The plugs were thoroughly mixed by inversion. The plugs were incubated overnight (16-
20 hrs) at 50ºC without agitation. The Lysis buffer was removed using a pipette and the 
plugs washed with approximately 5 ml of sterile water for 15 min at 50ºC in water bath 
(repeat twice). Thereafter, the plugs were washed again four times in 5 ml TE buffer (10 
mM Tris: 1 mM EDTA, pH 8.0) for 15 min at 50ºC in water bath without agitation. The 
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plugs were stored for 3-6 months at 4ºC in 1 x TE buffer for later use (the plugs should be 
stable). 
 
 
2.10.4. 2. DNA Restriction (Enzyme Digestion of Samples) 
Restriction endonuclease digestion was performed by transferring slices of the plugs into 
a sterile 2.0 ml microcentrifuge tube. Portions of plugs (2 mm) were cut, covered with 
180 µl of sterile water and 20 µl 10 x Buffer Tango in a 2.0 ml Eppendorf tube, and 
incubated for 15 min at 30°C. The reaction buffer was replaced with 175 µl of sterile 
water, plus 20 µl 10 x Buffer Tango and 5 µl of 50 U Sma I were added before incubation 
at 30ºC for 3 h or overnight. The buffer was discarded and 500 µl of 1 x TE buffer added 
to the plugs. The plugs were stored at 4ºC for 2-4 weeks for later use.  
 
 
2.10.4. 3. Pulse field Separation of DNA Restriction Fragments  
Agarose gel (1%) was freshly prepared in 100 ml 0.5 x TBE (Tris Borate EDTA). 
Digested plugs were loaded into wells with standard strains at either end of the gel and 
after every 5 lanes. PFGE performed with a CHEF DR II (Catalog number 170-3670, 
Bio-Rad) in 0.5 x TBE under the following conditions: 14ºC; initial start time 4 s; final 
start time 45 s; gradient 6 V; run time 24 h. Lambda DNA ladder was used as a standard 
marker (Catalog number 170-3635, Bio-Rad, Basingstoke, Hampshire, England) for all 
the gels and S. aureus and two of the GBS type strains (V and III) were used as controls. 
DNA fragments generated from GBS strains were run in every 2
nd
 and 3 
rd
 lane to allow 
normalization of gels and comparisons with database. The gels were stained for 15 min in 
ethidium bromide solution (5 drop off ethidium bromide to 300 ml deionized water), and 
destained in a dark room for 40 min in 500 ml distilled water, with a water change every 
20 min. Gels were visualized under UV illumination, photographed and the image was 
saved. 
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2.10.4. 4. PFGE analysis 
The PFGE profiles were analyzed by visual assessment of bands. The sample profiles of 
DNA fragments generated using PFGE were matched using the The AlphaEase FC image 
processing and analysis software (AlphaInnotech Comporation ™San Leondro, CA), 
Reference controls were used to merge profiles generated from different gels. The 
resulting nominal data was coded into presence (coded 1) or absence (coded 0) data 
creating a binary file for multivariate statistical analysis. The binary file was used to 
create a similarity matrix that was used for cluster analysis and Multidimensional Scaling 
(MDS) analysis using the Primer v6 software, also known as the Primer – E software 
(Clarke et al., 2001). The Unpaired Group Mean Weight Average (UPGMA, average) 
pairing was used to create hierarchical clustering based on Euclidean distance methods.  
While the MDS analysis was based on the original binary data according to Bray – Curtis 
similarity matrix.  
 
Cluster analysis methods are used to group objects according to their similarities and 
dissimilarities, based on measures of association.  
 
 
2.11. Statistical analysis 
Data were analyzed using the Statistical Package for the Social Sciences (SPSS) for 
window version 19.0. The Chi square test was used to determine the associations between 
two categorical variables, but when the number in a cell was less than five, instead of chi-
square, Fisher exact test was used. For both tests variables were not associated (not 
statically significant) if the p-value was greater than 0.05. The Chi square test/ Fisher 
exact test was used to evaluate associations between delivery status and marital status, 
social demographics, and obstetrics history. 
 
To measure the relationship between numerical variable (age, gravity, and parity) and a 
binary variable (delivery status) the Mann-Whitney U test was used because the 
numerical variable is not normally distributed (nonparametric test). To determine whether 
or not the numerical variable was normally distributed we used Shapiro-Wilk test. For the 
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Shapiro-Wilk test if the p value was greater than 0.05, it was considered to be normally 
distributed. For the Mann-Whitney U test, values less than 0.05, indicated a statistically 
significant difference between groups.  
 
A specimen was considered positive for GBS if it was positive by culture or by PCR 
assays. Sensitivity and specificity, positive predictive value, and negative predictive 
value were then calculated for each of the assays. Statistical work was performed by 
using the following formulae:  
Sensitivity = TP/ (TP+ FN), Specificity = TN/ (FP + TN), positive predictive value (PPV) 
= TP/ (TP + FP), negative predictive value (NPV) = TN/ (FN + TN). The following 
formula: Sensitivity/1–specificity was used in order to determine the positive odd ratio; 
while for the negative odd ratios the following formula was use (FN/TP + FN divided by 
TN/FP+TN.  
 
The percentage accuracy for each of the methods was determined using the following 
formula: TP + TN/sample number X 100, where TP = True positive, TN = true negative, 
FN = false negative, FP = false positive 
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CHAPTER 3: DEMOGRAPHICS OF STUDY POPULATION AS ESTABLISHED 
FROM THE QUESTINNAIRE 
 
Not all of the 301 recruited pregnant women responded to all of our questions in the 
questionnaire handed to the patients at recruitment. Therefore, the results in this section 
are exclusively based on the number of responses we obtained to each question rather 
than the total number of participants in the study. The women were not interviewed 
during labour nor after delivery. Pregnancy outcomes were extracted from the patients 
folders post delivery. The questionnaire covered possible risk factors associated with 
adverse pregnancy outcomes. 
 
 
3.1. Population locations  
Socioeconomic factors between the mothers from different locations were analyzed. The 
participants were from Guguletu (16.9%), Khayelitsha (KMOU, 24.6%), Mowbray 
(MMH, 29.9%) and Mitchells Plain (MP, 28.6%).  
 
 
3.2. Maternal Age  
The age distribution of the 301 pregnant women ranged from 17 - 42 years (Table 5). The 
mean age of the entire study population was 28.8 (± 5.2) years (Table 5). 
 
The results of the age distribution analysis show that among the 301 pregnant women the 
majority, 36.52% were from the age group 26 - 30 years, 27.65% were from the age 
group 17 - 25 years, 24.57% were age group 31 - 35 years, 8.87% were from age group 
36 - 40 years, and 2.39% were aged group 41 years and over (Table 5).  
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Table 5: Demographics of the study population 
Variables/ Categories Frequency (%) Mean (SD): 
Location of the population (MOU)   
MMH 90 (29.9%)  
KMOU 74 (24.6%)  
MP 86 (28.6%)  
GUG 51 (16.9%)  
Total 301 (100.0%)  
   
Age groups  28.8 (± 5.2) 
17-25 81 (27.65%)  
26-30 107 (36.52%)  
31-35 72 (24.57%)  
36-40 26 (8.87%)  
41 and over 7 (2.39%)  
Total  293 (100.0%)  
   
Marital status    
Married 134 (44.52%)  
Single 160 (53.15%)  
Missing 7 (2.33%)  
Total  301 (100.0%)  
   
   
Education    
Primary school (G1-G7) 14 (4.65%)  
High school(G8-12) 274 (91.03%)  
University 10 (3.32%)  
Missing 3 (1.0%)  
Total  301 (100.0%)  
   
Race   
Black 149 (78.4%)  
Coloured 41 (21.6%)  
White -  
Total  190 (100.0%)  
   
Height (cm)  158.07 (± 7.81) 
≤ 150 28 (9.30%)  
151 – 155 51 (16.94%)  
156 – 160 70 (23.26%)  
161 – 165 54 (17.94%)  
>165 28 (9.30%)  
Missing 70 (23.26%)  
Total  301 (100.0%)  
   
Weight (kg)   74.18 (± 15.41) 
≤ 50 10 (3.32%)  
51 – 55 12 (4.0%)  
56 – 60 29 (9.63%)  
61 – 65 37 (12.29%)  
>65 176 (58.47%)  
Missing 37 (12.29%)  
Total  301 (100.0%)  
   
Employment   
Yes 118 (39.60%)  
No 180 (60.40%)  
Total  298 (100.0%)  
Mowbray (MMH), Mitchells Plain (MP), Guguletu (GUG) and Khayelitsha (KMOU) 
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3.3. Marital Status  
The subjects did not differ significantly with marital status, with 44.52% being married 
and 53.15% being single women. Seven women (2.33%) did not respond to this question 
(Table 5).  
 
 
3.4. Education levels  
Ninety - nine percent of our study population had some form of education ranging from 
primary to university level (Table 5). The majority of subjects indicated that they had 
high school education (91.03%) with less than 5% having completed primary school and 
even less (3.32%) having had tertiary education (Table 5). One percent failed to reveal 
their educational background in this study population.  
 
 
3.5. Ethnicity 
The sample group comprised of mostly black (78.4%) and coloured (21.6%) mothers 
(Table 5). 
 
 
3.6. Maternal Height  
Out of the 301 women, only 231 women revealed their height in the study. Seventy 
women did not respond to this question. The overall mean (SD) height of the women was 
158.07 (± 7.81) cm (Table 5).  
 
 
3.7. Maternal Weight  
Two hundred and sixty - four women recorded their weights while the remaining 37 
women did not respond to the question. The mean (SD) weight was 74.18 (± 15.41) kg. 
The majority of mothers had a weight of >65 kg (Table 5).  
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3.8. Employment levels 
The majority of the women (180) in our studied population were unemployed (60.40%), 
and118 (39.60%) women were employed (Table 5). 
 
 
3.9. Behavioural patterns of the pregnant women 
 
Table 6: Behavioural patterns  
Variables/ Categories Frequency (%) 
Number of sexual partners  
1 263 (98.9%) 
2 and more 3 (1.1%) 
Total 266 (100.0%) 
  
Personal Hygiene  
Bath 72 (24.16%) 
Hand wash 207 (69.46%) 
Shower 18 (6.04%) 
Douching 1 (0.34%) 
Total  298 (100.0%) 
  
Smoking  
Yes 41 (13.62%) 
No 260 (86.38%) 
Total  301 (100.0%) 
  
Alcohol use  
Yes 29 (9.63%) 
No 272 (90.37%) 
Total  301 (100.0%) 
 
 
3.9.1. Number of sexual partners 
Of the 301 women investigated, the majority (98.9%) reported having one sexual partner 
while less than 2% had multiple sexual partners (Table 6).  
 
 
3.9.2. Personal hygiene habits 
Hand washing of the body was the most frequently reported means of hygiene practice 
(69.46%), followed by bathing (24.16%) and shower (6.04%). Only 1 mother reported 
douching (Table 6). 
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3.9.3. Smoking  
Two hundred and sixty women (86.38%) did not smoke and 41 (13.62%) smoked while 
pregnant (Table 6).  
 
 
3.9.4. Alcohol consumption 
Two hundred and seventy - two (90.37%) women did not consume alcohol and a small 
percentage (9.63%) admitted to consuming alcohol while pregnant (Table 6).  
 
 
3.10. Emotional well – being of the pregnant women 
The overall perinatal history of emotional well - being among the 301 pregnant women 
revealed that 111 (36.9%) women claimed to have experienced difficult situations not 
related to domestic violence in the previous year. They did not elaborate on what these 
situations were. Ninety - three percent of the women claimed that they did not experience 
any type of domestic violence while pregnant, while 21 (7.0%) reported experiencing 
violence at home (Table 7). 
 
 
Ninety – three point seven percent of the women were pleased about their pregnancy, and 
94.7% claimed that their partners were equally supportive of their pregnancy. Only 
5.32% claimed that the partners were not supportive (Table 7). 
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Table 7: Maternal emotional well–being  
Variables/ Categories Frequency (%) 
A) Experienced difficult situation in the previous year  
Yes 111 (36.9%) 
No 190 (63.12%) 
Total  301 (100.0%) 
  
B) Pleased about this pregnancy  
Yes 282 (93.7%) 
No 19 ((6.3%) 
Total  301 (100.0%) 
  
C) Partner supportive  
Yes 285 (94.7%) 
No 16 ((5.32%) 
Total  301 (100.0%) 
  
D) History of depression, anxiety or panic attacks  
Yes 142 (47.18%) 
No 159 (52.82%) 
Total  301 (100.0%) 
  
E) Experienced any type of domestic violence   
Yes 21 (6.98%) 
No 279 (92.69%) 
Missing 1 (0.33%) 
Total  301 (100.0%) 
 
One hundred and forty – two (47.18%) women had a history of depression, anxiety or 
panic attacks, while 52.8% did not suffer from any of these conditions in our studied 
population (Table 7). 
 
 
3.11. Obstetric and gynaecological history  
 
3.11.1. Parity 
The mean (SD) parity for women who participated in this study was 1.43 (± 1.04). Most 
of the mothers reported a parity of 0 – 3 (Table 8). 
 
 
3.11.2. Gravidity 
The overall mean (SD) gravidity was 2.72 (± 1.09) (Table 4). Here again, the most 
frequently reported gravidity was 0 – 3 (Table 8). 
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Table 8: Obstetric and Gynecological history 
Variables/Categories Frequency (%) Mean (±SD): 
   
Parity  1.43 (± 1.04) 
0 – 3 285 (94.68%)  
4 – 5 9 (3.0%)  
≥ 6 2 (0.66%)  
Missing 5 (1.66%)  
Total  301 (100.0%)  
   
Gravidity  2.72 (± 1.09) 
0 – 3 241 (80.07%)  
4 – 5 45 (14.95%)  
≥ 6 10 (3.32%)  
Missing 5 (1.66%)  
Total  301 (100.0%)  
   
Previous pregnancy outcomes   
Preterm 151 (50.2%)  
Full term 150 (49.8%)  
Total  301 (100.0%)  
   
Infant weight of previous delivery  4.87 g (± 1.46) 
≤ 499 g 3 (1.0%)  
500 - 999 g 8 (2.66%)  
1000 – 1499 g 19 (6.31%)  
1500 – 1999 g 21 (6.98%)  
2000 – 2499 g 28 (9.30%)  
2500 g + 76 (25.25%)  
Missing 146 (48.50%)  
Total  301 (100.0%)  
 
 
3.11.3. Previous pregnancy outcomes 
According to their obstetrics history, the 301 pregnant women were divided into two 
groups; 151 constituted those with a history of Preterm (PTD) delivery (<37 weeks of 
gestation), and the control group consisted of 150 mothers who had a history of Full term 
(FTD) delivery (>37 weeks of gestation). Preterm delivery was reported by 50.2% of the 
study group, while the remaining 49.8% reported previous deliveries to be at term (Table 
8).  
 
 
 
 
 
 
 
 
 
 
40 
 
3.12. Medical History 
 
3.12.1. Maternal Medical history  
 
Table 9: Medical history 
Variables/ Categories Frequency (%) 
Medical History  
Hypertension 30 (9.97) 
Diabetes 1 (0.33%) 
Urinary tract infection  4 (1.33%) 
Other: low blood pressure, asthmatic; 
anaemic, TB 
9 (2.99%) 
No symptoms 253 (84.05%) 
Hypertension & Diabetes 2 (0.66%) 
Hypertension & urinary tract infection 1 (0.33%) 
Hypertension & low blood pressure 1 (0.33%) 
 
 
Thirty women had a history of hypertension (Table 9). Nine women (2.99%) reported 
asthma, anaemia or low blood pressure. Two women had a history of both hypertension 
and diabetes, and one woman had hypertension and low blood pressure (Table 9). The 
majority (253) reported no diabetes or blood pressure disorders. Four women reported 
having had a urinary tract infection in the past.  
 
 
3.12.2. Maternal history of reproductive infections 
 
Of 301 women who participated in this study, 201 (66.8%) were HIV-negative, 74 
(24.6%) were HIV-positive and 26 (8.6%) did not disclose their HIV-sero-status. When 
asked about other STDs, the majority of the women (83.46%) in this study reported no 
history of STD (Table 10). Thirty - five of the women did not respond to the question.  
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Table 10: Maternal Infections 
Variables/ Categories Frequency (%) 
HIV status  
Positive 74 (24.6%) 
Negative 201 (66.8%) 
Unknown 26 (8.6%) 
Total  301 (100.0%) 
  
Previous STD  
Yes 44 (14.62%) 
No 222 (73.75%) 
Unknown 35 (11.63%) 
Total  301 (100.0%) 
  
  
Current Symptoms of infections  
Vaginal discharge 196 (65.12%) 
Urinary tract infection 21 (6.98%) 
Both 3 (1.0%) 
No symptoms 81 (26.91%) 
Total  301 (100.0%) 
 
There were no symptoms of current infection reported in 81 (26.58%) of the women 
while 196 (65.12%) reported a vaginal discharge, and 21 (6.98%) reported current 
urinary tract infections (Table 10). 
 
 
Table 11: Logistic regression analysis used to assess the influence of Obstetric factors 
associated with previous PTD  
Variables S. E. OR 95% CI for OR p - value 
Gravidity 0.431 0.2116 0.093 - 0.503 0.000** 
Parity 0.442 5.914 2.489 - 14.054 0.000** 
Infant weight 0.157 1.616 1.89 - 2.197 0.002** 
Current Symptoms (Ref = no symptoms)     
Vaginal discharge 0.560 8.955 2.988 - 26.842 0.000** 
Urinary tract infection 1.308 42.078 3.242 - 546.131 0.004** 
Symptoms (Both) 40192.970 .000 .000 -  1.000 
Smoking  (Ref = no smoking)     
Yes 0.643 0.215 0.061 - 0.759 0.016** 
Experienced any type of domestic violence  1.041 2.216 3.150 – 189.190 0.002** 
Experienced difficult situation in the previous 
year 
0.380 24.264 1.076 – 4.764 0.031** 
 
Cox and Snell R Square 37.8%    
Chi-square (Hosmer and Lemeshow Test sig) 12.823 (0.118)    
A p-value of less than (p < 0.05) was considered statistically significant. SE standard error, OR odd ratio, CI 
confidence interval  
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3.13. Multivariate analysis of confounding risk factors associated with previous PTD  
 
Since it was previously established that some mothers had a history of preterm delivery, 
we elected to compare them with the mothers who had previously delivered at term in 
order to establish whether any of the above factors may indeed have influenced their 
obstetrics and gynaecological history.  
 
A multivariable analysis were undertaken to identify and examine all the risk factors of 
PTD. Results of multiple logistic regression analysis are shown in Table 11. The 
multivariate analysis method used is the binary logistic regression because the dependent 
variables “delivery status” is qualitative with two categories (Preterm and Full term). The 
Homers – Lemeshow test for logistic regression analysis demonstrated a good model fit 
with p = 0.118 > 0.05. The independent variables included in the model explained 37.8% 
(Cox and Snell R square) of the variance of delivery history. Table 11 shows that gravity, 
parity, infant weight, smoking, vaginal discharge, urinary tract infection, domestic 
violence and stress (experiencing difficult situation in the previous year) were 
significantly associated with a history of previous PTD (Table 11).  
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CHAPTER 4: ISOLATION AND CHARACTERIZATION OF AV – 
ASSOCIATED AEROBES 
 
4.1. Microscopic diagnosis of AV  
 
AV was detected in 79 (26.2%) of the 301 pregnant women, and 222 (73.8%) presented 
with normal vaginal microbiota. Of those with AV, 67 were diagnosed with light AV, 11 
had moderate AV and severe AV was detected in 1 woman (Table 12).  
 
 
Table 12: Microscopic diagnostic criteria for AV (Donders et. al., 2011) 
Variable/categories Frequency (%) 
AV score  
  
Normal flora (< 3) 222 (73.8%) 
Light AV (3-4) 67 (84.8%) 
Moderate AV (5-6) 11 (13.9%) 
Severe AV (≥6) 1 (1.3%) 
Total of AV positive  79 (26.2%) 
Aerobic vaginitis (AV); high – power field (hpf) (400X magnification). “Severe AV” or “desquamative 
inflammatory vaginitis”: score > 6; “moderate AV”: score 5–6; “light AV”: score; “no signs of AV”: score < 3. 
 
 
4.2. Identification of AV – associated bacteria isolated from samples  
 
4.2.1. Identification of Gram-positive cocci 
Gram- positive cocci were examined for ß-hemolysis on Colistin nalidixic acid (CNA) 
blood agar containing 5% sheep blood (Fig. 2), catalase test, bacitracin sensitivity, 
hippurate and aesculin hydrolysis. 
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Fig. 2: Identification of GBS. Isolates were grown on CNA blood agar containing 5% 
sheep blood. The colonies are surrounded by narrow zones of ß-hemolysis. 
 
 
Table 13: Confirmatory tests for Gram-positive cocci 
 Positive (+ ve) Negative (- ve) 
Catalase 6 82 
Bacitracin - 82 
Hippurate 25 57 
Aesculin 26 56 
DNAse 4 2 
 
 
4. 2. 1.1. Catalase Test 
The catalase test was done to confirm that Gram-positive cocci isolates were streptococci 
(catalase-negative) or Staphylococcus (catalase-positive). Results were interpreted as 
shown in Fig. 3. Four isolates were catalase – positive and 82 isolates were catalase 
negative 82 (Table 13).  
 
Catalase negative Gram-positive cocci were further characterized using bacitracin, 
aesculin hydrolysis and hippurate hydrolysis tests, while catalase positive Gram-positive 
cocci were further characterized using the DNAse test. 
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Fig. 3: The Streptococci (left, absence of effervescence) are catalase negative, and 
Staphylococci are catalase positive (right), indicated by the production of effervescence.  
 
 
4. 2. 1.2. Bacitracin Test 
ß-hemolytic, catalase-negative Gram positive cocci were tested for bacitracin sensitivity 
to exclude Streptococcus pyogenes. Colonies were considered to be sensitive by 
observation of a zone of inhibition around the bacitracin disk and negative (resistant) if 
no zone of inhibition was observed around the disc. Positive (S. pyogenes) and negative 
controls (GBS) were included in the all tests performed. Staphylococcus, GBS, and 
Enterococcus show no zone of inhibition around the bacitracin disc. None of the isolates 
showed sensitivity to bacitracin (Table 13). 
 
 
4. 2. 1.3. HippurateTest 
The hippurate test in this study was used to determine the presence of the enzyme 
hippurate hydrolase, which hydrolyzes sodium hippurate to form benzoic acid and 
glycine. The addition of ferric chloride to benzoic acid forms an insoluble brown ferric 
benzoate precipitate (Fig. 4). 
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1 2 3 4 5  
Fig. 4: The hippurate hydrolysis test. A positive test is shown by the heavy brown precipitate at the bottom 
of the tube. Tube 1, positive control; and tube 2 – 5, represent test samples. The arrow indicates a heavy 
precipitate that lasts longer than 10 min, which is an indication of a positive test. 
 
 
4. 2. 1.4. Aesculin Test 
The bile aesculin test was performed to determine if the bacteria were able to hydrolyze 
aesculin in the presence of bile (Fig. 5). All E. faecalis isolates tested had an esculin 
positive reaction in this study. 
 
A
B
 
 
Fig. 5: The aesculin test reaction showing blackening of the medium (indicating a positive reaction, Tube 
A) and no change in color of the medium (negative reaction, Tube B). 
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4. 2. 1.5. Latex Agglutination Test  
Lancefield grouping of catalase-negative Gram-positive cocci was achieved using latex 
agglutination (Fig. 6). The intensity of the agglutination reaction (Fig. 6) was measured 
using a qualitative scale from weak (+) to strong (++++). Results showed that 57 of the 
isolates were GBS and 24 were Enterococcus (Table 14).  
 
 
Table 14: Tests used for the presumptive identification of GBS and E. faecalis  
Test GBS E. faecalis 
Haemolysis on Blood Agar β Y 
Catalase - - 
Growth on McConkey (6.5% NaCl) - + 
Aesculin hydrolysis - + 
Hippurate hydrolysis + - 
Lancefield groups B D/G 
Frequency of isolates  57 24/1 
 
 
 
Fig. 6: Slide agglutination test used to identify the group antigens of GBS and Enterococci. A positive 
agglutination reaction is indicated by clumping and grades as weak (+) to strong (++++) while a negative 
reaction is smooth with no apparent clumps. 2 – 3 are graded as weak (+), while 4 – 6 are strong (++++) 
 
 
4. 2. 1.6. Growth on MacConkey Agar 
MacConkey agar contains 6.5% NaCl and bile salts. Growth on MacConkey agar 
confirmed the identification of E. faecalis which grew as tiny magenta colonies. GBS did 
not grow on MacConkey agar.  
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4.2.1.7. Identification of Staphylococcus aureus  
Following overnight incubation of the DNAse plate, the plate was flooded with 1 N HCL. 
The presence of Staphylococcus aureus was confirmed by clear zones appearing on the 
plate indicating the production of DNAse while no clearing of staphylococcal growth was 
reported as Staphylococcus epidermidis. Four isolates were DNAse positive, while 2 
isolates were DNAse negative (Table 13).  
 
 
4.2.2. Identification of Gram-negative bacilli (enterobacteriaceae) 
The colonies from the MacConkey after overnight incubation at 37
o
C were picked for 
further identification using the API 20 E test.  
 
The identification of enterobacteriaceae Gram-negative bacteria was achieved with the 
7-digit numerical profile obtained according to prescribed values for each positive test 
(Fig. 7). This test was performed using the database (1.2.1) with the apiweb TM 
identification software. The 7-digit numerical profile was entered manually to obtain the 
profile of the microorganism.  
 
 
Fig. 7: API 20 E test was performed in order to identify the enterobacteriaceae 
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Of the 301 pregnant women who participated in the study, GBS and Enterococcus 
(Group D) were isolated from 50 and 21, with AV diagnosed in 10 and 9 respectively. E. 
coli, S. aureus, S. epidermidis, Group G, Citrobacter and Candida were isolated from 4, 
4, 2, 1, 1, 2 respectively (Table 15). 
 
 
Table 15: Number of women presenting with AV – associated microorganisms  
Organisms Frequency (%) of women 
  
E. coli 4 (1.3%) 
Citrobacter feundii 1 (0.33%) 
  
S. aureus 4 (1.3%) 
S. epidermidis 2 (0.66%) 
  
GBS 50 (16.6%) 
Enterococcus faecalis (Group D) 21 (7.0%) 
Enterococcus (Group G) 1 (0.33%) 
  
Candida species 2 (0.66%) 
 
With GBS and E. faecalis being the 2 species isolated from most women, the remainder 
of this study will be dedicated to the characterization of these two species, with particular 
emphasis on GBS which, as discussed in Chapter 1, has been frequently associated with 
maternal and neonatal morbidity.  
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4.2.3. Distribution of AV – associated species 
 
 
Fig. 8: Frequency of women with AV - associated microorganisms isolated in this study 
 
Figure 8 represents the number of women with AV – associated bacteria expressed as a 
% of the total number of women with AV (n = 79). As demonstrated in Table 15, GBS 
and E. faecalis were the species isolated from most women while other species were 
isolated from ≤ 5.06% of the women.  
 
 
4. 3. Distribution of GBS serotypes  
The distribution of GBS serotypes is believed to differ from one country to next and also 
from one province to another with changes in prevalence over time. With GBS being the 
predominant isolate in this population, we investigated the distribution of serotypes using 
GBS capsular polysaccharide antigens (CPA) typing (Fig. 9). Six different serotypes of 
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GBS were identified with serotype V predominating, followed by serotype III. Of the 
GBS positive isolates GBS serotype III and serotype V comprised 87.7% of the isolates. 
Only 1 (1.75%) isolate belonged to each of serotypes Ia, II, IV and IX in our study. One 
woman harboured more than 1 serotype of GBS (IV and V) in our population. No strains 
belonging to serotypes Ib, VI, VII, and VIII were found in any of the isolates in this 
study. Serotyping was not possible in 3 cases (5.3%), and defined as nontypeable (NT) 
(Fig. 9). In eight cases where GBS was cultured from both rectal as well as vaginal 
samples, serotyping resulted in identical findings for all of the paired samples, except for 
three. 
 
 
 
Fig. 9: Distribution of capsular antigen types among GBS culture positive isolates from 
women who had previous history of PTD of N=151 and of history of FTD of N=150 
pregnant women from Western Cape. NT, not typeable 
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4.4. Culture – independent detection of GBS 
In addition to culture, the use of molecular diagnostic techniques such as PCR and PFGE 
for the genomic analysis of GBS clinical isolates were employed.  
 
4.4.1. Extraction of metagenomic DNA from Ano-vaginal samples 
Fig. 10 shows purified metagenomic DNA from both the vaginal and rectal specimens. 
The DNA extraction using CATAB/NaCl method yielded DNA of high molecular weight 
of the metagenomic DNA (Fig. 10). Eight microliters (8 µl) of DNA was loaded from all 
the samples, and 2 µl of loading dye was loaded and viewed on 8% agarose gel. The 
DNA obtained in this present study had absorbance of 260nm, and the A260/280nm was 
varied from different ranges.  
22      23    24       25    26     27      28     29     30      31      32     33      34     35     36       37
1      2     3      4     5      6      7      8      9   10    11    12    13    14   15    16    17  18   19   20
11501 bp
5077 bp
4749 bp
1700 bp
1159 bp
805 bp
11.5 bp
Fig. 10: Genomic DNA run on Agarose gel (1%) comparing the distribution of GBS diversity in selected 
clinical samples from MOU in the Western Cape. Top gel: Lanes 1: Marker (λ Pst1), 2: sample # 111HVS, 
3: sample # 08 HVS , 4: ample #50 HVS, 5: sample # 62 HVS, 6: sample # 84 R, 7: sample # 95 R, 8: 
sample # 99 R, 9: sample # 130 HVS,10: sample # 116 HVS, 11: sample # 139 HVS; 12: sample # 139 R, 
13: sample # 141 HVS, 14: sample # 167 HVS, 15: sample # 193 HVS, 16: sample # 193R, 17: sample 3# 
194 HVS 18: sample # 211 HVS; 19: sample # 211 HVS, 20: sample # 216 HVS. Bottom gel: Lanes 22 & 
37: Marker (λ Pst1), Lanes 22-35: Clinical samples from vaginal and rectal specimens. 
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4.4.2. PCR amplification of 16S rRNA genes  
PCR analysis was positive for fifty women and negative for 251 women. No samples were 
positive by PCR and negative by culture. The overall GBS colonization rate by PCR was 
16.6% amongst the 301 pregnant women. 
 
 
1                           2                       3                         4                          5            6
11501 bp
5077 bp
4749 bp
1700 bp
1159 bp
805 bp
 
Fig. 11: Agarose electrophoresis gel (1%) showing the gel purified PCR products from the clinical samples 
using universal bacteria primers (E9F and U1510R). Lanes 1: Sample #139 HVS; 2: sample # 139 R, 3: 
sample # 447 HVS; 4: Positive control (GBS 11 strain); 5 Negative control; 6: Marker (λ Pst1).  
 
In order to check if the extracted DNA was suitable for PCR, the universal bacteria 
primers (U1510R) and (E9F) were used (Fig. 11). This shows that the DNA was indeed 
suitable for PCR amplification. It also did aid on the amount of template to be used, 5 ng 
of metagenomic was used in all PCR experiments. 
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1      2     3     4      5     6    7     8    9     10    11   12   13   14   15  16   17 1 8   19
1000 bp
500 bp
200 bp
100 bp
405 bp
 
Fig. 12: PCR amplification with the GBS-specific primers (405 bp). The purified DNA was run on agarose 
gel (1%). Lanes 1: Marker (50bp) 2: Negative control, 3: Positive control (GBS strain V) 3: sample # 95 R, 
5: sample # 112 HVS, 6: sample # 116 HVS, 7: sample # 139 HVS, 8: sample # 139R, 9: sample # 141 
HVS, 10: sample # 167 HVS, 11: sample 193 HVS, 12: sample # 193 R, 13: sample # 194 HVS, 14: 
sample # 219 HVS, 15: sample # 219 R; 16: sample # 221 R. 
 
The results in Fig. 12 show the PCR amplification obtained from genomic 16S rDNA 
from the clinical samples. The PCR product was amplified with GBS-specific primers 
(sag 40 and sag 445) and viewed on 1% agarose gel. The PCR product yielded a strong 
band which is observed (Fig. 12). After PCR analysis the size of GBS amplification 
fragment of expected size of 405 bp was obtained (Fig. 12). DNA template from GBS 
strains was used as a positive control and no target DNA was added to the negative 
control. The results obtained from the PCR assay resulted in fifty - seven isolates 
identified as GBS - positive from the vaginal and rectal swabs.  
 
 
4.4.3. Comparison of rectal and vaginal colonization 
The GBS were more frequently isolated from the vagina than the rectum in this study 
(Table 16). Of the total 57 GBS positive cultures, 26 derived from the vagina resulting in 
a frequency rate for this site of 45.6%. Twenty - three samples with negative vaginal 
cultures were positive by their anorectal samples (Table 16). This could have resulted in 
an error of 40.4% if only vaginal cultures had been considered (Table 16).  
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Table 16: Rates of detection of colonization with GBS culture positive according to the 
sources of specimens among the 301 (N=301) pregnant women  
 
SITES 
 
Women (N) 
 
GBS culture positive 
 
Positive anatomical culture site % 
 
   HVS specimen Rectal specimen Combined high vaginal and 
rectal swabs 
Total 301 57 26 23 8 
HVS (High Vaginal Specimen); Rectal (Anal Specimen) 
 
 
4.4.4. GBS culture and PCR assay comparison 
The PCR assay was compared to the culture methods (gold standard) for 301 pregnant 
women who were recruited in our study population. In order to ensure that we achieved 
the highest detection levels of GBS colonization using the PCR assay, both high vaginal 
samples (HVS) and rectal samples were collected from the pregnant women and tested. 
The results show that amongst the 301 pregnant women who participated in this study, 
16.6% (50/301) of the women were identified as GBS carriers.  
 
All specimens found to be positive by culture methods (N = 57) were also positive by 
PCR assay (Table 17).  
 
Table 17: Rates of GBS colonization detected among the 301 pregnant women by 
comparing the PCR technique versus culture for GBS detection.  
Methods of 
Detection  
 
Delivery history Frequency GBS 
positive specimen  
No. (%) 
Sampling sites 
High Vaginal 
Specimen 
Rectal 
Specimen 
Combine anatomical site 
specimen (high vaginal and 
rectal) 
Culture      
Total  57 (100.0%) 26 (100.0%) 23 (100.0%) 8 (100.0%) 
      
Conventional 
PCR assay  
     
Total  57 (100.0%) 26 (100.0%) 23 (100.0%) 8 (100.0%) 
HVS (High Vaginal Specimen); Rectal (Anal Specimen) and PTD= Preterm delivery; FTD =Full delivery 
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Specificity, sensitivity, and predictive values 
 
When the PCR assay was compared with culture, a sensitivity of 100% and specificity 
100% was obtained (Table 18).  
 
Table 18: Detection of GBS colonization by culture and PCR. The diagram was  used for 
sensitivity, specificity, positive and  negative predictive value. 
 CULTURE  
 Culture negative Culture positive Frequency (%) 
    
PCR    
negative 251 0 251 (83.4%) 
positive 0 50 50 (16.6%) 
Total 251 50 301 (100.0%) 
 
 
Both the culture and PCR methods were negative for 251 women (vaginal swabs; rectal 
swabs; and from both combined anatomical sites). None of the isolates which were GBS-
positive for culture were negative by PCR. The PCR was repeated to confirm the results. 
Sensitivity, specificity, negative and positive predictive values of the PCR assay were 
estimated in this study by comparing the PCR assay results with culture method. The 
results revealed sensitivity, specificity, negative and positive predictive values of the 
PCR assay was 100% (Table 18).  
 
Similar results were obtained when culture was used as the reference standard. The 
sensitivity, specificity, negative and positive predictive values of culture method when 
compared with PCR assay were all 100% (Table 18). 
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4.5. Antimicrobial susceptibility of isolates  
 
4.5.1. Kirby-Bauer disk diffusion method 
All culture positive isolates obtained from the pregnant women were tested for antibiotic 
susceptibility by performing the Kirby-Bauer disk diffusion method according to the 
National Committee for Clinical Laboratory Standards (NCCLS) guidelines. For Gram-
positive cocci the following eight antimicrobial drugs were tested: penicillin G (PG) 
1unit, clindamycin (CD) 2µg, gentamicin (GM) 10 µg, fusidic acid (FC) 10 µg, 
erythromycin (E) 5 µg, tetracycline (T) 10 µg, trimethroprin (TM) 1, 25 µg and 
sulphamethoxazole (SMX) 25 µg. Strains were considered as resistant or sensitive to 
specific antibiotics according to the inhibition zones measured (Fig. 13). Zones of 
inhibition were measured from the edge of the disk to the edge of the inhibition of 
bacterial growth using a ruler.  
 
Critical breakpoints for the interpretation of results are summarized in appendix (see 
appendix 2D) 
 
 
Fig. 13: Disc diffusion analysis of GBS antimicrobial susceptibility test 
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Fig. 14: Proportions of the responses of the 57 GBS culture positive isolates tested against eight different 
antibiotics: penicillin G (PG), clindamycin (CD), gentamicin (GM), fusidic acid (FC), erythromycin (E), 
trimethroprin (TM), sulphamethoxazole (SMX), and tetracycline (T).  
 
Fifty – six out of fifty - seven (98%) of GBS positive isolates were susceptible to 
clindamycin and erythromycin, followed by 96% (55/57) susceptible to penicillin G in 
this study. Only one isolate 2% (1/57) was found susceptible to each of tetracycline (T) 
and trimethroprin (TM) (Fig. 14). 
 
Total resistance of GBS isolates (100%) was demonstrated to fusidic acid and 98% 
(56/57) were resistant to tetracycline and trimethroprin (Fig. 14). Ninety - five percent of 
the isolates (54/57 isolates) were resistant to sulphamethoxazole, and 93% were resistant 
to gentamicin (Fig. 14).  
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4.5.2. MIC analysis using the TREK system  
The trek system was used to determine the MIC profiles of GBS and E. faecalis isolates 
since most of our study population were colonized with GBS followed by E faecalis. For 
the breakpoint EUCAST/ CLSI was used see (Appendix 2E). 
 
 
4.5.2. 1. GBS 
Susceptibility to antibiotics  
The results of the antimicrobial susceptibility analysis are summarized in Table 19. All 
the GBS strains were susceptible to tigecycline (100%), followed by 55 (96.5%) to 
linezolid, and moxifloxacin. Forty - eight (84.2%) isolates were found to be susceptible to 
trimethroprim/sulphamethoxazole (Table 19). Thirty – six of fifty – seven (63.2%) of 
GBS positive isolates were susceptible to ceftriaxone, clindamycin, and meropenem 
followed by 32 (56.1%) to erythromycin. The results showed that 45 (78.9%) of GBS 
isolates were susceptible to levofloxacin, to chloramphenicol 44 (77.2%), to vancomycin 
40 (70.2%), to daptomycin 38 (66.7%), to ceftriaxone, cefotaxime and meropenem 36 
(63.2%), to azithromycin 33 (57.9%), and to penicillin 31 (54.4%) in our studied 
population (Table 19). Three isolates (5.3%) were found to be susceptible to tetracycline 
(Table 19). 
 
 
Intermediate sensitivity to antibiotics  
Intermediate sensitivity to levofloxacin was found in 11 (19.3%) of the GBS isolates, 
with intermediate sensitivity to trimethroprim/sulphamethoxazole in 5 (8.8%) and 1 
(1.8%) isolate showed intermediate sensitivity to linezolid and moxifloxacin (Table 19).  
 
 
Resistance to antibiotics 
A high proportion of GBS isolates were resistant to tetracycline 94.7% (54/57) in this 
study, followed by 26 (45.6%) to penicillin (Table 19). Twenty – four (42.1%) of the 
GBS isolates were resistant to azithromycin. Twenty – two isolates (38.6%) were 
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resistant to ertapenem, followed by 23 (40.4%) to clindamycin, 21 (36.8%) to cefotaxime 
and meropenem respectively. Nineteen (33.3%) isolates were resistant to daptomycin, 
while 17 (29/8%) were resistant to vancomycin (Table 19). Twenty – two point eight 
percent of the isolates (13/57) were resistant to chloramphenicol.  
 
Whilst resistance to trimethroprim/sulphamethoxazole was detected in 4 (7.0%) of the 
GBS isolates (Table 19), 1 isolate (1.8%) was found to be resistant to each of the 
following levofloxacin, linezolid and moxifloxacin (Table 19). 
 
GBS isolates were divided into penicillin sensitive and penicillin resistant groups for 
further assignment into specific antimicrobial profile groups. If the profiles different by 
less than 3 antibiotics they were assigned to the same alphabetical group with a subgroup 
number i.e. a1, a2 etc (Table 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
Table 19: Antimicrobial susceptibility patterns for GBS and E faecalis 
ANTIMICROBIC 
Frequency (%) 
GBS 
N = 57 
 
Frequency (%) 
E. faecalis 
N = 24 
 
AMOXICILLIN/CLAVULANIC ACID 
 
Susceptible - - 
Intermediate - - 
Resistant - - 
AZITHROMYCIN 
 
Susceptible 33 (57.9%) - 
Intermediate - 1 (4.2%) 
Resistant 24 (42.1%) 23 (95.8%) 
CEFEPIME 
 
Susceptible - - 
Intermediate - - 
Resistant - - 
CEFOTAXIME 
 
Susceptible 36 (63.2%) - 
Intermediate - - 
Resistant 21(36.8%) 24(100%) 
CEFTRIAXONE 
 
Susceptible 36 (63.2%) - 
Intermediate - - 
Resistant 21(36.8%) 24(100%) 
CEFUROXIME  
 
Susceptible - - 
Intermediate - - 
Resistant - - 
CHLORAMPHENICOL 
 
Susceptible 44 (77.2%) 20 (83.3%) 
Intermediate - - 
Resistant 13 (22.8%) 4(16.7%) 
CLINDAMYCIN 
 
Susceptible 34 (59.6%) 2 (8.3%) 
Intermediate - - 
Resistant 23 (40.4%) 22 (91.7%) 
DAPTOMYCIN 
 
Susceptible 38 (66.7%) 2 (8.3%) 
Intermediate - - 
Resistant 19 (33.3%) 22 (91.7%) 
ERTAPENEM 
 
Susceptible 35 (61.4%) - 
Intermediate - - 
Resistant 22 (38.6%) 24(100%) 
ERYTHROMYCIN 
 
Susceptible 32 (56.1%) 1 (4.2%) 
Intermediate - 1 (4.2%) 
Resistant 24 (42.1%) 22 (91.7%) 
LEVOFLOXACIN 
 
Susceptible 45 (78.9%) 19 (79.2%) 
Intermediate 11 (19.3%) 3 (12.5%) 
Resistant 1 (1.8%) 2 (8.3%) 
LINEZOLID 
 
Susceptible 55 (96.5%) 21 (87.5%) 
Intermediate 1 (1.8%) 2 (8.3%) 
Resistant 1 (1.8%) 1 (4.2%) 
MEROPENEM 
 
Susceptible 36 (63.2%) - 
Intermediate - - 
Resistant 21(36.8%) 24 (100%) 
MOXIFLOXACIN 
 
Susceptible 55 (96.5%) 23 (95.8%) 
Intermediate 1 (1.8%) - 
Resistant 1 (1.8%) 1(4.2%) 
 
TETRACYCLINE 
 
Susceptible 3 (5.3%) 2 (8.3%) 
Intermediate - - 
Resistant 54 (94.7%) 22 (91.7%) 
TIGECYCLINE 
 
Susceptible 57 (100%) 24 (100%) 
Intermediate - - 
Resistant - - 
PENICILLIN 
 
Susceptible 31 (54.4%) - 
Intermediate - - 
Resistant 2 6 (45.6%) 24 (100%) 
TRIMETHOPRIM/SULPHAMETHOXAZOLE 
 
Susceptible 48 (84.2%) 22 (91.7%) 
Intermediate 5 (8.8%) - 
Resistant 4 (7.0%) 2 (8.3%) 
VANCOMYCIN 
 
Susceptible 40 (70.2%) 20 (83.3%) 
Intermediate - - 
Resistant 17 (29.8%) 4 (16.7%) 
The breakpoints were defined by the EUCAST/ CLSI  
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Table 20: Breakdown of antibiotic profile grouping based on penicillin sensitivity and penicillin resistance 
Number of resistant isolates in the all pregnancy outcomes  
Isolate Antibiotic Profiles PG CD E T CH VA DAP CEF CEFT AZI MER ER MOX TRM/SMX LIN LEV TIGER 
                   
P 59 H a S S S R S S S S S S S S S R I S S 
P 92 H a S S S R S S S S S S S S S R S S S 
P 92 R a S S S R S S S S S S S S S R S S S 
                   
P 93 R b S S S R S S S R R S S S S S S S  
P 50 H b S S S R S S S R R S S S S S S S S 
                   
P 08 H c1 S R S R S S S S S S S S S I S S  
P 04 H c1 S S S R S S S S S S S S S S S S S 
P 84 R c1 S S S R S S S S S S S S S I S S S 
112 H c1 S S S R S S S S S S S S S S S S S 
114 H c1 S S S R S S S S S S S S S S S S S 
114 R c1 S S S R S S S S S S S S S S S S S 
221 R c1 S S S R S S S S S S S S S S S S S 
139 H c1 S S S R S S S S S S S S S S S S S 
139 R c1 S S S R S S S S S S S S S S S S S 
116 H c1 S S S R S S S S S S S S S S S S S 
130 H c1 S S S R S S S S S S S S S S S S S 
99 R c1 S S S R S S S S S S S S S S S S S 
194 H c1 S S S S S S S S S S S S S S S S S 
118 R c1 S S S R S S S S S S S S S S S S S 
193 H c1 S S S R S S S S S S S S S S S S S 
P 123 H c1 S S S R S S S S S S S S S S S I S 
P 143 R c1 S S S R S S S S S S S S I S S I S 
95 R c1 S S S R S S S S S S S S S S S S S 
130 H c1 S S S R S S S S S S S S S S S S S 
167 H c1 S S S R S S S S S S S S S S S S S 
P 62 H c1 S S S R S S S S S S S S S I S S S 
193 R c1 S S S R S S S S S S S S S I S S S 
P 147 H c2 S S S R S S S S S S S S R S S S S 
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Table 20continues 
 
Number of resistant isolates in the all pregnancy outcomes 
Isolate Antibiotic Profiles PG CD E T CH VA DAP CEF CEFT AZI MER ER MOX TRM/SMX LIN LEV TIGER 
                   
P 130 H d R R R R S R R R R R R R S S S S S 
P 43 R d R R R R S R R R R R R R S S S S S 
P 133 H d R R R R S R R R R R R R S S S S S 
P 133 R d R R R R S R R R R R R R S S S S S 
P 131 R d R R R R S R R R R R R R S S S S S 
                   
P 132 H e R R R R R R R R R R R R S S S I S 
P 127 H e R R R R R R R R R R R R S S S S S 
P 131 R e R R R R R R R R R R R R S S S S S 
P 107 R e R R R R R R R R R R R R S S S S S 
                   
P 12 R f R R R R R R R R R R R R S S S S S 
P 151 R f R R R R R R R R R R R R S S S S S 
P 144 R f R R R R R R R R R R R R S S S S S 
                   
P 115 R j1 R R R R R S R R R R R R S S S I S 
104 R j2 R R R R R R R R R R R R S S S S S 
                   
P 129 R i R R R R S R R R R R R R S S S S S 
P 125 R i R R R R S R R R R R R R S S S I S 
                   
120 R g R R R R R S R R R R R R S R R I S 
                   
111 R h1 R R R R S S S S S R S R S I S I S 
P 53 R h2 R R R R S S R R R R R R S R S S S 
                   
P 112 H k1 R S S R S S S S S S S R S S R R S 
P 93 H k2 R  S S R S S S S S S S S S S R S S 
                   
P 145 R l R R R R R R S R R R R R S S S S  
                   
P 94 H m R R R R S S S S S R S S S S S I S 
NT = non-typeable, CEF= cefotaxime, CEFT= ceftriaxone, ERT= ertapenem, TRM/SMX= TRM/SMX=trimethroprin/sulphamethoxazole, CH chloramphenicol, 
CD = clindamycin, PG= penicillin G, MERO= meropenem, E= erythromycin, DAP= daptomycin, T= tetracycline, LEVO= levofloxacin, AZI= azithromycin, 
MOXI= moxifloxacin, LIN= linezolid, TIGER= tigecycline and VA= vancomycin 
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4.5.2. 2. Antibiotic susceptibility profiles of E. faecalis isolates 
Because the TREK system was found to give more accurate results the disc – diffusion, 
we elected to use only the TREK system for the E. faecalis antibiotic susceptibility 
testing.  
 
The antimicrobial susceptibility of the 24 E. faecalis isolates showed that all 24 (100%) 
isolates of E. faecalis were susceptible to tigecycline, followed by 95.8% (23/24) 
susceptible to moxifloxacin, 91.7% (22/24) to trimethroprim/sulphamethoxazole, 87.5% 
(21/24) to linezolid and 83.3% (20/24) to chloramphenicol and vancomycin in this study. 
Seventy – nine point two percent (19/24) of the isolates were susceptible to levofloxacin. 
Two isolates 8.3% (2/24) presented susceptibility to clindamycin, and daptomycin, and 
4.2% (1/24) to erythromycin (Table 19).  
 
Intermediate sensitivity to levofloxacin was found in 12.5% (3/24 isolates), to linezolid in 
2 isolates (8.3%), and to erythromycin and azithromycin in 4.2% (1/24 isolates) (Table 
19).  
 
Breakpoints for amoxicillin / clavulanic acid; cefepime and cefuroxime could not be 
established and were listed as none interpretable (NI).  
 
 
All 24 E. faecalis isolates (100%) were resistant to penicillin, ertapenem, cefotaxime, 
ceftriaxone, and meropenem, followed by 95.8% (23/24) resistant to azithromycin. 
Resistance to clindamycin, erythromycin, daptomycin and tetracycline was demonstrated 
by 91.7% (22/24) (Table 19). Four isolates were resistant to vancomycin and 
chloramphenicol. Two isolates were resistant to trimethroprim/sulphamethoxazole. 
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4.6. Comparison of specific serotypes of GBS with antibiotic profiles 
 
4.6. 1. Antibiotic susceptibility using the Kirby-Bauer disk diffusion method  
 
The susceptibility profiles of the GBS serotypes are summarized in Table (21).  
GBS serotypes Ia, II, IX and the three non-typeable strains showed susceptibility to 
clindamycin, erythromycin and penicillin G only. Serotype III was susceptible to 
Clindamycin, erythromycin, penicillin G and sulphamethoxazole. Serotype IV was 
susceptible to clindamycin, erythromycin, penicillin G, sulphamethoxazole and 
trimethroprin. Serotype V showed susceptibility to clyndamycin, erythromycin, penicillin 
G and gentamicin with increasing resistance to gentamicin, tetracycline, trimethroprin 
and sulphamethoxazole.  
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Table 21: Antibiotic susceptibility profiles of GBS serotypes using disc diffusion 
Antibiotic (µg/disc) 
No (%) of 
susceptible 
isolates by 
serotype 
Clindamycin (CD) 2 µg Erythromycin (E) 5 µg Fusidic acid (FC) 10 µg Gentamicin (GM) 10 µg 
 
 Susceptible 
(%) 
Resistan
t (%) 
Total Susceptible (%) Resistant 
(%) 
Total Susceptible 
(%) 
Resistant (%) Total Susceptib
le (%) 
Resistant 
(%) 
Total 
Ia [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 
II [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 
III [N = 12] 12 (21.05%) 0 (0%) 12 (21.05%) 12 (21.05%) 0 (0%)  0 (0%) 12 (21.05%) 12 (21.05%) 0 (0%) 12 (21.05%) 12 (21.05%) 
IV [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 
V [N = 38] 37 (64.91%) 1 (100%) 38 (66.67%) 37 (64.91%) 1 (1.75%) 38 (66.67%) 0 (0%) 38 (66.67%) 38 (66.67%) 4 (7.0%) 34 (59.6%) 38 (66.67%) 
IX [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 
NT [N = 3] 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 0 (0%) 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 
             
Total 
(Frequency 
%) 
56 (98.2%) 1 (1.8%) 57 (100.0%) 56 (98.2%) 1 (1.8%) 57 (100.0%) 0 (0%) 57 (100.0%) 57 (100.0%) 4 (7.0%) 53 (93.0%) 57 (100%) 
 
Antibiotic (µg/disc) 
No (%) of 
susceptible 
isolates by 
serotype 
Penicillin G (PG) 1 unit Tetracycline (T) 10 µg Trimethroprin (TM) 1.25 Sulphamethoxazole (SMX) 25 µg 
 Susceptible 
(%) 
Resistant 
(%) 
Total Susceptible 
(%) 
Resistant (%) Total Susceptible (%) Resistant (%) Total Susceptible 
(%) 
Resistant 
(%) 
Total 
Ia [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.85%) 1 (1.75%) 
II [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.85%) 1 (1.75%) 
III [N = 12] 12 (21.05%) 0 (0%) 12 (21.05%) 0 (0%) 12 (21.05%) 12 (21.05%) 0 (0%) 12 (21.05%) 12 (21.05%) 22 (38.6%) 10 (17.54%) 32 (56.14%) 
IV [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 
V [N = 38] 36 (63.16%) 2 (3.5%) 38 (66.67%) 1(1.75%) 37 (64.91%) 38 (66.67%) 0 (0%) 38 (66.67%) 38 (66.67%) 0 (0%) 38 (66.67%) 38 (66.67%) 
IX [N = 1] 1 (1.75%) 0 (0%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.75%) 1 (1.75%) 0 (0%) 1 (1.85%) 1 (1.75%) 
NT [N = 3] 3 (5.26%) 0 (0%) 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 0 (0%) 3 (5.26%) 3 (5.26%) 
             
Total 
Frequency 
(%) 
55 (96.5%) 2 (3.5%) 57 (100.0%) 1 (1.8%) 56 (98.2%) 57 (100.0%) 1 (1.8%) 56 (98.2%) 57 (100.0%) 3 (5.26%) 54 (94.7%) 57 (100.0%) 
NT, nontypeable 
*The numbers in brackets mean the total number of GBS isolates by serotype 
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4.6.2. Comparison of specific serotypes of GBS with antibiotic profiles from TREK 
system 
Antibiotic susceptibility was performed in all 57 GBS positive isolates and 24 E. faecalis 
isolates. The TREK susceptibility profiles of the GBS serotypes are summarized in Table 
22.  
 
GBS serotypes Ia, II, IX and the three non-typeable strains showed susceptibility to 
clindamycin, erythromycin daptomycin, erythromycin and penicillin G, trimethroprim/ 
sulphamethoxazole, cefotaxime, ertapenem, meropenem, moxifloxacin, tigecycline, 
linezolid, chloramphenicol, vancomycin, daptomycin and ceftriaxone excluding serotypes 
IX isolate which was intermediate. These serotypes were all resistant to tetracycline. Of 
the 3 isolates which were non-typeable (NT), 1 was susceptible to 
trimethroprim/sulphamethoxazole. One isolate (1/3) was also resistant to 
trimethroprim/sulphamethoxazole and intermediate susceptibility to levofloxacin and 
trimethroprim/sulphamethoxazole was also detected in 1 (1/3) isolate. 
 
Serotype III was susceptible to clindamycin, erythromycin, penicillin G, linezolid, 
chloramphenicol, ceftriaxone, cefotaxime, ertapenem, meropenem, vancomycin, 
daptomycin and azithromycin. Resistance was observed in 1 isolate (1/12) to levofloxacin 
(Table 22). Ten isolates belonging to serotype III were resistant to tetracycline (Table 
22). One out of twelve isolates (1/12) was resistant to moxifloxacin. Intermediate 
susceptibility to trimethroprim/sulphamethoxazole was observed in one (1/12) isolate.  
 
Serotype IV was susceptible to clindamycin, erythromycin daptomycin, erythromycin 
and penicillin G, trimethroprim/ sulphamethoxazole, cefotaxime, ertapenem, meropenem, 
moxifloxacin, tigecycline, linezolid, chloramphenicol, vancomycin, daptomycin and 
ceftriaxone.  
 
Isolates of serotype V were all susceptible to moxifloxacin, tigecycline, and 36 (36/38) 
isolates were susceptible to linezolid. Thirty – two (32/38) isolates were susceptible to 
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trimethroprim/ sulphamethoxazole. The majority of isolates (28/38) isolates were 
susceptible to levofloxacin, followed by 25 isolates susceptible to chloramphenicol. 
Twenty - one isolates (21/38) were susceptible to vancomycin. Susceptibility to the 
following antibiotics was also observed namely, 19 isolates (19/38) to daptomycin, 18 
isolates (18/38) to cefotaxime, 16 isolates (16/38) to ertapenem, 15 isolates (15/38) to 
clindamycin, 14 isolates (14/38) to azithromycin, 13 isolates (13/38) to erythromycin, and 
12 isolates (12/38) to penicillin G in this study. 
 
Thirty - seven out of thirty - eight (37/38) isolates belonging to serotype V were resistant 
to tetracycline. Resistance to penicillin G was detected in 26 isolates (26/38). Twenty – 
four isolates were resistant (24/38) to erythromycin and to azithromycin respectively. 
Resistance to clindamycin was observed in 23 (23/38) isolates. While 22 isolates were 
resistant to ertapenem, 20 were resistant to cefotaxime, and resistance to daptomycin was 
found in 19 isolates (19/38). 
 
Of the 38 isolates belonging to serotype V, 17 were resistant to vancomycin, and 13 
isolates were resistant to chloramphenicol. Resistance to trimethroprim/ 
sulphamethoxazole was found in fewer isolates (3/38), and 1 isolate was resistant to 
levofloxacin. 
 
Intermediate susceptibility to levofloxacin was found in 9 isolates from serotype V. Three 
of the thirty – eight isolates showed intermediate susceptibility to trimethroprim/ 
sulphamethoxazole, and 1 showed intermediate susceptibility to linezolid and 
erythromycin.  
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Table 22: Antibiotic susceptibility profiles of GBS serotypes using TREK 
 Antibiotic  
No (%) of 
susceptible 
isolates by 
serotype 
Clindamycin Tetracycline Trimethroprin/ Sulphamethoxazole Vancomycin 
 S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Ia [N = 1] 1 0 0 1 0 1 0 1 1 0 0 1 1 0 0 1 
II [N = 1] 1 0 0 1 0 1 0 1 1 0  1 1 0 0 1 
III [N = 12] 12 0 0 12 2 10 0 12 11 0 1 12 12 0 0 12 
IV [N = 1] 1 0 0 1 0 1 0 1 1 0 0 1 1 0 0 1 
V [N = 38] 15 23 0 38 1 37 0 38 32 3 3 38 21 17 0 38 
IX [N = 1] 1 0 0 1 1 1 0 1 1 0 0 1 1 0 0 1 
NT [N = 3] 3 0 0 3 0 3 0 3 1 1 1 3 3 0 0 3 
                 
 Frequency 34 23 0 57  3 54 0 57  48 4 5 57  40 17 0 57  
Percentage 59.6 40.4 0 100.0 5.3 94.7 0 100.0 84.2 7.0 8.8 100.0 70.2 29.8 0 100.0 
 
 Antibiotic 
No (%) of 
susceptible 
isolates by 
serotype 
Chloramphenicol Erythromycin Ertapenem Penicillin G 
 S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Ia [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
II [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
III [N = 12] 12 0 0 12 12 0 0 12 12 0 0 12 12 0 0 12 
IV [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
V [N = 38] 25 13 0 38 13 24 1 38 16 22 0 38 12 26 0 38 
IX [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
NT [N = 3] 3 0 0 3 3 0 0 3 3 0 0 3 3 0 0 3 
                 
Frequency 44 13 0 57 32 24 1 57 35 22 0 57 31 26 0 57 
Percentage 77.2 22.8 0 100.0 56.1 42.1 1.8 100.0 61.4 38.6 0 100.0 54.4 45.6 0 100.0 
NT= non-typeable, R = Resistant, S= Susceptible, I = Intermediate 
*The numbers in brackets mean the total number of GBS isolates by serotype 
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Table 22 (continued): Antibiotic susceptibility profiles of GBS serotypes using TREK 
 Antibiotic  
No (%) of 
susceptible 
isolates by 
serotype 
Cefotaxime Azithromycin Daptomycin Levofloxacin 
 S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Ia [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
II [N = 1] 1 0 0 1 1 0 0 1 1 0 0 0 1 0 0 1 
III [N = 12] 12 0 0 12 12 0 0 12 12  0 12 11 0 1 12 
IV [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
V [N = 38] 18 20 0 38 14 24 0 38 19 19 0 38 28 1 9 38 
IX [N = 1] 0 1 0 1 1 0 0 1 1 0 0 1 1 0  1 
NT [N = 3] 3 0 0 3 3 0 0 3 3 0 0 3 2 0 1 3 
                 
 Frequency 36 21 0 57 33 24 0 57 38 19 0 57 45 1 11 57 
Percentage 63.2 36.8 0 100 57.9 42.1 0 100 66.7 33.3 0 100 78.9 1.8 19.3 100 
 
 Antibiotic 
No (%) of 
susceptible 
isolates by 
serotype 
Linezolid Meropenem Moxifloxacin Tigecycline 
 S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Ia [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
II [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
III [N = 12] 12 0 0 12 12 0 0 12 11 0 1 12 12 0 0 12 
IV [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
V [N = 38] 36 1 1 38 18 20 0 38 38 0 0 38 38 0 0 38 
IX [N = 1] 1 0 0 1 1 0 0 1 1 0 0 1 1 0 0 1 
NT [N = 3] 3 0 0 3 3 0 0 3 2 1 0 3 3 0 0 3 
                 
 Frequency 55 1 1 57 36 21 0 57 55 1 1 57 57 0 0 57 
Percentage 96.5 1.8 1.8 100 63.2 36.8 0 100 96.5 1.8 1.8 100 100 0 0 100 
NT = non-typeable, R = Resistant, S= Susceptible, I = Intermediate 
*The numbers in brackets mean the total number of GBS isolates by serotype 
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Table 23: Antibiotic susceptibility profiles of E. faecalis using TREK 
 Antibiotic  
 Clindamycin Tetracycline Trimethroprin/ Sulphamethoxazole Vancomycin 
Susceptibility S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Number of 
isolates 
2 22 0 24 2 22 0 24 22 2 0 24 20 4 0 24 
Percentage 8.3 91.7 0  100 8.3 91.7 0  100 91.7 8.3 0  100 83.3 16.7 0 100 
                 
 Chloramphenicol Erythromycin Ertapenem Penicillin G 
Susceptibility S R I Total S  R  I Total S  R  I Total S  R  I Total 
Number of 
isolates 
20 4 0 24 1 1 22 24 0 24 0 24 0 24 0 24 
Percentage 83.3 16.7  100 4.2 4.2 91.7 100 0 100  100 0 100 0 100 
 
 Antibiotic 
 Cefotaxime Azithromycin Daptomycin Levofloxacin 
Susceptibility S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Number of 
isolates 
0 24 0 24 0 23 1 24 2 22 0 24 19 2 3 24 
Percentage 0 100 0 100 0 95.8 4.2 100 8.3 91.7 0  100 79.2 8.3 12.5 100 
                 
 Linezolid Meropenem Moxifloxacin Tigecycline 
Susceptibility S  R  I Total S  R  I Total S  R  I Total S  R  I Total 
Number of 
isolates 
21 1 2 24 0 24 0 24 23 1 0 24 24 0 0 24 
Percentage 87.5 4.2 8.3 100 0 100   100 95.8 4.2 0  100 100 0 0 100 
R = Resistant, S= Susceptible, I = Intermediate 
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Table 24: Breakdown of antibiotic profile grouping based on vancomycin sensitivity and vancomycin resistance 
Number of resistant isolates in the all pregnancy outcomes  
Isolate Antibiotic Profiles PG CD E T CH VA DAP CEF CEFT AZI MER ER MOX TRM/SMX LIN LEV TIGER 
P 96 H n1 S I R S S S R R R I S S S S S S S 
P 75 R n2 S R R S S S R R R S S R S S S S S 
                   
P 61 H o1 R S R R S S R R R R R R S S S R S 
P 72 H o2 R R S S R S R R R I R R S S S S S 
P119 R  o3 R R R R S S R R R S R R R S S S S 
                   
P 98 H p R R R R S S R R R R R R S S S S S 
P 85 H p R R R R S S R R R R R R S S S I S 
217 H p R R R R S S R R R R R R S S S S S 
217 R p R R R R S S R R R R R R S S S S S 
P 91 H p R R R R S S R R R R R R S S S S S 
231 H p R R R R S S R R R R R R S S S S S 
P 91 R q R R R R S S S R R R R R S S I S S 
P 88 H q R R R R S S S R R R R R S S S I S 
                   
P 95 R r R R R R S R R R R R R R S S R R S 
P 09 H r R R R R S R R R R R R R S S R R S 
175 R s1 R R R R R R R R R R R R S S S S S 
232 H s2 R R I R R R R R R R R R S S S S R 
                   
P 82 R  t1 R S R R S R R R R R R R R S I R S 
234 H t2 R I R R S R R R R R R R R R S S S 
P 82 H  t3 R R R S S R S R R R R R S S S I S 
                   
P 03 H  u R I S R S R R R R S R R S R S R S 
P 80 H v R I R R S R R R R S R R S S S S S 
NT = non-typeable, CEF= cefotaxime, CEFT= ceftriaxone, ERT= ertapenem, TRM/SMX= TRM/SMX=trimethroprin/sulphamethoxazole, CH chloramphenicol, 
CD = clindamycin, PG= penicillin G, MERO= meropenem, E= erythromycin, DAP= daptomycin, T= tetracycline, LEVO= levofloxacin, AZI= azithromycin, 
MOXI= moxifloxacin, LIN= linezolid, TIGER= tigecycline and VA= vancomycin 
*The numbers in brackets mean the total number of GBS isolates by serotype 
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All E faecalis isolates were susceptible to tigecycline and most were susceptible to linezolid, 
moxifloxacin, chloramphenicol, trimethroprim/ sulphamethoxazole and vancomycin (Table 23).  
 
Total resistance was observed to penicillin G, ertapenem, cefotaxime, and meropenem with 
increased resistance noted for clindamycin, tetracycline, azithromycin, and daptomycin (Table 
23). 
 
E. faecalis isolates were divided into vancomycin sensitive and vancomycin resistant groups for 
further assignment into specific antimicrobial profile groups as explained previously for Table 
20. The predominant antimicrobial profiles for E. faecalis was observed in AP profile p, 
followed by o (Table 24). 
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4.8. PFGE analysis 
The PFGE analysis of the 57 GBS positive isolates and 24 E faecalis was carried out using 
CHEF – DR II systems from Bio–Rad according to the protocol of Gautom et al., (1997) with a 
few modifications. Figures 15 - 24 show fingerprints or pulsotypes using Sma I restriction 
enzyme. PFGE patterns were analyzed by both computer – assisted program Primer V6 (Clarke 
et al., 2001) and by manual or visual comparison of each banding pattern using criteria 
developed by Tenover et al., (1995). 
 
One of the objectives of this study was to establish the diversity of the GBS and E faecalis 
strains in the population. Genomic DNA was extracted and separated using PFGE. In order to 
determine if the strains were similar or different, restriction digestion was used to generate 
fragments that were separated on agarose gel. Their patterns were analyzed using cluster analysis 
(and MDS ordination).  
 
In all cases, the GBS and E. faecalis samples were of diverse bacterial strains as shown by the 
presence of different restriction patterns arising from the DNA that had been separated using 
PFGE (see diagrams below). The significance of the clusters was to assess if there was any 
pattern that related the strains according to their distribution in an individual and geographic 
location or other biological significance. 
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Fig. 15: PFGE patterns for Group B streptococcus PTD isolates obtained from pregnant women. Lambda ladder was 
used as a standard size marker. Lanes 1& 5: Marker, 2: GBS strain V, 3: P04 H, 4: P12 R, 6: P14 R, 7: P84 R, 8: 
P94 H, 9: P125 R, 10: Control (S. aureus), 11: P131 R, 12: P133 H, 13: P133 R, 14: P143 R. Each lane shows the 
patterns obtained from an isolate from different individuals. Isolates which were obtained from single individuals 
yielded identical respective patterns.  
 
Figure 15 shows fingerprints or pulsotypes using SmaI restriction enzyme. Different band 
patterns are demostrated in lanes 6 and 7 (Fig. 15), while lanes 11 to 13 had identical band 
patterns (Fig. 15). Lane 6 was a NT and lane 7 belonged to serotype V. They both were 
susceptible to penicillin G, clindamycin, erythromycin, cefotaxime, ceftriaxone, moxifloxacin, 
levofloxacin, meropenem, ertapenem, tigecycline, azithromycin, daptomycin, linezolid, 
trimethroprin/sulphamethoxazole, and vancomycin, and resistant to tetracycline. Both were 
isolated from women who had a previous history of PTD.  
 
The serotypes in Lanes 12 and 13 were isolated from a woman who had a previous history of 
PTD and all isolates were susceptible to, moxifloxacin, trimethroprin/sulphamethoxazole, 
tigecycline and linezolid, and resistant to penicillin G, clindamycin, erythromycin tetracycline, 
cefotaxime, ceftriaxone, chloramphenicol, meropenem, ertapenem, azithromycin, daptomycin, 
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trimethroprin/sulphamethoxazole with vancomycin, and intermediate susceptibility to 
levofloxacin observed in one isolate. 
 
Lanes 8 and 14 (Fig. 15) represent serotypes, V and serotype II respectively. The isolates 
belonging to serotype II were susceptible to penicillin G, clindamycin, erythromycin, 
cefotaxime, ceftriaxone, chloramphenicol, meropenem, ertapenem, azithromycin, daptomycin, 
tigecycline, linezolid, trimethroprin/sulphamethoxazole, moxifloxacin, and vancomycin. 
Resistance to, tetracycline was observed in both isolates.  
 
The isolate belonging to serotype V (lane 8) was also resistant to penicillin G, clindamycin, 
azithromycin and erythromycin, with intermediate susceptibility to levofloxacin.  
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Fig. 16: Cluster analysis of the GBS-PTD diversity. 
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Figure 16 shows the dendogram based on PFGE of the GBS isolates, based on the Hierarchical 
clustering, average/UPGMA (Unpaired Group Mean Weight Average) and Euclidian distance 
methods using PRIMER V6. As per the generated dendogram, the results show that the isolates 
were categorized into 3 major cluster groups based on 60% similarity of the genetic profiles of 
the restriction patterns. Most of the GBS strains were genetically diverse except for P92 H, P92 
R and R131 R, P133 H and P133 R, which had 100% similarity and clustered together (Fig. 16). 
Four clusters (A, B, C and D) and 2 isolates with distinct GBS diversity profiles were identified 
(Fig. 15 and 16).  
 
The first cluster (labeled A) had 2 subgroups, A1 and A2. Subgroup A1 belonged to serotype V, 
which included isolate (P130 H), and the second subgroup (A2) consisted of 1 non - typeable 
(NT) isolate (P147 H) (Fig. 16). All the isolates in this cluster were susceptible to the following 
antibiotics tigecycline, chloramphenicol, linezolid, and levofloxacin as well as 
trimethroprin/sulphamethoxazole. The isolate (P130 H) was resistant penicillin G, erythromycin, 
clindamycin, cefotaxime, ceftriaxone, meropenem, ertapenem, daptomycin and vancomycin.  
 
The nontypeable isolate (P147 H) was susceptible to penicillin G, clindamycin, erythromycin, 
cefotaxime, ceftriaxone, meropenem, ertapenem, azithromycin, daptomycin, and vancomycin, 
and resistant to tetracycline and moxifloxacin. 
 
The second cluster (labeled B) had 1 subgroup, which included serotype II isolate P143 R and 
serotype V isolate P115 R plus 2 isolates (P92 H, and P62 H) (Fig. 17). All the isolates in this 
cluster had different serotypes but were all susceptible to the following antibiotics penicillin G, 
clindamycin, erythromycin, cefotaxime, ceftriaxone, chloramphenicol, meropenem, ertapenem, 
azithromycin, daptomycin, tigecycline, linezolid, trimethroprin/sulphamethoxazole, 
moxifloxacin, and vancomycin was observed in all isolates. All were resistant to tetracycline, 
however one isolate (P62 H) was also resistant to trimethroprin/sulphamethoxazole and showed 
intermediate susceptibility to linezolid and isolate P115 showed intermediate susceptibility to 
levofloxacin. In addition, 1 isolate (P115 R), was also resistant to penicillin G, clindamycin, 
azithromycin, cefotaxime, ceftriaxone, chloramphenicol, meropenem, ertapenem, daptomycin 
and clindamycin. 
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The third cluster (labeled C) included serotype V, and had 3 subgroups which included isolates 
(P43 R and P151 R) in the first subgroup, isolates (P144 R, P132 H, P145 R, and P127 H), plus 2 
isolates (P53 R and P129 R) in the third subgroup (Fig. 16 and Fig. 17). All the isolates in this 
third cluster were susceptible to the following antibiotics moxifloxacin, tigecycline, linezolid, 
trimethroprin/sulphamethoxazole and levofloxacin. One isolate was susceptible to 
chloramphenicol.  
 
The fourth cluster (labeled D) included 3 subgroups, one of which included serotype V, isolates 
(P84 R, P12 R, P125 R, P133 H), the second subgroup consisted of 3 isolates (P94 H, P14 H, 
P04 H), and the third subgroup included serotype Ia (P08 H) and serotype V isolate (P123 H) 
(Fig. 16). In the fourth cluster, all the isolates in the second subgroup were susceptible to 
penicillin G, clindamycin, erythromycin, moxifloxacin, tigecycline, linezolid, 
trimethroprim/sulphamethoxazole, levofloxacin, cefotaxime, ceftriaxone, daptomycin, 
meropenem, ertapenem, and vancomycin excluding isolate P94 H which was resistant to 
penicillin G, clindamycin, azithromycin and erythromycin and intermediate to levofloxacin. 
They were all resistant to tetracycline. Furthermore, serotype V which included isolate P112 H, 
was the only one in this cluster which was resistant to ertapenem.  
 
The third subgroup in the fourth cluster, comprised of serotype Ia (P08 H) and serotype V (P123 
H). All the isolates in this subgroup were susceptible to penicillin G, clindamycin, erythromycin, 
moxifloxacin, tigecycline, linezolid, levofloxacin, trimethroprim/sulphamethoxazole, 
cefotaxime, ceftriaxone, daptomycin, meropenem, ertapenem, vancomycin, chloramphenicol, 
and tigecycline, and they were resistant to tetracycline. 
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Fig 17: MDS analysis of the GBS PTD isolates diversity profiles based on a 50% and 60% (middle small circles) 
similarity. The distance between the points shows the relative differences between the isolates diversity profiles. An 
identical symbol shows the isolates that cluster together at 60% identical threshold.  
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Fig. 18: PFGE profiles for Group B streptococcus FTD obtained from clinical samples. Lambda ladder was used as 
a standard size marker. Lanes 1& 5: Marker, 2: GBS strain III, 3: 130 H, 4: 139 H, 6: 141 H, 7: 139 R, 8: 167 H, 
9&15: Control (S. aureus), 10: 193 H, 11: 193 R, 12: 194 H, 13: 216 H, and 14: 219 H. Each lane shows the patterns 
obtained from an isolate from different individuals. Isolates which were obtained from single individuals yielded 
identical respective patterns.  
 
Figure 18 shows the fingerprints of the GBS strains of which some demonstrated distinct band 
patterns. The isolates in lanes (4 and 7) presented identical PFGE fingerprint patterns (Fig. 18). 
For this reason they are considered to be possibly related. Furthermore the PFGE fingerprint 
patterns of isolates number P141 H and sample number 167 H (lanes 6 and 8) shows more than 4 
band differences, consistent with two genetic events. The 2 isolates belong to GBS serotype V, 
and they were isolated from women who had a previous history of FTD. Both isolates were 
susceptible to penicillin G, clindamycin, cefotaxime, ceftriaxone, chloramphenicol, linezolid, 
levofloxacin, ertapenem, vancomycin, tigecycline, trimethroprim/sulphamethoxazole and 
erythromycin excluding the isolate P141 H which showed intermediate susceptibility. Resistance 
to tetracycline was observed in both isolates. 
 
PFGE fingerprint patterns of isolate sample numbers 139 R and sample number 219 H (lanes 7 
and 14) shows more than 4 band differences, consistent with two genetic events of serotypes V 
and III respectively. Susceptibility to penicillin G, clindamycin, levofloxacin, ceftriaxone, 
cefotaxime, chloramphenicol, meropenem, ertapenem, tigecycline, trimethroprim  / sulpha-
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methoxazole, vancomycin and erythromycin was detected in both isolates with resistance to 
tetracycline. 
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Fig. 19: Cluster analysis of the GBS-FTD diversity. 
 
The dendogram shown in Fig. 19 was based on PFGE of the GBS isolates, the dendogram drawn 
based on the Hierarchical clustering, average/UPGMA (Unpaired Group Mean Weight Average) 
and Euclidian distance methods using PRIMER V6. Figure 19 show the dendogram presented 
using the cluster analysis. The results show that the isolates fall into 3 clusters based on 60% 
similarity of the genetic profiles of the restriction patterns (Fig. 19). As per the generated 
dendogram, most of the GBS strains here were genetically diverse except for those found in 
isolates number 114 H, 112 H and 114 R and also isolates number 139 H and 139 R, which had 
100% similarity and clustered together (Fig. 19). The results indicate that all individuals 
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harboured different strains of GBS in the rectal (R) and vaginal (H) samples. Three major 
clusters of the GBS strains were identified but they did not have a notable characteristic to 
explain the similarities between the isolates.  
 
The first cluster (labeled E) included one subgroup, which had serotypes III, consisting of 3 
isolates (114 H, 114 R 95 R and 112 H), and 1 isolate belonging to serotype V (99 R). 
 
The second cluster (labeled F) included one subgroup which consisted mostly of serotypes V and 
included 7 isolates (F1 to F7) (139 H, 139 R, 167 H, 130 H, and 193 R) excluding one isolate 
(193 H) belonging to serotype IV, plus 2 distinct isolates, the belonging to serotype V (104 R 
and 111 H) (Fig.19 and Fig.20). All the isolates in this cluster belonging to serotype V were 
susceptible to penicillin G, clindamycin and erythromycin. However, the distinct isolates were 
only susceptible to penicillin G and erythromycin. 
 
The third cluster (labeled G) included 1 subgroup, (G1) which included serotype III, isolate 118 
R, and the second one (G2) had serotype V, isolate 120 R (Fig. 19). All the isolates belonging to 
this cluster were susceptible to penicillin G, clindamycin and erythromycin. 
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Fig 20: MDS analysis of the GBS FTD isolates diversity profiles based on a 40% and 60% (middle small circles) 
similarity. The distance between the points shows the relative differences between the isolates diversity profiles. An 
identical symbol shows the isolates that cluster together at 60% identical threshold. 
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Fig. 21: PFGE patterns of three isolates with different DNA profiles. Lanes 1: Marker, Lanes 2 and 3, PFGE of two 
different isolates from samples with same patterns belonging to serotype V isolates Lanes 4 – 5, PFGE from strains 
with GBS serotypes III isolates 
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The results demonstrate that GBS colonized women may harbour different serotypes. 
Distinguishable PFGE profiles were observed for serotypes III and V (Fig. 21). The two isolates 
from serotype III were susceptible to penicillin G, clindamycin, erythromycin, tigecycline 
azithromycin, cefotaxime, ceftriaxone, ertapenem, meropenem, daptomycin, linezolid and 
vancomycin. Resistant was observed to tetracycline. Intermediated was detected in moxifloxacin 
and levofloxacin. These two isolates were isolated from women who had a previous history of 
FTD. 
 
Lanes 2 and 3 represent patterns of GBS serotype V (Fig. 21). They were susceptible to 
penicillin G, clindamycin, erythromycin, ertapenem, meropenem, moxifloxacin, 
chloramphenicol, daptomycin, trimethroprin/sulphamethoxazole, levofloxacin, linezolid, 
tigecycline azithromycin, cefotaxime, ceftriaxone, and vancomycin and they were resistant to 
tetracycline (Fig. 21). The isolates in Figure 21 were isolated from women who had a previous 
history of PTD. 
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Fig. 22: PFGE patterns for E. faecalis (Group D) obtained from clinical samples. Lanes 1& 5: Marker, 2: 175 R, 3: 
217 H, 4: 217 R, 6: 231 H, 7: 232 H, 8: P88 H, 9: Control (S. aureus), 10: P91 H, 11: P91 R, 12: P95 R, 13: P96 H, 
14&15: P98 H. Each lane shows the patterns obtained from an isolate from different individuals. Isolates which 
were obtained from single individuals yielded identical respective patterns.  
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Figure 22 shows the fingerprints of the epidemiologically unrelated strains (lanes 6 to 14) 
demonstrated distinct patterns. Both isolates were susceptible to 
trimethroprin/sulphamethoxazole, moxifloxacin, chloramphenicol, levofloxacin, linezolid, 
tigecycline and vancomycin. Resistance to penicillin G, clindamycin, erythromycin, tetracycline, 
ertapenem, meropenem, daptomycin, azithromycin, cefotaxime, and ceftriaxone was observed.  
 
The isolates of the two strains (lanes 3 and 4) as well as isolates in lanes (10 and 11) presented 
identical PFGE fingerprint patterns (Fig. 22). These isolates were found to be susceptible to 
trimethroprin/sulphamethoxazole, moxifloxacin, chloramphenicol, levofloxacin, linezolid, 
tigecycline and vancomycin. They were also resistant to penicillin G, clindamycin, 
erythromycin, tetracycline, ertapenem, meropenem, daptomycin, azithromycin, cefotaxime, and 
ceftriaxone. 
 
Sample numbers 231 H and 232 H (lanes 6 and 7) show more than 4 band differences, consistent 
with two genetic events. Susceptibility was detected in both isolates to 
trimethroprin/sulphamethoxazole, moxifloxacin, levofloxacin, linezolid, tigecycline. The 2 
isolates were resistant to penicillin G, clindamycin, tetracycline, ertapenem, meropenem, 
daptomycin, azithromycin, cefotaxime, and ceftriaxone. On the other hand the isolate in lane 7 
was resistant to chloramphenicol, vancomycin, and intermediate to erythromycin.  
 
 
E. faecalis and GBS 
The analysis of E. faecalis isolates revealed 19 pulsotypes. Their antimicrobial susceptibility 
patterns have already been described above.  
 
The results from the PFGE profiles revealed the diversity amongst the GBS strains by serotypes, 
serotypes Ia, II, and IV had 1 band patterns in this study. Serotype V strains had 32 patterns, 
serotype III had 9 patterns. The non-typeable strains had 2 patterns in the current pregnancy 
outcomes.  
 
 
 
 
 
86 
 
P96 H
P98 H
P80 H
P82 H
P82 R
P03 R
P72 H
232 H
P75 R
P85 H
175 R
231 H
234 H
P88 H
P61 R
P119 R
P95 R
P09 H
217 H
217 R
P91 H
P91 R
S
am
ples
100 80 60 40 20 0
Similarity (%)
R
e
se
m
b
la
n
ce
: S
1
7
 B
ra
y C
u
rtis sim
ila
rity
P96 H
P98 H
P80 H
P82 H
P82 R
P03 R
P72 H
232 H
P75 R
P85 H
175 R
231 H
234 H
P88 H
P61 R
P119 R
P95 R
P09 H
217 H
217 R
P91 H
P91 R
S
am
ples
100806040200
Similarity (%)
R
esem
blance: S
17 B
ray C
urtis sim
ilarity
R
e
se
m
b
la
n
ce
: S
1
7
B
ra
y
 C
u
rt
is
 S
im
il
a
ri
ty
Similarity (Bray Curtis; % )
2
0
  
  
   
  
   
4
0
  
  
   
  
   
6
0
  
  
   
  
   
8
0
  
  
   
  
   
1
0
0
  
  
  
  
   
 
H1
H2
H3
I1
I1
I2
I3
I4
J1
J2
J3
J4
J5
J6
J7
J8
J9
J10
J10
J11
J11
J12
J12
PFGE
H
I
J
 
Fig 23: Cluster analysis of the E. faecalis diversity. 
 
Figure 23 shows that most of the E. faecalis strains were genetically diverse except for those 
found in isolates number P91 H, P91 R and 217 R, 217 H and also isolates number P82 H and 
P82 R, which had 100% similarity and clustered together (Fig. 23).  
 
As indicated by the generated dendogram, isolates were categorized into 3 major cluster groups 
based on 60% similarity of the genetic profiles of the restriction patterns (Fig. 23). The results 
shows that all individuals were infected with different strains of E. faecalis in the rectal (R) and 
also in the vaginal (H) samples except for the isolates number P91, P 82 and 217 which had the 
same strain infecting the three isolates (Fig. 23). The first cluster had two subgroups, with 
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isolates (P98 H and P80 H) and isolate (P96 H) (Fig. 23). All isolates in this cluster were 
susceptible to trimethroprin/sulphamethoxazole, moxifloxacin, chloramphenicol, levofloxacin, 
linezolid, tigecycline and vancomycin, and resistant to penicillin G, clindamycin, tetracycline, 
ertapenem, meropenem, daptomycin, azithromycin, cefotaxime, and ceftriaxone. They were 
isolated from women who had a previous history of PTD.  
 
The second cluster included isolates (P72 H, P03 R and P82 H, P82 R). These isolates were 
susceptible to tetracycline, trimethroprin/sulphamethoxazole, moxifloxacin, chloramphenicol, 
linezolid, tigecycline and vancomycin, levofloxacin and erythromycin. All isolates were resistant 
to penicillin G, clindamycin, ceftriaxone, cefotaxime, ertapenem, meropenem. Furthermore, 2 
isolates in this cluster showed intermediate susceptibility to levofloxacin and the second, to 
azithromycin, and erythromycin. They all were isolated from women with a previous history of 
PTD.  
 
The third cluster had two subgroups, one which included isolates (P91 H, and 127 H) and the 
second subgroup, consisted of 5 isolates (232 H, P88 H, P61 R, P09 H, P119 R) (Fig. 23), plus 5 
distinct isolates (P75 R, P85 H, 175, 231 H, 234 H) (Fig. 24).  
 
In this cluster, all the isolates were susceptible to tigecycline and resistant to penicillin G, 
meropenem. The isolates in the first subgroup (P91 H, and 127 H) were susceptible to 
trimethroprin/sulphamethoxazole, moxifloxacin, levofloxacin, linezolid, tigecycline. They were 
all resistant to penicillin G, clindamycin, ceftriaxone, cefotaxime, ertapenem, meropenem, 
azithromycin, daptomycin, erythromycin, and ertapenem.  
 
The second subgroup, consisted of 5 isolates (232 H, P88 H, P09 H, P61 R, P119 R), 4 of which 
were isolated from women who had a previous history of PTD. All the isolates in the second 
subgroup were susceptible to trimethroprin/sulphamethoxazole, linezolid, tigecycline, 
chloramphenicol, and vancomycin and were all resistant to penicillin G, tetracycline, ertapenem, 
meropenem, daptomycin, cefotaxime, and ceftriaxone. However, one isolate (P61 R) was 
resistant to levofloxacin, azithromycin and daptomycin, while susceptibility to moxifloxacin and 
clindamycin was observed. Meanwhile, isolate (P88 H) was resistant to azithromycin, 
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clindamycin, and intermediate to levofloxacin, and was found to be susceptible to moxifloxacin. 
Isolate (P119 R) was susceptible to azithromycin and levofloxacin, while resistance to 
moxifloxacin, clindamycin and daptomycin was observed. 
 
The results of the 5 distinct isolates demonstrated that these isolates were very diverse, for 
example isolate 231 H showed susceptibility to trimethroprin/sulphamethoxazole, moxifloxacin, 
levofloxacin, linezolid, and tigecycline. Two (2) isolates were resistant penicillin G, 
clindamycin, tetracycline, ertapenem, meropenem, daptomycin, azithromycin, cefotaxime, and 
ceftriaxone. 
 
Isolate 234 H was susceptible to chloramphenicol, levofloxacin, linezolid, and tigecycline and 
resistant to penicillin G, clindamycin, tetracycline, ertapenem, meropenem, daptomycin, 
azithromycin, cefotaxime, trimethroprin/sulphamethoxazole, ceftriaxone and vancomycin. 
 
Isolate P85 H was susceptible to chloramphenicol, moxifloxacin, linezolid, tigecycline, 
trimethroprin/sulphamethoxazole, and vancomycin and resistant to penicillin G, clindamycin, 
erythromycin, tetracycline, ertapenem, meropenem, daptomycin, azithromycin, cefotaxime, 
ceftriaxone. Intermediate susceptibility to levofloxacin was also detected. This isolate was from a 
woman who had a previous history of PTD.  
 
Sample number 175 R was susceptible to moxifloxacin, linezolid, tigecycline, 
trimethroprin/sulphamethoxazole and vancomycin and resistant to penicillin G, clindamycin, 
erythromycin, chloramphenicol, tetracycline, ertapenem, meropenem, daptomycin, azithromycin, 
cefotaxime, and ceftriaxone. 
 
The isolate 75 R was susceptible to penicillin G, clindamycin, erythromycin, chloramphenicol, 
tetracycline, meropenem, azithromycin, cefotaxime, and ceftriaxone, tigecycline, 
trimethroprin/sulphamethoxazole, linezolid and vancomycin and was only resistant to ertapenem, 
daptomycin, erythromycin, cefotaxime and ceftriaxone. 
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Fig 24: MDS analysis showing the clustering of the E. faecalis isolates diversity profiles based on a 40% and 70% 
(middle small circles) similarity. The distance between the points shows the relative differences between the isolates 
diversity profiles. An identical symbol shows the isolates that cluster together at 70% identical threshold.  
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CHAPTER 5: COMPARISON OF GBS AND ENTEROCOCCUS FAECALIS ISOLATION 
WITH PATIENT DEMOGRAPHICS AND PROPOSED RISK FACTORS 
 
 
5.1. Association with maternal demography 
Because GBS and E. faecalis were the predominant Gram-positive cocci isolated, the following 
chapter will focus mainly on these 2 species. Furthermore, maternal height, weight, hygiene 
practices and ethnicity have frequently been associated with adverse pregnancy outcomes due to 
vaginal colonization of GBS and Enterococcus.  
 
 
5.1.1. Association with marital status 
No significant association (p = 1.000) was observed between GBS positive women and marital 
status although GBS was observed slightly more in single women than married women (Table 
25). Six percent of the GBS positive women did not reveal their marital status. This applied to E. 
faecalis as well (Table 25), where E. faecalis was more frequently isolated from single women 
(66.7%) than married women (33.3%). 
 
 
5.1.2. Association with ethnicity  
GBS and E. faecalis appeared to be more prevalent in black than coloured or white women 
(Table 25). Thirty - three of the 50 women who were colonized with GBS did not reveal their 
ethnicity or race group nor did 3 women colonized by E. faecalis. 
 
 
5.1.3. Association with age  
The mean (SD) age of GBS positive women was 28.6 (±5.3) years, with an age range from 17-42 
years. The study revealed a higher GBS colonization rate among the women in the age group 26-
30 years (34.0%), followed by age group 17-25 years (30.0%). GBS colonization appeared to 
decrease with increased age (Table 25). Lower rates were reported from age groups 31-35 years 
(20.0%), 36-40 years (10.0%), and ≥ 41 years (4.0%). One woman did not reveal her age and 
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despite the inverse proportion noted between increased age and decreased colonization, this was 
not statistically significant (p = 0.613).  
 
Unlike GBS, E. faecalis colonization was more frequently observed in women between 31-35 
years (47.6%), with a smaller percentage (23.8%) in the age groups of 17-25 years and 26-30 
years (Table 25). 
 
 
5.1.4. Correlation with maternal height 
The mean (SD) height of the GBS positive women was 158.3 cm (± 7.81), with only 30 women 
having recorded their height and the remaining 20 (40.0%) not responding to this question.  
 
No significant correlation was found between maternal height and E. faecalis colonization (Table 
25), and 2 women who were E. faecalis positive, did not reveal their height.  
 
 
5.1.5. Correlation with maternal weight  
No significant correlation could be found between maternal weight and GBS nor with E. faecalis 
colonization, although their prevalence increased in mothers weighing ≥ 61 kg (Table 25). 
 
 
5.1.6. Association with personal hygiene habits  
Personal hygiene habits were not significantly associated with GBS colonization, nor with E. 
faecalis colonization. Because most mothers reported hand-washing as their means of hygiene 
practice, the prevalence of both species was much higher in women who hand-washed (Table 
25). Similar proportions were noted for both species in women who bathed, while the lowest 
prevalence occurred in women who showered, since this was not the most frequently used 
method of keeping clean. 
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Table 25: Association between maternal demography and GBS/E. faecalis colonization  
Categories/ Variables GBS positive (n = 50)  
No. (%) 
E. faecalis positive (n = 21)  
No. (%) 
Marital status   
Married 21 (42.0%) 7 (33.3%) 
Single 26 (52.0%) 14 (66.7%) 
Missing 3 (6.0%) 0 (0%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 1.000 0.501 
   
Ethnicity   
Black 16 (32.0%) 15 (71.4%) 
Coloured 1 (2.0%) 3 (14.3%) 
White 0 (0%) 0 (0%) 
Missing  33 (66.0%) 3 (14.3%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 1.000 0.256 
   
Age groups Mean (SD): 28.6 (±5.3)   
17-25 15 (30.0%) 5 (23.8%) 
26-30 17 (34.0%) 5 (23.8%) 
31-35 10 (20.0%) 10 (47.6%) 
36-40 5 (10.0%) 1 (4.8%) 
≥41 2 (4.0%) 0 (0%) 
Missing 1 (2.0%) 0 (0%) 
Total 50 (100.0%) 21 (100.0%) 
p – value 0.613 0.291 
   
Height (cm) Mean (SD): 158.03 (±7.81)   
≤ 150 5 (10.0%) 3 (14.29%) 
151 – 155 8 (16.0%) 4 (19.05%) 
156 – 160 5 (10.0%) 7 (33.33%) 
161 – 165 8 (16.0%) 4 (19.05%) 
>165 4 (8.0%) 1 (4.76%) 
Missing 20 (40.0%) 2 (9.52%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.644 0.721 
   
Weight (kg) Mean (SD):72.8 (±15.41)   
≤ 50 1 (2.38%) 0 (0%) 
51 – 55 3 (7.14%) 2 (10.0%) 
56 – 60 4 (9.52%) 2 (10.0%) 
61 – 65 9 (21.43%) 3 (15.0%) 
>65 25 (59.52%) 13 (65.0%) 
Total  42 (100.0%) 21 (100.0%) 
p – value 0.630 1.000 
   
Personal Hygiene   
Bath 13 (26.0%) 5 (23.8%) 
Hand wash 34 (68.0%) 15 (71.4%) 
Shower/douche 3 (6.0%) 1 (4.8%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.950 0.616 
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test with Yates corrections and Fisher exact test 
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5.2. Association with socio – economic standards  
All participants in this study were from lower socio–economic groups. Locations of residence, 
level of education and employment status are closely inter–connected, since they provide 
evidence of the socio – economic standards of the mothers. This has a direct bearing on income 
and access to medical care. A significant correlation was found between GBS colonization and 
location but not for E. faecalis (Table 26). 
 
 
Table 26: Influence of socio – economic standards 
Categories/ Variables GBS positive (n = 50)  
No. (%) 
E. faecalis positive (n = 21)  
No. (%) 
Location of the population (MOU)   
MMH 18 (36.0%) 4 (19.0%) 
KMOU 16 (32.0%) 7 (33.3%) 
MP 12 (24.0%) 6 (28.6%) 
GUG 4 (8.0%) 4 (19.0%) 
Total 50 (100.0%) 21 (100.0%) 
p – value 0.000** 0.836 
   
Education   
Primary school (G1-G7) 2 (4.0%) 3 (14.3%) 
High school (G8-12) 48 (96.0%) 18 (85.7%) 
University 0 (0%) 0 (0%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.499 0.808 
   
Employment   
Yes 19 (38.0%) 6 (30.0%) 
No 31 (62.0%) 14 (70.0%) 
Total  50 (100.0%) 20 (100.0%) 
p – value 0.925 0.480 
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test with Yates corrections and Fisher exact test 
 
 
Although the prevalence of both GBS and E faecalis was considerably increased in mothers with 
high school education (96.0% and 85.7% respectively) and in those who were unemployed 
(62.0% and 70.0% respectively), this association was not significant (Table 26).  
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5.3. Medical history of the GBS – positive women 
 
5.3.1. Association with previous STD 
Seven (14.0%) of the women with GBS reported a history of STD. Six (12.0%) of the women 
did not respond to the question. There was no significant association between reported history of 
previous STD (p = 1.000) and GBS colonization (Table 27).  
 
Only 4 of the 21 women with E. faecalis reported a history of STD (19.0%) and 3 (14.3%) did 
not respond to the question.  
 
 
5.3.2. Association with HIV 
Fifteen (30.0%) women with GBS reported that they were HIV-positive and 4 (8.0%) refused to 
disclose their HIV-sero-status in this study. As with other STD history, no statistically significant 
association was revealed (p = 0.440) between HIV–sero-status and GBS (Table 27). 
 
Eleven of 21 (52.4%) of the women colonized with E. faecalis were HIV–positive, while 9.5% 
of women with E. faecalis refused to disclose their HIV–sero-status. E. faecalis colonization was 
not significantly associated with HIV infection.  
 
 
5.3.3. Association with current symptoms of genito – urinary tract infection 
GBS colonization was significantly associated (p = 0.000) with the presence of a vaginal 
discharge or current urinary tract infection (Table 27).  
 
Of those who haboured E. faecalis, 13 (61.9%) reported a vaginal discharge and 1 (4.8%) had a 
urinary tract infection. The association of E. faecalis with current symptoms of genito – urinary 
tract infection was not significant (p = 0.265). 
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Table 27: Maternal Medical History and GBS/E. faecalis colonization 
Categories/ Variables GBS positive (n = 50) 
No. (%) 
E. faecalis positive (n = 21)  
No. (%) 
Previous STD   
Yes 7 (14.0%) 4 (19.0%) 
No 37 (74.0%) 14 (66.7%) 
Unknown 6 (12.0%) 3 (14.3%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 1.000 0.332 
   
HIV status   
Positive 15 (30.0%) 11 (52.4%) 
Negative 31 (62.0%) 8 (38.1%) 
Unknown 4 (8.0%) 2 (9.5%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.440 0.061 
   
Current Symptoms of Genito – urinary tract infection   
Vaginal discharge 19 (38.0%) 13 (61.9%) 
Urinary tract infection 2 (4.0%) 1 (4.8%) 
Both 1 (2.0%) 1 (4.8%) 
No symptoms 28 (56.0%) 6 (28.6%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.000** 0.265 
   
Smoking   
Yes 9 (18.0%) 2 (9.5%) 
No 41 (82.0%) 19 (90.5%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.446 0.750 
   
Alcohol use   
Yes 4 (8.0%) 1 (4.8%) 
No 46 (92.0%) 20 (95.2%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.798 0.705 
   
Lifestyle illnesses   
Hypertension 4 (8.0) 3 (14.3%) 
Diabetes 1 (2.0%) 0 (0%) 
other: low blood pressure, asthma, anaemia, TB , previous 
UTI 
4 (8.0%) 1 (4.8%) 
No symptoms 41 (82.0%) 17 (81.0%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.326 0.477 
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). P-value obtained by Chi-square 
test with Yates corrections and Fisher exact test 
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5.3.4. Association with substance use  
No statistically significant association was observed between alcohol consumption and smoking 
with GBS nor E. faecalis colonization (Table 27). Nine (18.0%) of the 50 pregnant women 
colonized with GBS reported smoking and 4 (8.0%) consumed alcohol (Table 27). Only 1 
woman with E. faecalis reported consuming alcohol while pregnant and 2 admitted to smoking.  
 
 
5.3.5. Association with diseases of lifestyle  
Forty - one (82.0%) GBS positive women in this study had no medical history of hypertension, 
diabetes, urinary tract infection, asthma, TB nor low blood pressure. Four (8%) GBS-positive 
and 3 E. faecalis-positive women reported a medical history of hypertension. One (2.0%) GBS-
positive woman was diabetic (Table 27). Of those who reported a history of low blood pressure, 
asthma, anaemia, TB, urinary tract infection, 4 were GBS-positive and 1 was E. faecalis-positive 
(Table 27). No statistically significant association was observed with past medical history of the 
women and GBS or E. faecalis colonization in this study (Table 27).  
 
 
5.4. Reproductive histories of the women 
5.4.1. Association with parity  
The mean (SD) parity of the 50 GBS positive women in this study was 1.28 (±1.11), with a range 
from 0 - 5. A marginal significant difference was observed between GBS colonization and parity 
(p = 0.046).  
 
The mean (SD) parity of the 21 women who were colonized with E. faecalis in this study was 
1.42 (± 0.06), with a parity range from 0 – 3. No significant association was found between 
parity and E faecalis (Table 28). 
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5.4.2. Association with gravidity  
Gravidity ranged between 0 – 3 for GBS-positive women as well as for E. faecalis-positive 
women (Table 28). Although the colonization rate for both species decreased as the gravidity 
increased, this was not statistically significant.  
 
Table 28: Reproductive histories associated with GBS and E. faecalis prevalence  
Categories/ Variables GBS positive (n = 50) 
No. (%) 
E. faecalis positive (n = 21)  
No. (%) 
Parity Mean (SD): 1.28 (±1.11)   
0 – 3 49 (98.0%) 21 (100.0%) 
4 – 5 1 (2.0%) 0 (0%) 
≥ 6 0 (0.0%) 0 (0%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.046** 1.000 
   
Gravidity Mean (SD): 2.69 (±1.2)   
0 – 3 42 (84.0%) 17 (80.95%) 
4 – 5 6 (12.0%) 3 (14.28%) 
≥ 6 2 (4.0%) 1 (4.76%) 
Total  50 (100.0%) 21 (100.0%) 
p – value 0.150 0.685 
   
Previous Infant weight 
Mean (SD): 4.62 (±1.46) 
  
≤ 499 g 1 (3.4%) 0 (0%) 
500 - 999 g 2 (6.9%) 2 (10.5%) 
1000 – 1499 g 4 (13.8%) 1 (5.3%) 
1500 – 1999 g 5 (17.2%) 1 (5.3%) 
2000 – 2499 g 5 (17.2%) 4 (21.1%) 
2500 g + 12 (41.4%) 11 (57.9%) 
Total  29 (100.0%) 19 (100.0%) 
p – value 0.176 0.917 
   
Previous pregnancy outcomes   
PTD 29 (58.0%) 14 (66.7%) 
FTD 21 (42.0%) 7 (33.3%) 
Total 50 (100.0%) 21 (100.0%) 
p – value 0.290 0.117 
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test with Yates corrections Fisher exact test and Wilcoxon – Man U test 
 
 
5.4.3. Association with previous infant weight  
Of the 29 women with GBS who reported on the weight of previous infant delivery, 17 (58.6%) 
delivered infants weighing < 2500 g, i.e. low birth weight infants. Only 8/19 (42.1%) women 
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with E. faecalis reported previous delivery of low birth weight infants (Table 28). However, 
neither of these associations were found to be statistically significant.  
 
 
5.4.4. Association with previous preterm delivery  
A history of preterm delivery is considered by many to be a risk factor for future adverse 
pregnancy outcomes. Of the mothers who were GBS positive, 58.0% reported a history of PTD 
(Table 28). In the case of E. faecalis 66.7% reported a history of PTD. This association was not 
found to be significant (Table 28).  
 
5.5. Association of GBS and E. faecalis-positive AV with obstetric history 
The results show that in this studied population AV was detected in 79 women. Of these, 60 
(75.9%) presented without any GBS or E. faecalis, and 39.2% (31/79) had a history of previous 
PTD. AV with GBS was detected in 10 of 79 (12.7%) of the women (Table 29) and AV with E. 
faecalis was detected in 9 (11.4%) of the women. No statistically significant correlation between 
AV and GBS colonization nor with AV and E. faecalis colonization was observed with previous 
pregnancy outcomes (Table 29). 
 
Table 29: Compared AV with GBS in previous pregnancy outcomes (N = 79) 
Variables/ Categories Frequency (%) Previous pregnancy outcomes 
 
p – value 
PTD (n = 42)  
No. (%)  
FTD (n = 37)  
No. (%) 
     
GBS-associated AV 10 (12.7%) 5 (11.9%) 5 (13.5%) 1.000 
     
E. faecalis-associated AV 9 (11.4%) 6 (14.3%) 3 (8.1%) 0.490 
     
GBS and E. faecalis-negative 
AV  
60 (75.9%) 31 (73.8%) 29 (78.4%) 0.833 
     
Total AV 79 (100.0%) 42 (100.0%) 37 (100.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
GBS and E faecalis were simultaneously detected in 1 (1.3%) pregnant woman in this study 
population.  
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CHAPTER 6: CURRENT PREGNANCY OUTCOMES OF THE STUDY POPULATION 
 
Although not present at the time of delivery, we obtained the pregnancy outcomes of mothers 
who participated in the study from their folders. Not all of the folders could be retrieved, so this 
chapter will report only on the 199 of the 301 mothers (66.1%) whose folders we were able to 
access. One hundred and one of the 199 mothers (51.0%) delivered PT while the remaining 
(49.0%) delivered FT. 
 
 
Table 30: Current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
 
p – value 
PTD (n = 101)  
No. (%)  
FTD (n = 98)  
No. (%) 
     
Current Infant weight (kg) 
Mean (SD): 5.3 (±7.41) 
 Mean (SD): 4.96 (± 6.3) Mean (SD): 5.65 (± 8.30) 0.348 
≤ 499 g 0 (0%) 0 (0%) 0 (0%)  
500 - 999 g 5 (2.55%) 5 (5.0%) 0 (0%)  
1000 – 1499 g 3 (1.53%) 2 (2.0%) 1 (1.1%)  
1500 – 1999 g 8 (4.08%) 6 (5.9%) 2 (2.1%)  
2000 – 2499 g 16 (8.16%) 15 (14.9%) 1 (1.1%)  
2500 g + 164 (83.67%) 73 (72.3%) 91 (95.8%)  
Total  196 (100.0%) 101 (100.0%) 95 (100.0%)  
     
Current mode of delivery    0.753 
Abortion 1 (0.5%) 0 (0%) 1 (1.0%)  
Caesarian section 46 (23.1%) 32 (31.7%) 14 (14.3%)  
Normal vaginal delivery 146 (73.4%) 67 (66.3%) 79 (80.6%)  
Born before arrival at 
hospital 
4 (2.0%) 1 (1.0%) 3 (3.1%)  
Still born 2 (1.0%) 1 (1.0%) 1 (1.0%)  
Total  199 (100.0%) 101(100.0%) 98 (100.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
 
 
 
 
 
 
100 
 
 
 
6.1. Gestation age of infants  
One hundred and one (101) infants were born preterm (i.e. <37 weeks gestation) and 98 were 
born full – term (i.e. >37 weeks gestation) (Table 30).  
 
 
6.2. Infant birth weight  
The frequency of infants born with normal birth weight (>2500 g) and low birth weight (≤ 2500 
g) are listed in (Table 30). Thirty - two of the 196 recorded births were low birth weight (LBW) 
infants. Of these, 28 (88.0%) were delivered preterm (PT) and 4 were delivered full – term (FT). 
LBW infants constituted 28.0% of those born PT.  
 
 
6.3. Mode of delivery  
Thirty – two (31.7%) of the PTD infants were delivered by Caesarian section and 67 (66.3%) 
were by normal vaginal delivery (Table 30). One PTD infant and 1 FTD infant were still born. 
Only 14 FT infants were delivered by Caesarian section.  
 
 
6.4. Association of maternal demography with current pregnancy outcomes  
The questionnaire responses of the mothers were used to associate perceived risks for PTD with 
the current pregnancy outcomes. Maternal age, weight, height, ethnicity, personal hygiene habits 
and obstetric history were analyzed using Chi – square and Fisher’s exact tests. 
 
 
6.4.1. Association with Age  
Only 99 of the 101 mothers who delivered preterm recorded their ages. There was no significant 
difference between those who delivered PT and those who delivered FT (Table 31). 
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If we separated these into the groups according to current delivery status, those among PTD 
group, demonstrated an age range of 19 – 42 years. Of these women in PTD group, higher 
frequency was revealed among the age group 26 – 30 years (38.4%), followed by 27.3% from 
age group 17 – 25 years, 25.3% from 31 – 35 years, and 8.1% from age group 36 – 40 years 
(Table 31). One woman (1.0%) in the age group of ≥ 41 years delivered PT. Two women (2.0%) 
did not reveal their age in PTD group. 
 
In women from the FTD group, their ages ranged from 17 – 42 years (Table 31). The results 
showed that the majority of the women were from the age group 26 – 30 (35.8%), followed by 
25.3% aged 31 – 35 years and 22.1% from age group 17 – 25 years. Eleven (11.6%) women 
were from the age group 36 – 40 years, and 5 women aged ≥ 41 (5.3%). 
 
 
6.4.2. Association height  
Only 150 of the 199 mothers recorded their height. Of the 64 who delivered PT, most (70.3%) 
measured ≥ 165 cm in height. FTD increased in mothers with >160 cm in height but this 
difference was not significant (Table 31).  
 
 
6.4.3. Association with weight  
Although 7/10 mothers (70.0%) weighing between 51 – 55 kg delivered PT, maternal weight 
could not be significantly associated with pregnancy outcomes in this group (Table 31). Sixty 
percent of mothers delivering PT weighed > 65 kg.  
 
 
6.4.4. Personal hygiene  
Personal hygiene practices significantly affected pregnancy outcomes (p = 0.000). Thirteen of 
the mothers reported cleaning themselves by showering, of whom 9 (69.2%) delivered PT. Fifty 
– one point one percent (69/135) of mothers who reported hand washing, delivered PT 
constituting 68.3% of PT deliveries (Table 31). 
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Table 31: Pregnancy outcomes compared with maternal personal demography  
Variables/ Categories Frequency (%) Current pregnancy outcomes 
 
p – value 
PTD (n = 101)  
No. (%)  
FTD (n = 98)  
No. (%) 
     
Age groups Mean (SD): 29.3 
(± 5.4) 
 Mean (SD): 28.3 (± 5.11) Mean (SD): 29.8 (± 5.66) 0.390 
17-25 48 (24.7%) 27 (27.3%) 21 (22.1%)  
26-30 72 (37.1%) 38 (38.4%) 34 (35.8%)  
31-35 49 (25.3%) 25 (25.3%) 24 (25.3%)  
36-40 19 (9.8%) 8 (8.1%) 11 (11.6%)  
≥41 6 (3.1%) 1 (1.0%) 5 (5.3%)  
Total 194 (100.0%) 99 (100.0%) 95 (100.0%)  
Missing 5 (2.5%) 2 (2.0%) 3 (3.1%)  
     
Height (cm) Mean (SD): 
157.7 (± 8.2) 
 Mean (SD): 156.4 (± 9.58) Mean (SD): 158.7 (± 6.95) 0.063 
≤ 150 18 (12.0%) 9 (14.1%) 9 (10.5%)  
151 – 155 36 (24.0%) 17 (26.6%) 19 (22.1%)  
156 – 160 43 (28.7%) 19 (29.7%) 24 (27.9%)  
161 – 165 37 (24.7%) 14 (21.9%) 23 (26.7%)  
>165 16 (10.7%) 5 (7.8%) 11 (12.8%)  
Total  150 (100.0%) 64 (100.0%) 86 (100.0%)  
Missing 49 (24.6%) 37 (36.6%) 12 (12.2%)  
     
Weight (kg) Mean (SD):73.4 
(± 14.89) 
 Mean (SD): 71.07 (± 13.73) Mean (SD): 75.53 (± 15.63) 0.937 
≤ 50 4 (2.3%) 2 (2.5%) 2 (2.2%)  
51 – 55 10 (5.8%) 7 (8.6%) 3 (3.3%)  
56 – 60 22 (12.8%) 8 (9.9%) 14 (15.4%)  
61 – 65 25 (14.5%) 15 (18.5%) 10 (11.0%)  
>65 111 (64.5%) 49 (60.5%) 62 (68.1%)  
Total  172 (100.0%) 81 (100.0%) 91 (100.0%)  
Missing 27 (13.6%) 20 (19.8%) 7 (7.1%)  
     
Personal Hygiene     
Bath 48 (24.5%) 23 (22.8%) 25 (26.3%) 0.000** 
Hand wash 135 (68.9%) 69 (68.3%) 66 (69.5%)  
Shower 13 (6.6%) 9 (8.9%) 4 (4.2%)  
Total  196 (100.0%) 101 (100.0%) 95 (100.0%)  
Missing 3 (1.5%) 0 (0%) 3 (3.1%)  
     
Ethnicity    0.000** 
Black 147 (78.2%) 70 (73.7%) 77(82.8%)  
Coloured 41 (21.8%) 25 (26.3%) 16 (17.2%)  
Total  188 (100.0%) 95 (100.0%) 93 (100.0%)  
Missing  11 (5.5%) 6 (5.9%) 5 (5.1%)  
     
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
 
6.4.5. Ethnicity  
A significant difference between PT and FT deliveries was observed for the different ethnic 
groups (Table 31). Of the 95 PT deliveries, 73.7% were blacks, compared with 26.3% who were 
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coloured. This represented 78.2% of black mothers and 21.8% of coloured mothers whose 
records we were able to access (Table 31). 
 
6.4.6. Association with socio – economic status  
MMH and GUG were the 2 areas with more PTD than FTD (Table 32). It was not surprising 
since most complicated pregnancies are referred to MMH and patients in GUG were found to be 
extremely disadvantaged socio-economically, with poor education resulting in frequent 
unemployment.  
 
Marital status did not significantly affect pregnancy outcomes. Nor did education and 
employment status. Five of 7 mothers who had university education delivered FT infants 
suggesting a greater awareness of antenatal care among the higher educated.  
 
Table 32: Correlation between maternal socio – economic status and current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
 
p – value 
PTD (n = 101)  
No. (%)  
FTD (n = 98)  
No. (%) 
     
Location of the population 
(MOU) 
   0.152 
MMH 15 (7.5%) 10 (9.9%) 5 (5.1%)  
KMOU 56 (28.1%) 23 (24.8%) 33 (33.7%)  
MP 94 (47.2%) 47 (46.5%) 47 (48.0%)  
GUG 34(17.1%) 21 (20.8%) 13 (13.3%)  
Total 199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Marital status    0.495 
Married 91 (46.2%) 46 (45.5%) 45 (46.9%)  
Single 106 (53.8%) 55 (54.5%) 51 (53.1%)  
Total  197 (100.0%) 101 (100.0%) 96 (100.0%)  
Missing 2 (1.0%) 0 (0%) 2 (2.0%)  
     
Education    0.537 
Primary school (G1-G7) 9 (4.6%) 3 (3.0%) 6 (6.19%)  
High school (G8-12) 181 (91.9%) 95 (95.0%) 86 (88.66%)  
University 7 (3.6%) 2 (2.0%) 5 (5.15%)  
Total  197 (100.0%) 100 (100.0%) 97 (100.0%)  
Missing 2 (1.0%) 1 (1.0%) 1 (1.02%)  
     
Employment     
Yes 78 (39.8%) 40 (40.0%) 38 (39.6%) 0.160 
No 118 (60.2%) 60 (60.0%) 58 (60.4%)  
Total  196 (100.0%) 100 (100.0%) 96 (100.0%)  
Missing 3 (1.5%) 1 (1.0%) 2 (2.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
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6.5. Maternal medical history and pregnancy outcomes  
 
Table 33: Maternal medical history relative to current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
 
p – value 
PTD (n = 101)  
No. (%)  
FTD (n = 98)  
No. (%) 
     
Previous STD    0.278 
Yes 30 (15.08%) 18 (17.8%) 12 (12.2)  
No 143 (71.86%) 69 (68.3%) 74 (75.51%)  
Unknown 26 (13.1%) 14 (13.9%) 12 (12.24%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
HIV status    0.037** 
Positive 50 (25.1%) 26 (25.7%) 24 (24.5%)  
Negative 133 (66.8%) 68 (67.3%) 65 (66.3%)  
Unknown 16 (8.0%) 7 (7.0%) 9 (9.2%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Current Symptoms of Genito – 
urinary tract infection 
   0.001** 
Vaginal discharge 128 (64.3%) 51 (50.5%) 77 (78.6%)  
Urinary tract infection 13(6.5%) 2 (2.0%) 11 (11.2%)  
Both 3 (1.5%) 2 (2.0%) 1 (1.0%)  
No symptoms 55 (27.6%) 46 (45.5%) 9 (9.2%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Smoking    0.011** 
Yes 21 (10.6%) 15 (14.9%) 6 (6.1%)  
No 178 (89.4%) 86 (85.1%) 92 (93.9%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Alcohol use    0.445 
Yes 17 (8.5%) 7 (6.9%) 10 (10.2%)  
No 182 (91.5%) 94 (93.1%) 88 (89.8%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Lifestyle illnesses    0.935 
Hypertension 15 (7.5%) 11 (10.9%) 4 (4.1%)  
Diabetes 1 (0.5%) 1 (1.0%) 0 (0%)  
Other: low blood pressure, asthma, 
anaemia, TB , previous UTI 
9 (4.5%) 7 (6.9%) 2 (2.0%)  
No symptoms 170 (85.4%) 79 (78.2%) 91 (92.9%)  
Hypertension and diabetes 2 (1.0%) 1 (1.0%) 1 (1.0%)  
Hypertension and urinary tract 
infection 
2 (1.0%) 2 (2.0%) 0 (0%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
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6.5.1. History of STD  
Sixty percent of the mothers (18/30) who reported a history of STD delivered PT. This formed 
17.8% of the total PTD (Table 33). There was no significant association between a history of 
STD and pregnancy outcomes. Fourteen of the women who delivered PTD did not respond to the 
question on STD history. 
 
 
6.5.2. HIV status  
Fifty of the 199 recorded births (25.1%) were mothers who were HIV-positive (Table 33). Of 
these, 52.0% delivered PT. Although the frequency of HIV-positive mothers appeared very 
similar when comparing PTD and FTD, a significant difference was evident (p = 0.037) when 
comparing them with HIV-negative mothers. Seven of the women who delivered PT did not 
reveal their HIV status. 
 
 
6.5.3. Genito - urinary tract infections  
One hundred and twenty – eight women (64.3%) presented with a vaginal discharge, of whom 51 
(40.0%) delivered PT. Vaginal discharge and UTI constituted 50.0% and 2.0% respectively of all 
PTD which differed significantly from the 78.6% and 11.2% with similar symptoms who 
delivered FT (Table 33). Of the 3 mothers who reported both vaginal discharge and UTI, 2 
delivered PT and 1 delivered FT. Fifty – five mothers reported no symptoms which may have 
indicated a genito - urinary tract infection. Of these, 46 (83.6%) delivered PT and 16.4% 
delivered FT. This may indicate the high prevalence of asymptomatic pregnancy complications 
which could be attributed to endogenous microflora imbalance.  
 
 
6.5.4. Smoking and alcohol consumption  
Twenty – one of 199 mothers (10.6%) reported smoking while pregnant. Fifteen of the 21 
mothers (71.4%) delivered PT even though PTD constituted only 14.9% of the total PTD (Table 
33). There was a significant association with smoking between PTD and FTD (p = 0.011). 
Among the 98 who delivered FT, 92 (93.9%) were non- smokers. 
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No significant association was observed for alcohol consumption and pregnancy outcomes 
(Table 33). Only 6.9% acknowledged that they consumed alcohol while pregnant.  
 
 
6.5.5. Lifestyle illnesses  
Eleven of the 15 mothers (73.3%) who reported hypertension delivered PT. When hypertension 
was combined with diabetes, no difference was observed, but when hypertension and urinary 
tract infection were reported in the same individuals (in this case 2) they were both found to 
deliver PT (Table 33). Other illnesses such as low blood pressure, asthma, anaemia, TB or 
previous UTI were reported by 9 of the 199 mothers (4.5%). Despite the above mentioned 
association between hypertension and PTD, no statistically significant association was found (p 
= 0.935).  
 
 
6.6. Previous obstetric histories 
Previous obstetric histories were compared with current pregnancy outcomes in order to identify 
the relevant risk factors for PTD.  
 
No significant difference was observed between pregnancy outcomes of the mothers reporting 
parity of 0 – 3. This group constituted 94.5% of the total of mothers whose pregnancy outcomes 
we managed to access (Table 34). The same applied to gravidity where similar frequency of PTD 
and FTD was reported in the 0 – 3 group. No significant association was found between 
gravidity and current pregnancy outcomes (Table 34). 
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Table 34: Correlation between previous obstetric history and current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
 
p – value 
PTD (n = 101)  
No. (%)  
FTD (n = 98)  
No. (%) 
     
Parity Mean (SD): 1.47 
(±1.12) 
 Mean (SD): 1.30 (± 1.2) Mean (SD): 1.65 (± 1.00) 0.788 
0 – 3 188 (94.5%) 96 (95.0%) 92 (93.1%)  
4 – 5 9 (4.5%) 3 (3.0%) 6 (6.1%)  
≥ 6 2 (1.0%) 2 (2.0%) 0 (0%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Gravidity Mean (SD): 2.8 
(±1.15) 
 Mean (SD): 2.77 (± 1.26) Mean (SD): 2.73 (± 1.03) 0.079 
0 – 3 163 (81.9%) 80 (79.2%) 83 (84.7%)  
4 – 5 28 (14.1) 16 (15.8%) 12 (12.2%)  
≥ 6 8 (4.0%) 5 (5.0%) 3 (3.1%)  
Total  199 (100.0%) 101 (100.0%) 98 (100.0%)  
     
Previous gestation time 
of delivery 
   0.001** 
Preterm delivery (PTD) 101 (50.75%) 22 (21.78%) 79 (80.6%)  
Full term delivery (FTD) 98 (49.25%) 5 (4.95%) 93 (94.9%)  
Total 199 (100.0%)    
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
Ninety – three mothers with a history of FTD, delivered FT in the current pregnancy. A history 
of PTD did not appear to influence current pregnancy outcomes, since 80.6% delivered FT. Even 
though the majority of the women who had a history of PTD delivered full term, they gave birth 
to low birth weight infants in the current pregnancy outcome (Table 30). A statistically 
significant association was observed between obstetric history and current pregnancy outcome (p 
= 0.001). 
 
 
6.7. The effect of AV, GBS and E. faecalis on current pregnancy outcomes 
Seventy – nine women were found to have AV as per the microscopic criteria outlined in chapter 
4. Of these, 50 were GBS – positive and 21 were E. faecalis positive. Of the 301 mothers who 
originally participated in the study, we managed to obtain the pregnancy outcomes for only 199 
women and these will be described in the sections which follow. 
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Table 32 describes the distribution of total AV, GBS and E. faecalis in the 199 cases, while 
Table 34 describes the breakdown of the AV cases in Table 32 into GBS – associated AV, E. 
faecalis – associated AV and AV not associated with either of these species (n = 52). 
 
 
6.7.1. Effect of AV on current pregnancy outcomes 
Fifty – two of the 199 (26.13%) women had AV. Of the mothers with AV, 31 (59.6%) delivered 
PT infants and 21 (40.4%) delivered FT. 
 
No significant difference was observed in pregnancy outcomes of the 52 mothers with AV 
(Table 35) even after these were divided into GBS – associated, E. faecalis – associated and non 
– GBS and non – E. faecalis – associated AV (Table 37).  
 
 
6.7.2. Effect of GBS on current pregnancy outcomes 
GBS was detected in 27 of the 199 women (13.6%) whose pregnancy outcomes were recorded 
(Table 35). Of these 18 (66.67%) delivered PT and 9 (33.33%) delivered FT. GBS accounted for 
17.8% of PTD and 9.18% of FTD. 
 
Four of the 52 cases of AV were GBS – associated (7.7%), all of whom delivered PT (Table 37). 
Because of the small sample number, this association was not considered to be significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
109 
 
Table 35: Effect of AV, GBS and E. faecalis on current pregnancy outcomes  
  Current pregnancy outcomes 
(n = 199) 
 
Variables/ Categories Frequency  PTD (n = 101) 
No. (%) 
FTD (n = 98) 
No. (%) 
p – value 
     
     
AV 52 31 21  
Row %  59.6% 40.4% 0.185 
Column %  30.7% 21.4% 0.185 
     
GBS 27 18 9  
Row %  66.67% 33.3% 0.116 
Column %  17.8% 9.18% 0.116 
     
E. faecalis 17 11  6  
Row %  64.7% 35.3% 0.342 
Column %  10.9% 6.1% 0.342 
     
Total 96 60 36  
     
Non - GBS, Non - E. faecalis - AV 103 41 62  
Row %  39.8% 60.2% 0.002** 
Column %  40.6% 63.3% 0.002** 
     
Total  199 101 98  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
Table 36 describes the GBS serotypes associated with the current pregnancy outcomes. While 
not significantly so, serotype V (80%) appears to be most frequently associated with PTD 
followed by serotype III (10%). One mother who delivered PT had serotypes III and IX (Table 
36) while a NT species was also associated with PT. 
 
Table 36: Correlation of specific GBS serotypes with current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
(n = 32) 
 
p – value 
PTD (n = 20)  
No. (%)  
FTD (n = 12)  
No. (%) 
Specific serotypes of GBS     
III 7 (21.9%) 2 (10.0%) 5 (41.67%) 0.073 
V 23 (71.9%) 16 (80.0%) 7 (58.33%) 0.361 
III & IX 1 (3.13%) 1 (5.0%) 0 (0%) 1.000 
NT 1 (3.13%) 1 (5.0%) 0 (0%) 1.000 
Total 32 (100.0%) 20 (100.0%) 12 (100.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
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6.7.3. Effect of E. faecalis on current pregnancy outcomes 
E. faecalis was found in 8.54% (17 of 199) women (Table 35). Of the 17 mothers who were 
colonized by E. faecalis, 11 (64.7%) delivered PT and 6 (35.3%) delivered FT (Table 35). 
 
Six mothers with E. faecalis had AV (Table 37), but this did not have a significant effect on 
pregnancy outcomes. 
 
 
Table 37: Breakdown of AV – associated bacteria with current pregnancy outcomes 
Variables/ Categories Frequency (%) Current pregnancy outcomes 
(n = 52) 
 
p – value 
PTD (n = 31)  
No. (%)  
FTD (n = 21)  
No. (%) 
     
Non – GBS, Non – E. faecalis 
associated AV  
42 (80.8%) 24 (77.4%) 18 (85.7%) 0.721 
     
GBS – associated AV 4 (7.7%) 4 (12.9%) 0 (0%) 0.138 
     
E. faecalis – associated AV 6 (11.5%) 3 (9.7%) 3 (14.3%) 0.675 
     
Total  52 (100.0%) 31 (100.0%) 21 (100.0%)  
A p-value of less than (p < 0.05) was considered statistically significant at 95% significance level; and p < 0.01 at 
99% significance level.*Highly Significant for the category (**p < 0.01 and *p < 0.05). ). P-value obtained by Chi-
square test (with Yates corrections for 2 x 2 tables) and Fisher exact test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
6.8. Antimicrobial profiles of GBS associated with pregnancy outcomes 
Antibiotic sensitivity patterns were compared with pregnancy outcomes in order to establish 
whether the pregnancy outcomes could be related to the antimicrobials to which the GBS and E. 
faecalis showed resistance. The numbers reflected below, therefore only refer to the positive 
cultures from the 199 mothers whose pregnancy outcomes we were able to record from the 
folders to which we had access.  
 
The sensititre trek system results of the antimicrobial susceptibility analysis for both GBS and E. 
faecalis are shown in Tables 38 and 39 respectively.  
 
GBS isolates showed susceptibility to levofloxacin, linezolid, moxifloxacin, tigecycline, and 
trimethroprim/sulphamethoxazole (Table 38). Increasing resistance was noted for azithromycin, 
cefotaxime, ceftriaxone, chloramphenicol, clindamycin, daptomycin, ertapenem, erythromycin, 
meropenem, tetracycline, penicillin, and vancomycin.  
 
Significant associations were observed between resistant GBS strains and PTD for azithromycin, 
cefotaxime, ceftriaxone, ertapenem, erythromycin, meropenem, tetracycline, penicillin, and 
vancomycin.  
 
The present study had demonstrated the prevalence of resistance among the isolates to antibiotics 
which are commonly used for treatment of GBS infections. When comparing PTD with FTD, 
there was a significant association between pregnancy outcomes and GBS antibiotic resistance to 
the following drugs: azithromycin (p = 0.011), cefotaxime, (p = 0.000), ceftriaxone (p = 0.000), 
meropenem (p = 0.000), ertapenem (p = 0.000), erythromycin (p = 0.011), clindamycin, (p = 
0.000), chloramphenicol (p = 0.012), daptomycin (p = 0.001), penicillin (p = 0.005), tetracycline 
(p = 0.44) and vancomycin (p = 0.002) (Table 38).  
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Table 38: Antimicrobial susceptibility analysis for GBS isolates in the current pregnancy 
outcomes 
 
Current pregnancy outcomes 
 
 
ANTIMICROBIC 
Frequency (%) 
PTD GBS 
N = 20 
 
Frequency (%) 
FTD GB 
N = 12 
 
Frequency (%) 
(N=32) 
P – value 
      
AMOXICILLIN/CLAVULANIC ACID 
 
Susceptible - - -  
Intermediate - - - 
Resistant - - - 
     0.011 
AZITHROMYCIN 
 
Susceptible 6 (30.0%) 10 (83.33%) 16 (50.0%)  
Intermediate - - - 
Resistant 14 (70.0%) 2 (16.67%) 16 (50.0%) 
      
CEFEPIME 
 
Susceptible - - -  
Intermediate - - - 
Resistant - - - 
     0.000 
CEFOTAXIME 
 
Susceptible 6 (30.0%0 12 (100.0%) 18 (56.3%)  
Intermediate - - 
- 
Resistant 14 (70.0%) - 14 (43.8%) 
     0.000 
CEFTRIAXONE 
 
Susceptible 6 (30.0%) 12(100.0%) 
18(56.3%)  
Intermediate - - - 
Resistant 14 (70.0%) - 14 (43.8%) 
      
CEFUROXIME  
 
Susceptible - - -  
Intermediate - - - 
Resistant - - - 
     0.012 
CHLORAMPHENICOL 
 
Susceptible 11(55.0%) 12 (100.0%) 23 (71.9%)  
Intermediate - - - 
Resistant 9 (45.0%) - 9 (28.1%) 
     0.000 
CLINDAMYCIN 
 
Susceptible 6 (30.0%) 12 (100.0%) 18 (56.3%)  
Intermediate - - - 
Resistant 14 (70.0%) - 14 (43.8%)  
     0.001 
DAPTOMYCIN 
 
Susceptible 8 (40.0%) 12 (100.0%) 20 (62.5%)  
Intermediate - - - 
Resistant 12 (60.0%) - 12 (37.5%) 
     0.000 
ERTAPENEM 
 
Susceptible 7 (35.0%) 12 (100.0%) 19 (59.4%)  
Intermediate - - - 
Resistant 13 (65.0%) - 13 (40.6%)  
     0.011 
ERYTHROMYCIN 
 
Susceptible 6 (30.0%) 10 (83.33%) 16 (50.0%)  
Intermediate - - - 
Resistant 14 (70.0%) 2 (16.67%) 16 (50.0%) 
     0.433 
LEVOFLOXACIN 
 
Susceptible 16(80.0%) 8 (66.67%) 24 (75.0%)  
Intermediate 4(20.0%) 4 (33.33%) 8 (25.0%) 
Resistant 0 (0%) - - 
      
LINEZOLID 
 
Susceptible 20 (100.0%) 12 (100.0%) 32 (100.0%)  
Intermediate 0 (0%) - 
- 
Resistant 0 (0%) - - 
     0.000 
MEROPENEM 
 
Susceptible 7(35.0%) 12 (100.0%) 19 (59.4%)  
Intermediate - - - 
Resistant 13 (65.0%) - 13 (40.6%) 
      
MOXIFLOXACIN 
 
Susceptible 19 (95.0%) 11 (91.67%) 30 (93.8%)  
Intermediate - 1 (8.33%) 1 (3.1%) 
Resistant 1 (5.0%) - 1 (3.1%) 
     0.044 
 
TETRACYCLINE 
 
Susceptible 0 (0%) 3 (25.0%) 3 (9.4%)  
Intermediate - - - 
Resistant 20 (100.0%) 9 (75.0%) 29 (90.6%) 
      
TIGECYCLINE 
 
Susceptible 20 (100.0%) 12 (100.0%) 32 (100.0%)  
Intermediate - - - 
Resistant - - - 
     0.005 
PENICILLIN 
 
Susceptible 5 (25.0%) 10 (83.33%) 15 (46.9%)  
Intermediate - - - 
Resistant 15 (75.0%) 2 (16.67%) 17 (53.1%) 
     1.000 
TRIMETHROPRIM/SULPHAMETHOXAZOLE 
 
Susceptible 19 (95.0%) 12 (100.0%) 31 (96.9%)  
Intermediate - - - 
Resistant 1 (5.0%) - 1 (3.1%) 
     0.002 
VANCOMYCIN 
 
Susceptible 9 (45.0%) 12 (100.0%) 21 (65.6%)  
Intermediate - - - 
Resistant 11(55.0%) - 
11 (34.4%) 
The breakpoints were defined by the EUCAST/ CLSI  
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Susceptibility to antibiotics in E. faecalis isolates 
The antimicrobial susceptibility of the 20 E. faecalis isolates shows that 95.0% (19/20) isolates 
of E. faecalis were susceptible to moxifloxacin, followed by susceptible 90.0% (18/20) to 
tigecycline, 85.0% (17/20) to trimethroprim/sulphamethoxazole, 85.0% (17/20) to linezolid and 
75.0% (15/20) to chloramphenicol and vancomycin in this study. Sixty percent (12/20) of the 
isolates were susceptible to levofloxacin. Two isolates 10.0% (2/20) expressed susceptibility to 
clindamycin, 15.0% to daptomycin, and 10.0% (2/20) to erythromycin (Table 39).  
 
 
Intermediate sensitivity to antibiotics in E. faecalis in the current pregnancy outcomes  
For E. faecalis, intermediate sensitivity to levofloxacin was found in 10.0% (2/20 isolates), to 
linezolid in 2 isolates (10.0%), to erythromycin and azithromycin in 5.02% (1/20 isolates) (Table 
39).  
 
 
All 20 E. faecalis isolates (100%) were resistant to ertapenem, cefotaxime, and ceftriaxone, 
followed by 95.0% (19/20) resistant to penicillin, meropenem, azithromycin. Seventeen out of 
twenty isolates 85.0% (17/20) were resistant to, erythromycin, daptomycin and tetracycline 
(Table 37). Resistance to azithromycin was observed in 15 (75.0%), to clindamycin in 13 
(65.0%), to levofloxacin (30.0%), and to tigecycline and linezolid 5.0% respectively. Five 
isolates were resistant to vancomycin. Three isolates were resistant to 
trimethroprim/sulphamethoxazole and chloramphenicol (Table 39). A significant association was 
observed between chloramphenicol resistance and PTD (Table 39). PTD was also associated 
with E. faecalis resistance to ertapenem, cefotaxime, and ceftriaxone, ertapenem, meropenem, 
tetracycline and penicillin.  
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Table 39 Antimicrobial susceptibility patterns for E faecalis isolates (N = 20) in the current 
pregnancy outcomes 
 Current pregnancy outcomes 
 
ANTIMICROBIC 
Frequency (%) 
PTD E. faecalis isolates 
N = 13 
Frequency (%) 
FTD E. faecalis isolates 
N = 7 
Frequency (%) 
(N=20) 
P –value 
      
AMOXICILLIN/CLAVULANIC ACID 
 
Susceptible - - -  
Intermediate - - - 
Resistant - - - 
      
AZITHROMYCIN 
 
Susceptible 4 (30.8%) - 4 (20.0%)  
Intermediate 1 0 (0%) 1 (5.0%) 
Resistant 8 (7.7%) 7(100.0%) 15 (75.0%) 
      
CEFEPIME 
 
Susceptible - - -  
Intermediate - - - 
Resistant 13 (100.0%) 7(100.0%) 20 (100.0%) 
      
CEFOTAXIME 
 
Susceptible - - -  
Intermediate - - - 
Resistant 13 (100.0%) 7 (100.0%) 20 (100.0%) 
      
CEFTRIAXONE 
 
Susceptible - - - 
 
Intermediate - - - 
Resistant 13 (100.0%) 7(100.0%) 20 (100.0%) 
      
CEFUROXIME  
 
Susceptible - - -  
Intermediate - - - 
Resistant - - - 
     0.031 
CHLORAMPHENICOL 
 
Susceptible 13 (100.0%) 4 (57.1%) 17 (85.0%)  
Intermediate - - - 
Resistant - 3 (42.9%) 3 (15.0%) 
      
CLINDAMYCIN 
 
Susceptible 2 (15.4%) 0 (0%) 2 (10.0%)  
Intermediate 4 (30.8%) 1(14.3) 5 (25.0%) 
Resistant 7 (53.8%) 6 (85.7%) 13 (65.0%) 
     0.521 
DAPTOMYCIN 
 
Susceptible 3 (23.1%) 0 (0%) 3 (15.0%)  
Intermediate - - - 
Resistant 10 (76.9%) 7 (100.0%) 17 (85.0%) 
      
ERTAPENEM 
 
Susceptible - - -  
Intermediate - - - 
Resistant 13 (100.0%) 7 (100.0%) 20 (100.0%) 
      
ERYTHROMYCIN 
 
Susceptible 2 (15.4%) 0 (0%) 2 (10.0%)  
Intermediate - 1 (14.3%) 1 (5.0%) 
Resistant 11 (84.6%) 6 (85.7%) 17 (85.0%) 
      
LEVOFLOXACIN 
 
Susceptible 6 (46.2%) 6 (85.7%) 12 (60.0%)  
Intermediate 2 (15.4%) 0 (0%) 2 (10.0%) 
Resistant 5 (38.5%) 1 (14.3%) 6 (30.0%) 
      
LINEZOLID 
 
Susceptible 10 (76.9%) 7 (100.0%) 17 (85.0%) 
 
Intermediate 2 (15.4%) 0 (0%) 2 (10.0%) 
Resistant 1 (7.7%) 0 (0%) 1 (5.0%) 
     1.000 
MEROPENEM 
 
Susceptible 1(7.7%) - 1 (5.0%)  
Intermediate - - - 
Resistant 12 (92.3%) 7 (100.0%) 19 (95.0%)  
     1.000 
MOXIFLOXACIN 
 
Susceptible 11 (84.6%) 6 (85.7%) 17 (85.0%)  
Intermediate - - - 
Resistant 2 (15.4%) 1 (14.3%) 3 (15.0%)  
     0.521 
 
TETRACYCLINE 
 
Susceptible 3 (23.1%) 0 (0%) 3 (15.0%) 
 
Intermediate - - - 
Resistant 10 (76.9%) 7 (100.0%) 17 (85.0%)  
TIGECYCLINE 
 
Susceptible 12 (92.3%) 6 (85.7%) 18 (90.0%) 
Intermediate 1 (7.7%) - 1 (5.0%) 
Resistant 0 (0%) 1(14.3%) 1(5.0%)  
     1.000 
PENICILLIN 
 
Susceptible 1 (7.7%) - 1 (5.0%)  
Intermediate - - - 
Resistant 12 (92.3%) 7 (100.0%) 19 (95.0%)  
     0.270 
TRIMETHOPRIM/SULPHAMETHOXAZOLE 
 
Susceptible 12 (92.3%) 5 (71.4%) 17 (85.0%) 
 
Intermediate - - - 
Resistant 1 (7.7%) 2 (28.6%) 3 (15.0%)  
     1.000 
VANCOMYCIN 
 
Susceptible 10 (76.9%) 5 (71.4%) 15 (75.0%)  
Intermediate - - - 
Resistant 3 (23.1%) 2 (28.6%) 5 (25.0%) 
The breakpoints were defined by the EUCAST/ CLSI  
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6.9. Comparison of serotypes, antibiotic profiles and PFGE profiles with pregnancy 
outcomes 
Summarized results of the antimicrobial pulsotypes using SmaI restriction enzymes for all  GBS 
are shown in (Tables 40). Profiles were indistinguishable if they showed no difference in bands 
and had the same band size. One to 2 band differences were considered to be closely related in 
this study. Profiles within four band differences were considered to be possibly related. Profiles 
that has ≥ 4 or more band differences were considered to be genetically unrelated.  
 
Of the 199 folders we managed to access, only 28 of the 57 GBS isolates were represented with 
24 distinct PFGE profiles (Table 40). Serotypes Ia, II, and IV will not be discussed here because 
we could not access the folders of the mothers from whom they were isolated in order to record 
their pregnancy outcomes. Serotype V had 18 PFGE patterns of which only 4 were associated 
with PTD. Serotype III had 4 patterns which were all FTD, along with the one isolate of serotype 
IX which was also associated with FTD. One NT strain was associated with PTD and was 
distinctly different from the other PFGE patterns (Table 40) and antimicrobial profile (AP) 
groups. Six strains of serotype V, 4 of serotype III, I of serotype IV and 1 NT strain showed the 
same antibiotic profile (Table 40). 
 
Twelve different antimicrobial profiles were observed, of which antimicrobial profile c 
predominated (Table 40), followed by profiles e and f (3 isolates each, 10.7%). Antimicrobial 
profiles a and i were represented (2 isolates each, 7.1%) with only one isolate (3.6%) from 
antimicrobial profiles b, d, j1, h2, l and m (Table 40). 
 
Seven of the PFGE profiles designated C belonged to serotype V, the most common serotype, 2 
of which belonged to antimicrobial profiles e and f each, and the remainder belonged to 
antimicrobial profiles i, h2, and l respectively (Table 40). 
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Table 40: Distribution of GBS serotypes in PTD and FTD 
 
 
 
Only 19 of the outcomes recorded were E. faecalis-positive. For E. faecalis 16 distinct profiles 
was observed. E. faecalis similar profiles revealed similar resistance patterns. Of the 4 PTD, all 
had different PFGE and antimicrobial patterns (Table 41).  
 
Nine diverse antimicrobial profiles were observed in 19 E. faecalis isolates of the mothers whose 
records we accessed. Of the19 E. faecalis isolates, 6 were from antimicrobial profile p (Table 
41), 3 from antimicrobial profiles t and 0, and  2 each from antimicrobial profiles a and s 
respectively (Table 41).  
 
PFGE profiles patterns J11 and J12 showed similar antibiotic profiles with all the other PFGE 
showing heterogeneity (Table 41). 
 
Number of isolates in the current pregnancy outcomes 
Isolate Serotype Antibiotic Profiles (AP) PFGE patterns PTD FTD TOTAL 
       
P 92 H III a B2  1 1 
P 92 R V a B2  -  
P 93 R IX b B1  1 1 
P 04 H III c1 D5  1 1 
P 84 R V c1 D9 1 - 1 
114 H III c1 E3  1 1 
114 R III c1 E3  1 1 
139 H V c1 F7  1 1 
139 R V c1 F7  -  
118 R III c1 G1  1 1 
193 H V c1 F4  1 1 
193 R IV c1 F3  -  
P 123 H V c1 D2  1 1 
167 H V c1 F6  1 1 
P 147 H NT c2 A2 1 - 1 
P 130 H V d A1  1 1 
P 132 H V e C4  1 1 
P 127 H V e C6  1 1 
P 107 R V e D3 1 - 1 
P 12 R V f D8  1 1 
P 151 R V f C2  1 1 
P 144 R V f C3  1 1 
P 115 R V j1 B4 1 - 1 
P 129 R V i C8 1 - 1 
P 125 R V i D8  1 1 
P 53 R V h2 C7  1 1 
P 145 R V l C5  1 1 
P 94 H V m D7  1 1 
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Table 41: Distribution of E. faecalis isolates in the PTD and FTD 
Number of isolates in the current pregnancy outcomes 
Isolate Antibiotic Profiles (AP) PFGE patterns PTD FTD TOTAL 
P 96 H n1 H1 - 1 1 
P 98 H p H2 - 1 1 
P 80 H v H3 - 1 1 
P 82 H  t1 I1 - 1 1 
P 82 R t3 I2 - -  
P 03 H  u I3 1 - 1 
P 72 H o2 I4 - 1 1 
232 H s2 J1 - 1 1 
175 R s1 J4 1 - 1 
231 H p J5 - 1 1 
234 H t2 J6 - 1 1 
P88 H q J7 1 - 1 
P61 H o1 J8 1 - 1 
P119 R o3 J9 - 1 1 
P 95 R r J10 - 1 1 
217 H p J11 - 1 1 
217 R p J11 - -  
P 91 H p J12 - 1 1 
P 91 R p J12 - -  
 
 
A statistical significant association was observed between chloramphenicol (p = 0.031) and E. 
faecalis in current pregnancy outcome (Table 41). 
 
 
6.10. Multivariate analysis of confounding risk factors associated with current PTD 
There are various predisposing factors which have been previously associated with an increased 
risk of GBS colonization, which in turn causes the increased risk for GBS infections in neonates. 
The prevalence of GBS and E. faecalis, in AV was used to determine the confounding risk 
factors for PTD by comparing maternal personal demography of the women (such as location of 
the population (MOU), marital status, education, employment, ethnicity, maternal age, height, 
weight, and personal hygiene), reproductive histories (for example parity, gravidity, previous 
infant weight, and previous delivery history) and medical history of the women (for instance 
previous STD, HIV status, current symptoms of genito - urinary tract infection including AV, 
smoking, alcohol consumption and lifestyle illness).  
 
The multivariate analysis method that was used is the binary logistic regression because the 
dependent variables “delivery status” is a categorical qualitative with two categories (Preterm 
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and Full term). The independent variables included in the model explained 37.4% (Cox and Snell 
R square) of the total variance of the model. The results in Table 42 show that gravidity (p = 
0.003), parity (p = 0.000), current symptoms such as vaginal discharge (p = 0.000) and urinary 
tract infection (p = 0.000), other vaginal species (p = 0.000), and smoking (p = 0.021), are 
significantly associated PTD. When gravidity increases 1 unit (pregnancy) the likelihood of PTD 
decreases 2.624 (OR = [95% CI 1.380 – 4.988]). Similarly when parity increases 1 unit (child) 
women are 0.292 (OR = [95% CI 0.147 – 0.583]) times less at risk of PTD. All the other risk 
factors were found not to be insignificant associated with current PTD. 
 
No statistical significant association was observed between alcohol consumption (p = 0.052), 
GBS (p = 0.061), GBS serotypes (p = 0.063) and current PTD (Table 42). 
 
Table 42: Logistic regression analysis used to assess the influence of obstetric factors associated 
with current PTD  
 Variables B S.E. OR 95% C.I. for OR 
P-value 
Race       
Black -0.231 0.600 0.794 0.245 - 2.572 0.700 
Coloured 0.718 0.851 2.050 0.387 - 10.872 0.399 
HIV status -0.198 0.463 0.820 0.331 - 2.033 0.669 
Current Symptoms of the genitor – urinary infection          
Urinary tract infection -4.049 0.965 0.017 0.003 - 0.116 0.000** 
Vaginal discharge -2.547 0.541 0.078 0.027 - 0.226 0.000** 
Both (discharge and urinary tract infection) -1.789 1.894 0.167 0.004 - 6.846 0.345 
Alcohol consumption -1.773 0.911 0.170 0.029 - 1.012 0.052 
Smoking 2.002 0.868  7.403  1.352 - 40.535 0. 021** 
Parity -1.230 0.352 0.292 0.147 - 0.583 0. 000** 
Gravidity 0.965 0.328 2.624 1.380 - 4.988 0. 003** 
Personal Hygiene  0.250 0.395 1.284 0.592 - 2.782 0.527 
Previous PTD 0.491 0.672 1.634 0.438 - 6.097 0.465 
 GBS  -0.807 0.965 0.164 0.025 - 1.089 0.061 
AV -0.042 0.416 0.959 0.424 - 2.166 0.919 
E. faecalis 0.781 0.706 2.184 0.547 - 8.715 0.268 
Other vaginal species 1.768 0.419 5.858 2.575 - 13.326 0. 000** 
Serotypes 2.066 1.112 7.892 0.892 - 69.837 0.063 
Constant -0.025 1.006 0.975  0.980 
Cox and Snell R Square  37.4%    
Chi-square (Hosmer and Lemeshow Test sig.) 93.281 0. 000 
A p-value of less than (p < 0.05) was considered statistically significant. SE standard error, OR odd ratio, CI 
confidence interval, AV = Aerobic vaginitis, GBS = Group B Streptococci, E. faecalis = Enterococcus faecalis, PTD = 
Preterm Delivery 
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CHAPTER 7: DISCUSSION AND SUMMARY 
 
The World Health Organization (WHO) defines preterm birth (PTB) as birth < 37 weeks 
gestation and low birth weight (LBW) as birth weight < 2500 g, the latter being determined by 
both duration of gestation as well as foetal growth rate (Kramer 1987).  
 
The literature is filled with studies associating maternal infection with adverse pregnancy 
outcomes. Less frequently studied are maternal endogenous infections and the role they play in 
pregnancy outcomes.  
 
This study investigated the prevalence of aerobic vaginitis (AV) in a cohort of pregnant women 
in the Western Cape, South Africa and focused particularly on the role of GBS and Enterococcus 
faecalis on the pregnancy outcomes of the study group. PTD is the leading cause of peri – natal 
mortality and long – term morbidity (Antsaklis et al., 2013), with up to 50% of PTD occuring in 
pregnancies with no known risk factors. 
 
 
FACTORS ASSOCIATED WITH THE RISK FOR PTD 
A number of studies have investigated the demographic factors and past medical history of 
pregnant women who have given birth to early - onset - disease infected neonates (EOD), age, 0-
6 days) (Mellin 2011; Javanmanesh et al., 2012). Risk factors include the maternal age (< 20 
years), ethnicity, the number of previous pregnancies (multiparous), multiple partners, a neonate 
previously diagnosed with EOD, and also socio - economic status (Namavar Jahromi et al., 
2008; Kim et al., 2011; Chawanpaiboon 2011; Zhang et al., 2012). It is believed that women 
from low socio - economic background, women with diabetes, or women colonized with 
sexually transmitted infection (STI) or lower genital tract Candida species, are more likely to be 
at high risk of delivering preterm (Chawanpaiboon 2011; Mellin 2011; Zhang et al., 2012). 
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7.1. Patient demography 
In the present study, demographic factors were examined by way of a questionnaire handed to 
mothers when they were recruited for the study and their responses correlated with the microbial 
analyses and pregnancy outcomes which follow. 
 
7.1.1. Age  
Mothers of very young or advanced age are at risk for adverse pregnancy outcomes (Maghaddam 
et al., 2010; Rocchetti et al., 2011). While some say that an association with age only becomes 
significant when the mother is older than 40 (Hoffman et al., 2007; Nybo Andersen et al., 2000), 
others maintain that ≥ 36 years poses an equal risk (Cnattingius et al., 1992; Delbaere et al., 
2007).  
 
In the present study, the majority of mothers (37%) were aged between 26 – 30 years, followed 
by 28% in the 17 – 25 year age group, of whom very few were aged < 20 years, ruling out the 
risk of adolescent pregnancies which have been associated with increased maternal and infant 
morbidity and mortality (Shrim et al., 2011). A study comparing < 15 year – old mothers with > 
20 year – olds found that mothers ≤ 15 years had a higher risk for both maternal and early 
neonatal death compared with their older counterparts (Conde – Agudelo et al., 2006; Offiah et 
al., 2012), with a likelihood of more PTLBW deliveries (Jolly et al., 2000; Gilbert et al., 2004; 
Chen et al., 2007). 
 
On the other hand, only 25 of the 199 recorded pregnancy outcomes (12.5%) were of mothers > 
36 years of age, of whom 9 (36%) delivered PT and 16 (64%) delivered FT. Childbirth at 
advanced maternal age (i.e. > 35 years) has increased remarkably over the past 3 decades with 
the literature reporting it as 1/12 in 2006, compared with 1/100 in the 1970s (Mathews et al., 
2002; Martin et al., 2009).  
 
Reasons for this increase can be attributed to women becoming more career oriented and 
independent, thus delaying marriage and motherhood. The association of advanced age with PTD 
has also been attributed to associated hormonal factors (Offiah et al., 2012). With the majority of 
mothers in the present study coming from disadvantaged backgrounds, delayed pregnancy was 
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not a factor for consideration, particularly since they were unlikely to be pursuing a career which 
might necessitate such a delay.  
 
Advanced maternal age has been reported with adverse pregnancy outcomes such as miscarriage, 
small for gestational age infants but not with still births and preterm delivery (Goldergberg et al., 
2008; Offiah et al., 2012; Khalil et al., 2013), while in contrast, Kenny et al (2013) found a 
significant correlation between advanced maternal age and still birth, and extremely large for 
gestational age infants. Studies which looked at the relationship between advancing maternal age 
and preterm delivery, reported preterm births in 8% of mothers more than 35 years of age 
compared to less than 4% of births amongst women younger than 35 years (Offiah et al., 2012). 
However there is not enough evidence to establish if advancing maternal age is an independent 
risk factor for preterm birth (Carolan et al., 2010; T’sang – T’ang et al., 2010). Furthermore, 
even though advances in medical care have favoured healthy mothers of advanced age, the need 
for an awareness of possible risk should not be ignored (Seda et al., 2013). 
 
Maternal age has also been significantly associated with caesarian section (Kenny et al., 2013; 
Khalil et al., 2013). Caesarian section in this study appeared to be largely due to concerns for the 
welfare of the infant rather than because of advanced maternal age. Age was therefore not found 
to be an independent risk factor for adverse pregnancy outcomes in this study.  
 
 
7.1.2. Maternal height and weight 
The literature suggests that mothers of shorter stature are more likely to deliver preterm than 
taller mothers with a better developed physical statute (Lao et al., 2000; Chan et al., 2009; 
Mykelstad et al., 2013; Vogel et al., 2014). Increased height, on the other hand was associated 
with decreased PTB in a study by Dickey et al., (2012). It appears that shorter mothers have a 
smaller pelvis which directly influences pregnancy length. This is particularly true in Asian 
mothers and in malnourished underweight mothers of black ethnicity (Lao et al 2000; Patel et 
al., 2004). 
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Underweight and obesity are also recognized risk factors for adverse pregnancy outcomes such 
as preterm birth and LBW (Zhang et al., 2012; van den Broek et al., 2014), with underweight 
mothers showing a 3 – fold increase in risk for PTD (van den Broek et al., 2014). Obese mothers 
weighing > 65 kg are likely to carry heavier infants which may not be carried to term because of 
their weight (Dickey et al., 2012), thereby necessitating medically induced PTD (Parker et al., 
2014). Likewise, underweight mothers have an increased risk of PTD of LBW infants (Han et 
al., 2011; Fujiwara et al., 2014).  
 
Height did not appear to significantly affect pregnancy outcomes nor did colonization of AV – 
associated bacteria in this study although more mothers between 156 and 165 cm in height 
delivered FT infants. On the other hand, mothers weighing less than 55 kg appeared to deliver 
more PT than FT. However this association was not statistically significant, nor was a significant 
association found between weight and colonization of AV - associated GBS and E. faecalis.  
 
 
7.1.3. Socio – economic status of the mothers 
Ethnicity, location, education, employment, marital status and access to medical care are all 
important socio – economic indicators which have independently been implicated as risk factors 
for adverse pregnancy outcomes (Chawanpiaboon et al., 2011; Offiah et al., 2012).  
 
Black ethnicity has been associated with PTD (Aveyard et al., 2002; Goldenberg et al., 2008; 
Subramaniam et al., 2011). However, the approach to ethnicity is often problematic in that there 
is often no standardized classification of ethnicity with some researchers basing their 
classification on skin colour (Sedaghatian et al., 2000) while others base it on area of origin or 
self – reporting. The way in which women assign themselves to a particular ethnic group may 
also bias the outcomes of a study. Mothers classifying themselves as coloured in this study, 
showed a greater risk for PTD then black mothers. This association was found to be statistically 
significant. The difference in proportions between black and coloured mothers (78.2% vs 21.8%) 
may have influenced this association significantly. Their ethnicity would also govern their areas 
in which they lived, which in turn would affect their access to prenatal care. With reduced access 
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to medical care reported in this study, social disadvantage rather than biological factors may 
explain the risk for PTD.  
 
Access to prenatal care has been regarded as a way to reduce prematurity (Lams et al., 2008). 
This seems to originate from the high rate of preterm birth reported in women who receive no 
prenatal care than from the content of care (Lams et al., 2008). A neonate born from a mother of 
African origin was found to have a three times greater chance of developing late - onset disease 
(LOD, age 7 to 90 days) compared to infants of mothers from other ethnic groups (Patel et al., 
2004). 
 
Minority groups are often socio – economically deprived which may compound the issue since it 
includes multiple factors which collectively or independently may contribute to the risk of PTD 
of LBW infants. Other factors such as the small structure associated with mothers of Asian origin 
highlight differences in anatomical differences associated ethnicity (Patel et al., 2004).  
 
All of the subjects in this study came from lower socio – economic areas. This would impact 
directly on their general health and well–being, particularly those from the black community. 
Adequate sanitation and availability of water sources are an important factor to consider. For 
many of the women, the location of their water source required long walking distances which 
could prevent weight gain during pregnancy while also putting a strain on them when carrying 
these water supplies.  
 
Their socio – economic status would also be reflected in their education, employment and 
knowledge of risk factors for adverse pregnancy outcomes. Coming from low socio – economic 
backgrounds, many in this study did not receive any tertiary education and reported only having 
attended high school (91.9%). This directly influenced their employment status with > 60% 
reporting that they were unemployed. Added to this was the fact that the majority were 
unmarried (53.8%). Educational level could also be linked to personal hygiene habits. 
 
With water facilities not being conveniently situated, their consumption of water for personal 
hygiene practices would also be affected. Cleanliness is an important basic concept for maternal 
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and neonatal health and adequate hygiene practices cannot be over – emphasized. Mothers in this 
study were asked to list their general personal hygiene practices. The majority reported that they 
washed by hand (68.9%) while others reported bathing (24.5%) and a few (6.6%) reported that 
they shower. A significant difference in pregnancy outcomes was noted with these different 
practices, (p = 0.000) with showering reflecting the lowest association with PTB.  
 
 
7.1.4. Emotional well – being of the mother 
Previous studies found that maternal exposure to severe life events contributed significantly to 
the risk of preterm birth (Dole et al., 2003; Kramer et al., 2009; Khashan et al, 2009; Zhang et 
al., 2012). These exposures could be defined as death or serious illness of close relatives prior to 
conception or in the first or second trimester of pregnancy (Khashan et al, 2009), increasing the 
preterm birth rate by 16%, while if the severe life event involved an older child, the risk of 
preterm and very preterm birth could be increased by 23% and 59% respectively (Khashan et al, 
2009). This could also be exacerbated by the use of anti – depressants (Huybrechts et al., 2014). 
 
In the present study, around 37% of the women claimed that they had experienced difficult 
situations in the past year but they did not elaborate on what the situations were. Domestic 
violence was only reported by 7.0% with 5% indicating that their partners were not supportive of 
having a baby. One can only assume that the difficult situations described included their living 
conditions and general low socio – economic status.  
 
Besides maternal psychological and social stress, physically strenuous work and lack of social 
support may be related to PTD (Zhang et al., 2012). With the increasing number of mothers who 
carry on to work late into their pregnancy, occupational stress is hypothesized to be an important 
contributor to adverse reproductive outcomes, both for mother and baby (Mutambudzi et al., 
2011). Physical stresses such as shift work, long hours of standing and heavy lifting have 
consistently been associated with increased risk of preterm birth (Mutambudzi et al., 2011). 
Theoretically, having and being able to maintain a job, is in itself an indicator of a higher 
socioeconomic status, which has an inverse effect on preterm birth rates (Offiah et al., 2012). 
Recent studies have found no increase in the rate of preterm birth and employment, but these are 
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mainly studies carried out in developed countries, where physical strain and hazardous working 
conditions are not the norm (Offiah et al., 2012). 
 
With the majority of women in the present study being unemployed (60%), work – related stress 
was not found to be a risk factor. 
 
 
7.1.5. Life – style habits  
Habits such as smoking, alcohol and illicit drug use, poor eating habits, sexual and physical 
activity, are of enormous significance as modifiable risk factors which, if eliminated may lead to 
an effective reduction in the preterm birth rate (Aliyu et al., 2009; Offiah et al., 2012). 
 
Cocaine use has been significantly associated with PTB, LBW, SGA and is associated with 
smoking (Gouin et al., 2011). Cocaine use can also lead to hypertension in the mother and foetus 
which may result in haemorrhages during gestation (Addis et al., 2001). 
 
Cigarette smoking is considered to play a very crucial role in foetal growth restriction (Behrman 
et al., 2007; Murphy 2007; Lams, et al., 2008) and has been strongly associated with adverse 
pregnancy outcomes (Conter et al., 1995; D´onofrio et al., 2003; Knopik et al., 2005; Bada et al., 
2005: Salihu et al., 2005; Kyrklund – Blomberg et al., 2005; Murphy 2007; Behrman et al., 
2007; Lams et al., 2008: Stroud et al., 2009; McCowan et al., 2009; Thiriez et al., 2009). 
Fantuzzi et al., (2007) reported a dose – dependent relationship, while Andres et al., (2013) 
reported no association between smoking and adverse pregnancy outcomes. Smoking has also 
been associated with impaired learning (Cornelius et al., 2001; Batstra et al., 2003; Mortensen et 
al., 2005; Lambe et al., 2006). The effects are more pronounced in women with low socio – 
economic background (Odendaal et al., 2001). 
 
Our results revealed a significant association between smoking and PTD (p = 0.011), where 
15/21 mothers who smoked, delivered PT. Of the 98 who delivered FT, 92 (94%) were non – 
smokers. Furthermore, depression is considered to be associated with the increase in smoking, 
therefore the relation between depression and preterm birth might be mediated by this behaviour.  
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Alcohol consumption during pregnancy may have detrimental effects on foetal development and 
subsequent neonatal survival. Women who have more than one drink a day are at an increased 
risk of preterm delivery. According to a previous study, the risk of preterm delivery and very 
preterm birth (< 32 completed weeks) among women who drink while pregnant, is believed to be 
around 2 – 4% compared to women who do not drink (Offiah et al., 2012). However, earlier 
studies (Shiono et al., 1986) showed no association between PTD and alcohol consumption. The 
impact of alcohol consumption in the present study was significantly associated with PTD (p = 
0.044). Less than 7% of mothers in this study acknowledged that they consumed alcohol during 
pregnancy.  
 
 
7.1.6. Medical history 
Pre – existing hypertension is a major risk factor for adverse pregnancy outcomes. In the present 
study, 15 of 199 mothers (7.5%) reported pre – existing hypertension of whom 11 (73%) 
delivered PT. Of the 4 mothers who reported a combination of hypertension and diabetes, or 
hypertension and UTI, 3 (75%) delivered PT. However, these associations were not statistically 
significant. Since obesity is directly related to hypertensive disorders and diabetes, their control 
is essential to reduce the risk of PTD (Lepercq et al., 2004). 
 
No association between PTB and HIV has been established in recent studies (van den Broek et 
al., 2014; Ndirangu et al., 2014). Even though HIV infection has been reported to have little 
effect on pregnancy outcomes in the developed countries, previous studies from sub – Sahara 
Africa have suggested that infants of HIV infected mothers might be at risk for adverse 
pregnancy outcomes such as lower birth weight, prematurity and neonatal death (Rollins et al., 
2007).  
 
In this study, although the difference between HIV positive and HIV negative mothers showed a 
statistical difference (p < 0.05), HIV could not be significantly associated with pregnancy 
outcomes.  
 
 
 
 
 
127 
 
This study showed that 60% of mothers with a history of STD delivered PT, but this did not 
significantly correlate with pregnancy outcomes although gonorrhea has previously been 
reported to contribute to PTD (Waight et al., 2010).  
 
UTI can cause uterine contractions resulting in PTD (Schieve et al., 1994). A significant 
association (p = 0.001) was observed in this study between current symptoms of genito – urinary 
tract infection of the women and PTD. Women who had a vaginal discharge and urinary tract 
infection were more likely to deliver PT baby.  
 
 
7.1.7. Obstetric and gynaecological history  
A history of PTD has been reported to greatly increase the risk for future PTD (Giraldo et al., 
2012; van den Broek et al., 2014). However, surveys demonstrated that only 24.3% of health 
professionals were aware of the risk of PTD recurrence and only 4% were aware of prophylaxis 
to prevent PTD (Clark et al., 2014). In the present study, only 22 of 101 women who delivered 
PT had a history of previous PTD, while 93/98 who delivered FT had previous FT deliveries. A 
significant difference between PT and FT deliveries was observed in this study (p = 0.001). 
 
PTD was significantly associated with parity (p = 0.000) and gravidity (p = 0.001) in this study. 
Other studies reported that nulliparous women are at greater risk for PTD than multiparous 
women (Hannoun et al., 2012). Particularly if aged < 18 years and > 35 years (Seoud et al., 
2002; Kozuki et al., 2013). Older primiparous women were at greater risk for PTD than older 
multiparous (Lisonkova et al., 2010), and primiparous teenage mothers do not have a risk for 
PTD (Ekwo et al., 2000). Mothers with parity ≥ 6 in the present study delivered PT. No 
association was found between parity and GBS colonization in a study from Turkey (Aynur et 
al., 2005) 
 
Short pregnancy intervals may also influence pregnancy outcomes because the mothers body 
may need time to recover from the stress of the previous pregnancy (Howard et al., 2013), and 
the depletion of essential nutrients (Scholl et al., 2000; Smits et al., 2001). The questionnaire for 
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the present study did not interrogate pregnancy interval so no information is available in this 
regard. 
 
 
7.2. AV –associated bacteria and pregnancy outcomes 
 
7.2.1 Association of AV with pregnancy outcomes 
The typical vaginal microbiota of a woman during her childbearing age is characterized by a 
prevalence of H2O2 – producing Lactobacillus which determine and regulate the vaginal pH, and 
also contribute to the creation and maintenance of a balanced microbiota hostile to the attack of 
microbial pathogens (Shamim et al 2008; Donati et al., 2010). The vagina is a complicated 
environment, containing many microbiological species in variable quantities and relative 
proportions (Shamim et al., 2008). An imbalance of the normal vaginal microbiota has been 
linked to many severe gynecological and obstetric complications such as pelvic inflammatory 
disease, increased risk of acquiring sexually transmitted diseases (STD) and preterm birth 
(Marconi et al., 2013).  
 
Aerobic vaginitis is a vaginal endogenous infection characterized by an imbalance of the normal 
vaginal microbiota and is distinguished from bacterial vaginosis by its ability to promote an 
inflammatory response and its high prevalence of aerobic/facultatively anaerobic microbial 
community as opposed to the predominantly anaerobic microflora of bacterial vaginosis 
(Donders et al., 2011). 
 
The prevalence of mild to moderate AV in pregnancy has been reported as 8 – 10% (Rezeberga 
et al., 2008; Donders et al., 2009; Zodzika et al., 2011). The prevalence in our study was 26%., 
which denotes a very high prevalence among the pregnant women. 
 
The literature reports that AV has an association with miscarriage, preterm labor and preterm 
delivery, due to the inflammation derived from the cervical – vaginal environment (vaginitis) and 
urinary tract infections (Cribby et al., 2008). The cellular components of bacteria such as GBS 
(peptidoglycan and hemolysin) and E. coli (lipopolysaccharide (LPS), are known mediators that 
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trigger the inflammatory reaction, and are proposed to be the contributing agents that could 
initiate preterm labour and neonatal sepsis (Donders et al. 2011). 
 
In the present study, AV was diagnosed microscopically using lactobacilli grading (Donders et 
al., 1999; Donders 2000). Of the 199 pregnancy outcomes which we were able to access, 52 
(26%) were AV-positive. Thirty – one of the 52 (60%) delivered PT, constituting 30% of the 
total (n = 101).  
 
Twenty – seven of the 199 mothers (13.6%) were GBS-positive of whom 18 (66%) delivered PT. 
E. faecalis was isolated from 17/52 (32%) mothers with AV of whom 11 (64%) delivered PT. 
This represented 18% and 11% of the total PTD for GBS and E. faecalis respectively. 
 
The finding of enteropathogenens and S. aureus has previously been reported to be predictive for 
preterm birth (McDonald et al., 1991). In the present study, GBS and E. faecalis were 
predominating isolates and thus further investigation of these two species ensured. 
 
 
7.2.2. Association of GBS with pregnancy outcomes 
Of the bacteria implicated in the aetiology of AV, the presence of GBS in the maternal tract has 
been found to be the major determinant of both infection in the neonate and colonization of the 
newborn (Baltimore 2007). Approximately 10% to 40% of pregnant women are colonized with 
GBS, either in the vagina or rectum, and about 40% to 70% pass on the microorganisms to their 
newborns unknowingly (Votava et al., 2001; Konikkara et al., 2013). For this reason, this study 
will focus mainly on GBS and E. faecalis and their impact on pregnancy outcomes. 
 
The presence of Group B Streptococcus (GBS) in pregnant women is regarded to be one of the 
leading causes of neonatal mortality and morbidity in the world, and is reported to occur in 5 – 
35% of pregnant women (Giraldo et al., 2012). The present study was done in order to determine 
the prevalence of AV and the colonization of AV-associated bacteria in pregnant women in the 
Western Cape, South Africa. In this studied population, (n = 301) the overall GBS prevalence 
among the pregnant women was shown to be high (16.6%). These findings are in accordance 
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with reports from other developing or industrialized countries, such as Germany (16.5%, 
Dzowela 2005); Argentina (3.2%, Toresani et al., 2001); Turkey (8.0%, Bararos et al., 2005); 
India (2.3%, Sharmila et al., 2011); and Mozambique (1.8%, De Steenwinkel et al., 2008), but 
lower than those reported in Ethiopia (20.9%, Mohammed et al., 2012); Tanzania (23%, Joachin 
et al., 2009); Zimbabwe (31.6%, Moyo et al., 2002); the Netherlands (17.2%, Valkenburg – van 
den Berg et al., 2006); Iran (22.76%, Javanmanesh et al., 2013); Brazil (24%, Soares et al., 
2013) and Switzerland (21%, Rausch et al., 2009). Variations between different counties could 
be due to multiple factors including sampling and detection techniques, as well as maternal socio 
– economic and other personal demography (Fatemi et al., 2010). However, identification of risk 
factors are important for the prevention of maternal and neonatal infectious (Mohammed et al., 
2012). 
 
Knowledge of the prevalence of GBS in women would lead to a greater understanding of EOD 
and LOD potential. Regardless of the fact that incidence rates of GBS disease and GBS carrier 
rates are known in numerous industrialized countries, this is often not the case in developing 
countries, although some information is available (Moyo et al., 2002). With prevalence rate 
varying between 12% and 25% in studies reported from South Africa (Schrang et al., 2004; 
Dagnew et al., 2012), little is known about the prevalence of GBS – related adverse pregnancy 
outcomes in the Western Cape, South Africa, making the present study a much needed and 
important one. 
 
 
GBS isolation and characterization 
Routine methods for the identification of GBS  involves culture on blood agar supplemended 
with sheep blood, producing β haemolysis, CAMP testing and biotyping using agglutin reaction 
(Verani et al., 2010). 
 
Association of maternal risk factors for adverse pregnancy outcomes and GBS colonization 
revealed that ethnicity, medical history and personal hygiene habit did not appear to influence 
GBS colonization in this study. Contrary to the findings of Joachim et al., (2009) who reported a 
 
 
 
 
131 
 
higher rate of GBS in women with no education, the highest rate of GBS colonization in this 
study was found in women with a high school qualification (96%).  
 
GBS colonization was also increased in women who were unemployed (62%) compared to those 
who were employed and more frequently isolated from women in the 26 – 30 year age group. 
Increased GBS colonization was reported from women aged > 20 years (Joachim et al., 2009; 
Dechen et al., 2010) while Kim et al., (2011); Mahboobeh et al., (2010); Maghaddam et al., 
(2010); and Rocchetti, et al., (2011) reported higher rates of colonization in younger women (< 
20 years). 
 
The highest prevalence of GBS was found to be among women who reported a vaginal discharge 
(38.0%) in this study, significantly supporting the theory that GBS should be considered a 
vaginal pathogen (El-Kersh et al., 2002; Donders et al., 2005; Nahaei et al., 2007). 
 
 
In the present study, no association was observed between smoking, alcohol consumption and 
GBS colonization. Smoking was considered to be one of risk factors associated with GBS 
colonization. But this was not in agreement with a study by (Nasri et al., 2013). Terry et al., 
(1999) which showed no significant difference in GBS in colonization between smokers and 
non-smokers. 
 
Other studies have associated the intake of alcohol during pregnancy with adverse pregnancy 
outcomes, including foetal growth restriction (Aliyu et al., 2009).  
 
In our studied population, parity was significantly associated with GBS colonization, unlike 
another study involving Turkish pregnant women, where parity was observed to be unrelated to 
GBS colonization (Kucukercan et al., 2005).  
 
Colonization rates were reported to be significantly greater among multi gravidity women than 
primi gravidity women (Orrett 2003; Shamila et al., 2011) but our study showed that GBS 
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colonization rate was lower 8/50 (16.0%) in women who had delivered four or more times and 
higher in primigravid women.  
 
In the current study, stressful life situations of the women also appeared to influence GBS 
colonization. Life changing events such as divorce, illness, injury, and passing of a family 
member cause stress which may threaten the maternal well being (Zhang et al., 2012).  
 
It has been suggested that the gastro-intestinal tract may be the primary site of colonization by 
group B streptococci (Stronati et al., 2004; Moghaddam 2010; Khan et al., 2011) and that 
vaginal colonization may occur through contamination from the rectum (Moghaddam, 2010). 
Swabbing of multiple sites, especially the lower vagina and anorectal region, increases the 
isolation rate (Aynur et al., 2005; Simoes et al., 2007).  
 
In the present study, several isolates were obtained simultaneously from both the vaginal and 
rectal specimens, and some were isolated only from either rectal (23/57) specimens or vaginal 
specimens. In similar study, swabbing both the vagina and rectum was found to increase the 
yield substantially compared with sampling either the vagina or the rectum alone (Sharmila et 
al., 2011). 
 
The fact that GBS was sometimes isolated from only one site and not the other shows how 
imperative it is to sample both anatomical sites (vagina and rectum) when screening for GBS 
carriage in pregnant women. The exclusion of rectal samples in our study would have resulted in 
false negative results in 40% of cases. Higher GBS detection rates in the rectum than the vagina 
have been previously reported (Moghaddam 2010). 
 
A limitations of culture includes the possibility of mixed culture resulting in the overgrowth of 
competitive species and the labour intensity. 
 
Molecular diagnostic techniques such as PCR have the advantage of rapidly identifying bacteria, 
which are difficult to grow and identifying newly emerging strains of bacteria (Bergeron et al., 
2004; Lavigne et al., 2012). The benefit of rapid reporting of bacteria in pregnant women can 
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significantly impact their pregnancy outcomes, and improve mortality rate (Lavigne et al., 2012) 
and allowing for a simpler and more efficient prevention programme, which is speedy, sensitive, 
and precise test (Ke et al., 2000; Manning et al., 2005; Riedlinger et al., 2010; Lavigne et al., 
2012). 
 
 
PCR offers a good alternative to culture in the absence of susceptibility testing (Vervi et al.2000) 
with 97% sensitivity and 100% specificity reported (Bergeron et al., 2000).  
 
In the present study, the sensitivity and specificity of the PCR assay were 100% respectively 
when compared with culture. The overall performance of the PCR assay shows acceptable 
negative and positive predictable values at 100% also.  
 
 
The use of Lancefield grouping as a confirmatory test for streptococci is well favoured with both 
sensitivity and specificity close to 100% (Platt et al., 1995; Guerrero et al., 2004).  
 
Lancefield grouping identified both GBS and E. faecalis, in this study once Lancefield groups 
were established, the isolates were subjected to Serotyping in order to identify the predominant 
serotypes in this population.  
 
Capsular serotype has been one of the mainstays in the explanatory epidemiology of the GBS 
(Jones et al., 2003). The polysaccharide capsule, which is the source for serotyping, is the most 
important known GBS virulence factor (Borchardt et al., 2004; Manning et al., 2005). Ten 
distinct capsular serotypes have been described in the classification of GBS (Ia, Ib, and II to IX) 
according to the immunologic reactivity of the polysaccharide capsule (Sellin et al., 2000; Jones 
et al., 2003; Lin et al., 2006; Ramaswamy, et al., 2006; Boswihi et al., 2012). Distributions of 
these serotypes differ by geographic location and study population (Borchardt et al., 2004, 
Boswihi et al., 2012). Although classified into ten distinct serotypes, 4 to 7% do not react with 
hyperimmune sera to the characterized capsular polysaccharides (CPS) and are referred to as 
nontypeable (Diedrick et al., 2010; Afshar et al., 2011). Nontypeability might be explained if the 
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isolate is a nonencapsulated variant and if the isolate produces an uncharacterized polysaccharide 
for which antibodies are not yet available (a new serotype). Nontypeability can also be described 
if the isolate has an insertion or a mutation in genes that are essential for capsule expression 
(Afshar et al., 2011). Human error must also be considered. 
 
Six different serotypes of GBS were identified in this study group with serotype V 
predominating, followed by serotype III. Three isolates were non-typeable. Serotypes Ib, VI – 
VIII were not present in our study despite being reported from other countries. Serotyoes Ia, II 
and IX were reported in lower numbers in our study, although Ia has been reported predominate 
in Finland and Sweden (Kalliola et al., 1999; Berg et al., 2000) and serotype II was reported to 
predominate in Asia (Turner et al., 2012). Serotype VI and VIII are the predominant serotypes 
reported in Japan (Lachenauer et al., 1999) and are rarely found elsewhere.  
 
Serotype III GBS strains are considered to be accountable for the majority of infections, in 
neonates worldwide (Jones et al., 2003; Manning et al., 2005; Melin 2011; Kiely et al., 2011). 
With invasive strains reported in Nairobi (Huber et al., 2011) and Soweto, South Africa 
(Madzivhandila et al., 2011). 
 
Eight women tested positive for GBS in both vaginal and rectal sites in this study and 5 out of 
the 8 women had identical isolates in both sites. The remaining 3 women were colonized with 
two different serotypes namely, serotypes III/IX, serotypes IV/V and serotype s III/V. 
 
 
7.2.3. Association of Enterococcus with pregnancy outcomes 
Enterococcus has been associated with PTD (Miedema et al., 2000; Hufnagel et al., 2007) and 
can be life threatening to the neonate (Maki 1988) with associated increased maternal morbidity 
and mortality (Gribby et al., 2008).  
 
Enterococcus was found to be the predominant aerobe along with E. coli in AV (Jahic et al., 
2013). Made up of > 40 species the most common enterococcal pathogens are E faecalis (80-
90% of enterococcal infections), followed by E. faecium (5-10%) (Murray 1990; Hidron et al., 
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2008). The cytolysin of E faecalis allows it to colonize different body sites, thereby contributing 
to its role in intrauterine infection and adverse pregnancy outcomes (van Tyre et al., 2013).  
 
Having emerged as a multi-drug resistant organism (Huycke et al 1998; van Tyne et al 2013; 
Multrick et al 2003; McBride et al., 2007), significant associations have been reported between 
multi – drug resistant enterococci and gestational age as well as birth weight (Hufnagel et al., 
2007). Newborns have been reported to be colonized with more enterococci from the first day of 
life. This could be problematic if the infant developed subsequent infection. Prevention strategies 
targeting adverse pregnancy outcomes are an important area of study if these adverse outcomes 
are to be reduced or eliminated.  
 
In the present study, E. faecalis was more frequently isolated from single than married women 
and more prevalent in black than coloured or white women. E. faecalis colonization was also 
more frequently observed in order women. 
 
No significant correlation was found between E. faecalis-associated AV and pregnancy 
outcomes. 
 
 
7.3. Prevention and Treatment of AV – associated adverse pregnancy outcomes 
Bacterial infection can be attributed to half of all placentas delivered before the end of the second 
trimester (Onderdonk et al., 2008). Most infections of the amniotic cavity are polymicrobial in 
nature (Steel et al 2005) with the vagina being the potential source of infection. Vaginal 
colonizers such as GBS and enterococci are transmitted from mother to infant intrapartum 
resulting in Early-onset sepsis (EOS) in the neonate within 6 hours of birth. Most cases of EOS 
are caused by GBS, Enterococcus and E. coli.  
 
Screening of pregnant women for BV/AV revealed that AV was more frequently detected than 
BV (Tomusiala et al., 2013). The failure of metronidazole treatment to prevent PTD in patterns 
with BV (Klebanoff et al., 2001; Odendaal et al., 2002) resulted in the use of broad spectrum 
antibiotics (Lamont et al., 2003; Ugwumadu et al., 2003; Larsson et al., 2006) to reduce PTB by 
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eliminating the overgrowth of organisms such as GBS and Enterococcus which have been 
implicated in AV, thought to occur as a result of improper treatment for BV (Donders et al., 
2002; Tansarli et al., 2013). The ability of GBS and E. faecalis to induce the production of toxic 
shock syndrome -1 (TSST - 1) suggested that women colonized by AV-associated bacteria 
would benefit from prophylactic treatment (McPhee et al., 2013) to prevent pregnancy 
complications (Hay et al., 1994; Carey et al., 2005; Rezeberga et al., 2008; Donders et al., 2009). 
 
Strategies to prevent GBS infection can be obtained by the elimination of exposure to GBS or the 
enhancement of the resistance of the host to the organism. Chemopromophylaxis and vaccines 
are the possibilities available to prevent GBS. 
 
Neonatal GBS infection is often prevented by identifying and treating pregnant women who 
carry GBS or who are at highest risk of transmitting the bacteria to newborns (Keenan 1998; 
Artz et al., 2003). One recommended approach for preventing the transmission of GBS from 
mothers to neonates is to screen pregnant women by culture of combined vaginal and rectal 
regions at 35 to 37 weeks of gestation and to treat empirically those with positive cultures or risk 
factors for disease transmission (Schrang et al., 2002; Brimil et al., 2006; Rabiee et al., 2006).  
 
Intrapartum chemoprophylaxis has greatly reduced the risk of neonatal infection in women who 
carry GBS (Uy et al., 2002; Borchardt et al., 2004; Verani et al., 2010), but despite these 
measures, GBS remains a leading cause of infectious neonatal morbidity in the world (Atkins et 
al., 2006). 
 
The Centers for Disease Control recommend that only mothers with history of previous PTD 
should be treated with antibiotics if found to have vaginosis or vaginitis, since previous PTD is a 
powerful indicator of risk for PTD (Romero 2004). 
 
In the present study, the Kirby – Bauer method of disc diffusion antimicrobial susceptibility was 
used. Zones of inhibition were used to classify isolates into susceptible, intermediate or resistant 
to a series of antibiotics and their MIC (minimum inhibitory concentrations) determined by using 
the Titretrel system.  
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Appropriate methods for susceptibility testing are very important because of reported resistance 
in strains that appear susceptible in broth susceptible tests. In this study the Kirby – Bauer disc 
diffusion method and TREK minimum inhibitory concentrations (MIC) methods were compared 
for agreement and where discordance was indicated, MIC was considered as the most reliable 
outcomes. PFGE was used to genotype sensitive and resistant strains. 
 
 
Antibiotic resistance patterns of 57 GBS strains were tested for their susceptibility to eight 
different types of antibiotics that have been recommended for eradication of carriage and 
treatment of invasive GBS diseases. 
 
Penicillin G remains the antibiotic of choice for the intrapartum prophylaxis for GBS (CDC 
2002) with erythromycin and clindamycin used as alternatives for those allergic to penicillin 
(CDC 2002; Simores et al., 2004; Sharmila et al., 2011). GBS has been frequently been reported 
to be susceptible to ampicillin (AMP) cefazolin, erythromycin, imipenem, norfloxacin penicillin 
vancomycin (Soares et al., 2013). 
 
GBS positive cultures isolated from colonized pregnant women demonstrated that few were 
resistant to penicillin (5%), erythromycin (2%) and clindamycin (2%). Although strains resistant 
to penicillin have been described in previous studies, they remain rare (Almedura et al., 2011; 
Nakamura et al. 2011). 
 
Resistance to clindamycin and erythromycin is on the increase and along with amoxicillin, have 
not been successful in reducing PTD (McGregory et al., 1990; Andrews et al., 2003; Goldenberg 
et al., 2006). 
 
The frequency of clindamycin and erythromycin resistance was very low in our study compared 
to those reported in other studies (Movales et al., 1999; Andrews et al., 2000; Castello-Filho et 
al., 2010; de Almida et al., 2011). With respect to resistance to clindamycin, resistance 
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frequencies of 4% to 19% have been reported (Simores et al., 2007) compared to the 2% from 
this study. This resistance has been attributed to specific serotypes. 
 
All the GBS strains isolated from the study population in the present study were resistant to 
fusidic acid (FC), while others were resistant to trimethroprim/sulphamethoxazole (98%), 
tetracycline (98%), and gentamicin (93%). Resistance to tetracycline, clindamycin, and 
trimethroprim/sulphamethoxazole has also been reported in asymptomatic GBS carriers (Soares 
et al., 2013). 
 
Resistance of GBS to tetracycline in our study population were similar to the results observed in 
other studies (Aynur et al., 2005; Duarte et al., 2005; Soares et al., 2013).  
 
 
Sulfamethoxazole, has been found to be associated with high risks of adverse pregnancy 
outcomes, such as birth defects, placental abruption, foetal growth restriction, and foetal death. It 
has also been reported that maternal exposure to this folic acid antagonist is harmful (Yang et al., 
2011). Resistance to sulphamethoxazole has also been reported in Brazil (Soares et al., 2013) 
and Crotia (Boris et al., 2003). In our study population, susceptibility to sulphamethoxazole was 
only found in three women, two of whom were HIV positive.  
 
GBS is a common cause of UTI recommended therapy being trimethroprim/sulphamethoxazole 
(Sweith et al., 2005). Our results stress the importance of epidemiological updates, particularly 
for those with penicillin allergies.  
 
A significant association was established between pregnancy outcomes and GBS antibiotic 
resistance patterns for cefotaxime (p = 0.000), ceftriaxone (p = 0.000), meropenem (p = 0.000), 
ertapenem (p = 0.000), erythromycin (p = 0.011), clindamycin, (p = 0.000), chloramphenicol (p 
= 0.012), daptomycin (p = 0.001), penicillin (p = 0.005), tetracycline (p = 0.44), vancomycin (p 
= 0.002) and azithromycin (p = 0.011).  
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It has been suggested that GBS resistance to antimicrobials is related to specific serotypes 
(Motlava et al., 2004). Different serotypes predominate in different population groups with 
associated antimicrobial resistances. Serotypes III, V, II, Ia and Ib are prevalent among pregnant 
women and neonates with EOD in USA and in Europe (; Kvam et al., 1995; Harrison et al., 
1998). Serotypes VI and VII are rarely found (Harrison et al., 1998). 
 
Serotype III and V are reported to be the most resistant (Oliviera et al., 2005; Soares et al., 2013) 
particularly to erythromycin and clindamycin (Fernandez et al., 1998; De Azavedo et al., 2001). 
In the present study, GBS serotype V was the most resistant with 26/38 showing resistance to 
penicillin, 24/38 resistant to erythromycin and azithromycin, 23/38 resistant to clindamycin, 
22/38 resistant to ertapenem, 20 resistant to cefotaxime, 19/38 resistant to daptomycin, 17/38 
resistant to vancomycin, 13/38 resistant chloramphenicol and few (3/38) resistant to 
trimethroprim/sulphamethoxazole. Both serotypes V and III were resistant to tetracycline, while 
serotype III demonstrated susceptibility to most of the other antimicrobials testes, as did Ia, II, 
and IX. How these antimicrobial profiles relate to the genetic heterogeneity of the GBS strains 
among and within serotypes, will be discussed later in this chapter in the section on PFGE. 
 
 
E. faecalis 
Of the 199 mothers whose pregnancy outcomes were available, 20 were colonized by E. faecalis. 
Of these, all showed susceptibility to tigecycline, 19/20 were susceptible to moxifloxacin, 17 to 
thrimethoprim/sulphamethoxazole, 17/20 to linezolid, 15/20 to chloramphenicol and 
vancomycin, 12/20 to levofloxacin. Only 2/20 were sensitive to clindamycin and erythromycin, 
demonstrating the increased resistance of E. faecalis to these antimicrobials. 
 
Total resistance was observed to ertapenem, cefotaxime, ceftriaxone, penicillin, meropenem, 
azithromycin. Of the 20 E. faecalis strains, 17 were resistant to tetracycline.  
 
PTD was associated with resistance to cephalosporins, ertapenem, meropenem, tetracycline, and 
penicillin in this study. Trimethroprim/sulphamethoxazole (co-trimoxazole) appears to be the 
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drug of choice for E. faecalis prophylaxis since most strains have demonstrated sensitivity, along 
with norfloxacin and ciprofloxacin (Peter et al., 1997; Delzell et al., 2000). 
 
Ampicillin and cefuroxime administration was reported as safe and effective for the prevention 
of infections following caesarian delivery (Ziogos et al., 2010). However, according to FDA, 
safety for use of amoxicillin, Ampicillin, augmentin, Cefuroxime, cephalexin has not been 
established with a recommendation that ciprofloxacin, catifloxacin, levofloxacin, and 
trimethroprim/sulphamethoxazole only be used if the potential benefit justifies the potential risk 
to the foetus. 
 
Like GBS, Enterococcus has frequently been isolated from asymptomatic mothers delivering PT 
and much controversy exists regarding the administration of antimicrobial agents to mothers with 
asymptomatic infections as a means of preventing preterm birth since there is little convincing 
evidence for this theory (Carey et al., 2000; Kenyon et al., 2001; Larsson et al., 2005). 
 
 
It is therefore advisable when antimicrobial agents are prescribed for prophylaxis, that not only 
the antimicrobial spectrum but also the presumed ecological disturbance on the anaerobic and 
aerobic vaginal and rectal microbiota should be taken into account (Tempera et al., 2010). 
Because of their very low impact on the vaginal microbiota, kanamycin or quinolones are 
considered to be a good choice for therapy (Boswihi et al., 2012). 
 
 
7.4. PFGE analysis 
Serotyping has for decades been of great significance in epidemiological studies of GBS disease 
and has more lately been supplemented by methods for molecular typing such as molecular 
finger printing PFGE and multi – locus enzyme genotyping (Moyo et al., 2002; Jones et al., 
2003). 
 
Molecular typing methods such as PFGE have distinct advantages over the original Serotyping 
methods in that it is far more reliable while also differentiating between strains of the same 
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serotypes (Blumberg et al., 1992, Fasola et al., 1993; Roland et al., 1999; Le Thomas-Bories, et 
al., 2001; Moyo et al., 2002; Thong et al., 2004).  
 
PFGE is extensively used, is a sensitive technique for subtyping strains, and has been used to 
define distinct clusters of specific genotypes that have significant value for epidemiological 
studies (Murray 2010) despite its limitations of being expensive and technically challenging.  
 
PFGE has turned out to be an influential tool for typing of diverse bacteria, both in relation to 
outbreak of infections in hospitals and also in the community (Skjaervold, et al., 2004; Benson, 
et al., 2002; de Almeida Correa et al., 2011; Thong et al., 2004). PFGE has furthermore been 
used for characterization of group B streptococci (Qasem et al., 2009), and compared with other 
typing methods to observe the discriminatory power when applied to strains that were 
epidemiologically unrelated (Moyo et al., 2002) or non-typeable (Benson, et al., 2002; 
Skjaervold et al., 2004).  
 
PFGE might be used to study reinfection by antibiotic resistant strains of group B streptococcus 
(Benson et al., 2002) and compares genomic DNA fragments after being digested with a 
restriction enzyme (Benson et al., 2001) yielding numerous linear molecules of DNA (Jordan et 
al., 2005). Comparing clonal strains would reveal that the sites at which the restriction enzymes 
act on the DNA and the length flanked by these sites would be the same (Le Thomas-Bories, et 
al., 2001). Alternatively, unlike strains would yield diversity at the sites at which the restriction 
enzymes act on the DNA and the length flanked by these sites (Le Thomas-Bories, et al., 2001). 
In the present study, DNA was digested by SmaI restriction enzyme and submitted to PFGE for 
definition of clonality. Isolates of a specific serotype and displaying identical or related PFGE 
profiles were assigned to the same cluster. 
 
In the present study, PFGE profiles have shown that a good number of the women studied were 
colonized by a single GBS strain and E. faecalis strain, although closely related strains may 
coexist in the vaginal and rectal samples collected from the pregnant women.  PFGE was very 
useful to distinguish amongst the isolates of GBS and E. faecalis. The PFGE analysis for both 
GBS and E. faecalis were clustered into three major clusters with the similarity of 60%. The 
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majority of the isolates in E. faecalis were susceptible to trimethroprin/sulphamethoxazole, 
moxifloxacin, chloramphenicol, levofloxacin, linezolid, tigecycline and vancomycin. The E. 
faecalis isolates were resistant to penicillin G, clindamycin, tetracycline, ertapenem, meropenem, 
daptomycin, azithromycin, cefotaxime, and ceftriaxone was also observed amongst the majority 
of the E. faecalis isolates. 
 
The PFGE profiles of all GBS isolates were distinguishable. The results also demonstrate the 
genetic diversity among the isolates from different body sites isolated from same individuals 
with 2 women who had two different serotypes also having different band patterns. 
 
Different PFGE types in the same individual may be due to mutation, co-colonization with 
strains from different sources (i.e. different sex partners or contamination). This is important 
when genotypic information is used to establish proof of epidemiological linkage in disease 
transmission (Thong et al., 2004). The same serotypes belonging to different women were 
genetically heterogeneous. Fewer GBS strains were genetically similar with 100% similarity and 
clustered together. Additionally, strains belonging to different women were genetically 
heterogeneous even though they had the same serotypes.  
 
 
7.5. CONCLUSION 
AV and its association with PTD has not been extensively studied, nor has its prevention and 
treatment received the attention it deserves. It has been suggested that it may play a more 
important role than BV in maternal and neonatal morbidity.  
 
The aim of the study was to detect the prevalence of AV and its association with preterm 
delivery in the Western Cape, South Africa. As well to identify and characterize the predominant 
facultative anaerobes implicated in AV. Furthermore, it sought to examine and investigate the 
predictive value of GBS and E. faecalis in PTD and determine the serotype distribution of GBS 
isolated from the women. It also aimed to establish whether maternal demography and 
reproductive history may predict current pregnancy outcomes. This aim was reached by 
establishing the risk factors which may contribute to preterm delivery. A significant association 
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between smoking, ethnicity, previous gestation time at delivery, personal hygiene, alcohol used, 
parity, gravidity and current symptoms of genito – urinary tract infection (such as urinary tract 
infection and vaginal discharge) and pregnancy outcome was observed in our studied population. 
 
Furthermore, this study has demonstrated the serotype distribution in GBS isolated from 
pregnant women with serotype V followed by serotype III as the dominant GBS serotypes 
amongst the colonized women in this studied population. 
 
Genetic and epidemiological relatedness defined strains for GBS and E. faecalis, into 24 GBS 
pulsotypes and 16 profiles for E. faecalis pulsotypes as follows: GBS serotype V strains had 18 
patterns, serotype III had 4 patterns and serotype IX had 1 pattern in the current pregnancy 
outcomes. The non-typeable strains had 1 pattern. The degree of genetic heterogeneity of GBS 
strains among and within serotypes is an indication of endemic nature of the isolates in this study 
population.  
 
Our results indicate that, the high prevalence of GBS colonization among pregnant women 
warrants for regular screening of this bacterium in women attending antenatal care. 
 
 
A speedy and reliable detection of GBS colonization and E. faecalis would benefit mothers, 
especially those with poor prenatal care during pregnancy, and also will permit more effective 
prevention of GBS infections. The development of a rapid test for detection would aid in the 
instant identification and management of women those with unknown GBS and E. faecalis status 
at the onset of labour or rupture of membranes. Prevention of neonatal GBS morbidity and 
mortality is directly related to the care the mother has received during the prenatal and 
intrapartum period.  
 
 
Limitations  
The limitation of the study was we could not manage to get access to all the folders of the 
women who participated. Also not all the women gave birth at the specific MOUs were they 
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initially receive the antenatal care and some also gave birth at home and their information about 
their current pregnancy outcomes were not recorded.  
 
 
Asymptomatic colonization present a challenge in that colonization may be largely transitory and 
may be intermittent or persistent, reaching a stable profile around 5 weeks prior to delivery 
(Motlava et al., 2004). We were only able to collect samples during the first trimester of 
pregnancy. Ideally sample collection should have been repeated at 35-37 weeks gestation (El 
Beitrie et al., 2005).  
 
As in Brazil, South Africa has a “coloured” population of racial miscegenation, complicating and 
precise association with race or ethnic group. 
 
Furthermore, we did not investigate birth interval in our study. Short interpregnancy interval has 
also been associated with PTD (Howard et al., 2013) due to insufficient time for the mother to 
recover from the stress of the previous pregnancy (Miller et al., 1991; Winkuist et al., 1992; 
Scholl et al., 2000; Smits et al., 2001)  
 
Previous infections are also self reported and often provided no indication if diagnosis resulted in 
treatment which may have impacted on pregnancy outcomes. 
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APPENDIX 2 (A) 
 
Sample number: _________________________________________________ 
Folder number: ____________________________ KMOU   MPP        GUG 
Residence: ___________________________________________________ 
Age: ____________ Grav: _____________ Para: ________________ 
Height:_________________ Weight: _________________ 
 
PAST OBSTETRIC HISTORY 
Year 
Gestation/Birth 
weight
1
 
Complication
s
2
 
Neonatal 
Outcome
3
 
        
        
        
Please code as follows: 
1. GESTATION/BIRTHWEIGHT 
500-999g 1 
1000-1499g 2 
1500-1999g 3 
2000-2499g 4 
2500g+ 5 
unknown 6 
2. COMPLICATIONS 
Extreme multi-organ 
immaturity 
1 
Hyaline membrane disease 2 
Intraventricular haemorrhage 3 
Necrotizing enterocolitis 4 
Pulmonary haemorrhage 5 
Hypoxic ischaemic 
encephalopathy 
6 
Meconium aspiration 7 
Septicaemia 8 
Pneumonia 9 
Unknown 10 
3. NEONATAL OUTCOME 
Neonatal death 1 
Admitted to NICU 2 
Discharged 3 
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PAST MEDICAL HISTORY 
Hypertension 1 
Diabetes 2 
Previous urinary tract 
infections 3 
Other 4 
If other, please specify: __________________ 
 
PAST SURGICAL HISTORY  
Myomectomy 1 
Ectopic 2 
Other uterine surgery 3 
Other non-gyneacological 
surgery 
4 
If 3, please specify: _____________________________ 
If 4, please specify: _____________________________ 
 
DEMOGRAPHIC & LIFESTYLE FACTORS 
 
MARITAL STATUS 
Single   Married   Separated  Divorced  
 
Other (Please specify) _________________________________________________________ 
 
HIGHEST LEVEL OF EDUCATION Please tick (√) the correct box 
G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 UNIVERSITY NONE 
                            
 
EMPLOYMENT  YES  NO 
If yes, please specify: ____________________________________________________________ 
 
SMOKING HABITS 
DO YOU SMOKE?          Y      N 
HOW MANY A DAY?     <10          10-20 >20 
HOW LONG HAVE YOU SMOKED? ______________________ 
DO YOU SMOKE DURING PREGNANCY? Y     N 
DO YOU USE TIK?          Y      N 
DO YOU USE ANY OTHER SUBSTANCES?         Y     N 
IF YES, PLEASE SPECIFY___________________________________ 
 
ALCOHOL USE 
DO YOU DRINK ALCOHOL          Y  N 
IF YES, WHAT DO YOU CONSUME? _________________________ 
HOW MANY DRINKS PER WEEK DO YOU DRINK? 
          <5  5-10          >10 
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DO YOU DRINK DURING PREGNANCY?  Y        N 
 
REPRODUCTIVE HEALTH 
HIV STATUS  POS  NEG  UNKNOWN  CD4____________ 
HAART___________ 
HAVE YOU VER BEEN TREATED FOR A SEXUALLY TRANSMITTED DISEASE?  
Y  N 
 
HOW MANY SEXUAL PARTNERS DO YOU HAVE CURRENTLY? ________________ 
IS THIS A NEW PARTNER?   Y  N 
CURRENT SYMPTOMS:  VAGINAL DISCHARGE  URINARY 
SYMPTOMS  
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PERSONAL HYGIENE  
BATH   SHOWER   HANDWASH 
OTHER ___________________________________________________________ 
 
DOUCHING  Y  N 
OTHER VAGINAL PRODUCTS? _______________________ 
 
UNDERWEAR?  NONE   COTTON  NYLON 
OTHER? ____________________________ 
 
 
PERINATAL HEALTH SCREENING 
 
1. Have you had some very difficult things happen in the 
last year? 
 
2. Are you pleased about your pregnancy? 
 
3. Is your partner supportive? 
 
4. Have you had problems with depression, anxiety or panic 
attacks before? 
 
5. Is your partner or someone at home sometimes violent 
towards you? 
Yes No 
Yes No 
Yes No 
Yes No 
Yes No 
 
For total, add all shaded areas that are marked  Total………… 
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APPENDIX 2 (B) 
 
CONSENT FORM FOR PARTICIPATION IN THE RESEARCH PROJECT 
 
 
Title of project: The frequency and characteristic of Group B Streptococci (GBS) in aerobic 
vaginitis (AV) and its association with pregnancy outcomes in a sample of pregnant women 
attending Maternity Obstetric Units (MOU) in the Western Cape 
 
 
Name of Researchers: Eveline Kaambo and Prof. Charlene W. J. Africa 
 
I,……………………………………………… (Full name), hereby consent to participate in the 
above mentioned research study. I fully understand the nature of the study, and have had all my 
questions answered by………………………………………………………. (name and rank). 
 
 
I understand that all information supplied by me will be strictly confidential. 
 
I further consent to have vaginal and rectal swabs taken from me by …………………………… 
(name and rank).  
 
These samples will be identified by a folder number only, and not by my name. 
 
Signed this…………………………..Day of………………………………2009, at Cape Town 
 
…………………………. 
Patient signature 
…………………………. 
Witness 
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APPENDIX 2 (C) 
INFORMATION SHEET 
Prospective participants are requested to read this information sheet carefully and to ask questions 
where necessary, before signing the attached consent form. This sheet must be detached and 
retained by the participant and the consent form filed for record. 
 
The vaginal microbiota is important for maintaining vaginal health and preventing infections of the 
reproductive tract. Women who are colonized with GBS, E. faecalis, and other AV-associated bacteria 
may causing adverse pregnancy outcomes. The aim of this study is to establish whether the prevalence of 
AV and its associated between bacteria can be linked to preterm delivery. 
 
The clinical procedure will entail the collection of samples from the vagina and rectum using cotton 
swabs. The samples collections are safe and will be carried out with the utmost care to ensure the comfort 
of the patient. 
 
Patients will be required to sign the attached form granting consent for the collection of swab samples and 
for the subsequent use of the samples and clinical parameters recorded. The patient will also be required 
to grant permission for her medical history to be disclosed. Participants will not be recorded by name, but 
samples and information will be coded to protect the identity of the individual. However, the coding will 
be used by the clinic to trace the individual if relevant information (as a result of the study) should be 
passed to her or her doctor. Permission will also be sought for the use of additional biological material 
collected in the clinic, which is usually discarded but which the researchers may find useful for future 
research. 
 
Participation in this study is voluntary and refusal to participate will not prejudice the treatment of the 
patient in any way. Consent to participate will be recorded by completing the attached form. Should 
individuals agree to participate and later change their minds, they may withdraw by calling the following 
person: Prof C. Africa, University of the Western Cape, Department of Medical Biosciences, Tel: 021 
9592342 
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APPENDIX 2 (D) 
 
In this particular study, Figure 1 illustrates a schematic for the isolation and identification of 
Gram positive cocci in vaginal and rectal swabs cultures that was used in this study (Fig. 1). Two 
selective methods for detection of GBS from vaginal and rectal swabs were tested for all swabs. 
 
For the reasons outlined in Chapter 1 the study focused on GBS for detailed characterization. 
 
GRAM POSITIVE COCCI
CATALASE TEST
STREPTOCOCCUS
ALPHA HEMOLYSIS
BACITRACIN
SENSITIVE RESISTANCE
STREPTOCOCCI 
PYOGENES
OTHER B – HEMOLYSIS 
STREPTOCOCCI (A, B, C, D)
LANCEFIELD GROUPING
GROUP B STREPTOCOCCI
BILE ESCULIN, CAMP 
TEST
ENTEROCOCCUS
GROUP D STREPTOCOCCI
STREPTOCOCCI FAECALIS
STREPTOCOCCI BOVIS
ANTIBIOTIC RESIST TO: B - LACTAMS, AMYNOGLYCOSIDES, 
GENTAMICIN, VANCOMYCIN, CHLORAMPHENICOL, 
TETRACYCLINES, MACROLIDES, LINCOSAMIDES, 
QUINOLORIES, STREPTOGRAMINS
STREPTOCOCCI SUIS
NEGATIVE
POSITIVE
STAPHYLOCOCCUS
DNASE
POSITIVE NEGATIVE
STAPHYLOCOCCI AUREUS
OTHER STAPHYLOCOCCI
B - HEMOLYSIS
 
Fig. 1: Procedure used for the isolation and identification and detection of Gram positive cocci from the vaginal and 
rectal samples from the pregnant women. 
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APPENDIX 2 (E) 
 
Table 7: EUCAST/ CLSI antibiotic susceptibilities of GBS isolates from both groups (N=57) 
  STP6F MIC (μg/Ml) 
 
RANGE 
Group B streptococcus 
 ANTIMICROBIC Susceptible Intermediate Resistant 
AMOXICILLIN/CLAVULANIC ACID 2- 16  μg/Ml - - - 
AZITHROMYCIN 
 
0.25 – 2 μg/Ml ≤0.5 μg/mL  > 1 μg/mL ≥ 2 μg/mL 
CEFEPIME 
 
0. 5 – 8 μg/mL -  - - 
CEFOTAXIME 
 
0.12 - 4 µg/mL ≤0.5 μg/mL  - -  
CEFTRIAXONE 
 
0.12- 2 µg/mL ≤0.5 μg/mL  - -  
CEFUROXIME  
 
0.5 – 4 µg/mL - - -  
CHLORAMPHENICOL 
 
1 – 32 µg/mL ≤ 4 μg/mL  > 8 μg/mL ≥ 16 μg/mL 
CLINDAMYCIN 
 
0.12 – 1 µg/mL ≤0.25 μg/mL  > 0.5 µg/mL > 1 µg/mL 
DAPTOMYCIN 
 
0.06 - 2 µg/mL ≤1 µg/mL - >1 μg/mL 
ERTAPENEM 
 
0.5 - 4 µg/mL ≤ 1 μg/mL  - > 1 μg/mL  
ERYTHROMYCIN 
 
0.25 – 2 μg/mL ≤0.25 μg/mL  0.25 - 0.5 
µg/mL 
≥ 1 µg/mL 
LEVOFLOXACIN 
 
≤0.5 – 4 µg/mL ≤ 2 μg/mL  >4 μg/mL  ≥ 8 µg/mL 
LINEZOLID 
 
0.25  – 4 µg/mL ≤  2 μg/mL  > 2 -4 μg/mL  > 4  
MEROPENEM 
 
0.25 – 2 µg/mL ≤ 0. 5 μg/mL  - >0. 5 μg/mL  
MOXIFLOXACIN 
 
1 – 8 µg/mL ≤ 1 μg/mL  2 μg/mL  ≤ 4 μg/mL  
PENICILLIN 
 
0.03 – 4 µg/mL ≤ 0. 25 μg/mL  - > 0. 25 μg/mL  
TETRACYCLINE 
 
1 – 8 µg/mL ≤2 μg/mL  >4 μg/mL  ≥ 8 µg/mL 
TIGECYCLINE 
 
0.015 – 0.12 µg/mL ≤0.25 μg/mL  > 0. 25 μg/mL  > 0. 5 μg/mL  
TRIMETHOPRIM/SULPHAMETHOXAZOLE 
 
0.5 – 4 µg/mL ≤ 1 μg/mL  > 1 - 2 μg/mL   > 2 μg/mL  
VANCOMYCIN 
 
0.5 – 4 µg/mL ≤ 2 μg/mL  - > 2 μg/mL  
The breakpoints were define by the EUCAST/ CLSI  
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APPENDIX 2 (F) 
 
Buffers used in this study 
 
10X TBE buffer 
108 g Tris, 55 g boric acid and 9.3 g EDTA. 
Dissolved and make up to 1 liter. Autoclave 
 
0.5X TBE buffer  
45mM Tris-borate (v/v) 
1mM EDTA (w/v) 
pH was adjusted to 8.3 
 
TE buffer  
10 mM Tris-HCl,  
1 mM EDTA(w/v) 
pH 8.0) 
 
Lysis buffer  
50 mM Tris: 50 mM EDTA, pH 8.0 + 1% Sarcosyl 
 
Ethidium Bromide (EtBr) 
1x (0.2 ml/ml glycerol and 5 mg/ml bromophenol). To dissolved shake it. 
 
Loading buffer 
0.25% (w/v) bromophenicol blue and 0.25% (w/v) xylene cyanol in 30% (v/v) glycerol in sterile 
distilled water. 
 
10X TE 
100mM Tris-Cl pH 7.5 
10mM EDTA 
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Dissolve 12.11 g Tris and 3.72 g of EDTA in 700 ml distilled water. pH was adjusted to 7.5 with 
concentrated HCL. The volume was filled up to 1 L before autoclaving.  
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